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ABSTRACT 
 
Background: As the elderly population in Britain continues to grow, so will the 
number  of  people  with  dementia.  Notably,  those  affected  will  include  an 
increasing  proportion  of  people  from  black  and  minority  ethnic  (BME) 
communities, as they too are reaching old age in large numbers. Preliminary 
studies  indicate  that  African-Caribbean  people  may  be  at  higher  risk  of 
developing dementia than the indigenous, white older population, although the 
findings  are  inconclusive.  It  has  also  been  hypothesised  that  an  excess  of 
dementia in this group may be related to an increased risk of hypertension and 
its ineffective detection or treatment. Hypertension and diabetes, also common 
in  African-Caribbean  people,  are  established  risk  factors  for  cerebrovascular 
disease and dementia. However, despite these findings, it has been observed 
that people from BME groups, including those of African-Caribbean descent, 
may  be  less  likely  to  have  their  dementia  treated  with  an  equitable  level  of 
resources.  
 
Aims and Hypotheses: The aim of this study is to enhance our knowledge 
regarding  dementia  and  its  risk  factors  in  older  African-Caribbean  people  in 
Britain. It tests the primary hypothesis that the prevalence of dementia is higher 
in  the  African-Caribbean,  than  the  white  British-born  older  population,  using 
General Practice lists in the London Borough of Haringey as sampling frames. 
The  study  also  tests  the  secondary  hypothesis,  that  dementia  in  African-
Caribbean  people  is  under-recognised  in  primary  care  and  that  the  rate  of 
referral  to  specialist  dementia  services  is  lower  than  that  in  the  white-British 
population. 
 
Methods: The study comprises a comparative cross-sectional and a medical 
notes survey. Five General Practices were recruited in Haringey, North London. 
From their practice lists, 218 African-Caribbean people and 218 white-British 
people aged !60 years were recruited and screened for cognitive impairment 
using culturally valid versions of the Mini Mental State Examination (MMSE). 
Those in either group who screened positive (scoring <26/30), were offered a 
standardised diagnostic interview and physical examination. Two independent 
assessors  blind  to  ethnicity,  used  this  information  to  diagnose  dementia 
according to operationalised criteria and from this, the prevalence of dementia   3 
was calculated for each group. Participants diagnosed with dementia, had their 
primary  care  medical  notes  scrutinised  for  documentation  of  cognitive 
impairment or dementia. Use of brief screening tools for cognitive impairment 
and referrals to secondary health care or social services were also recorded. 
The frequency of documented cognitive impairment, dementia and referral to 
specialist services were compared between the two groups. 
 
Results:  The  prevalence  of  dementia  was  higher  in  the  African-Caribbean 
(9.6%) than the white-British group (6.9%), and the difference was significant 
after controlling for age and socioeconomic status (OR=3.1; 95%CI=1.3 -7.3; 
p=0.012). African-Caribbean participants were on average two years younger, 
and  those  with  dementia  nearly  eight  years  younger  than  their  white-British 
counterparts. There was a significantly higher proportion of vascular dementia 
diagnosed in the African-Caribbean group, although the numbers were small 
and  participants  only  met  the  criteria  for  a  possible r a t h e r  t h a n  probable 
diagnosis.  There  were  higher  rates  of  both  treated  and  unrecognised 
hypertension  in  the  African-Caribbean  group.  A  history  of  hypertension  was 
associated  with  cognitive  impairment,  but  not  dementia.  The  rate  of 
documented dementia was 42% and referral to specialist dementia care 36% 
for all participants combined. The African-Caribbean group was at least as likely 
to  have  their  dementia  recognised  and  documented  in  primary  care  as  the 
white-British group. However, they were less likely to be referred to specialist 
dementia services, although the numbers were small and this finding was not 
statistically significant. 
 
Conclusions: There  is  now  strong  evidence  for  an  increased  prevalence of 
dementia in older African-Caribbean people in Britain and that this may occur at 
significantly younger ages than in the indigenous white population.  There is 
also some evidence for an excess of hypertension and vascular dementia in 
this  group.  These  findings  have  implications  for  service  provision  and 
preventative interventions. Although General Practitioners are at least as likely 
to recognise and document a diagnosis of dementia in African-Caribbean than 
white  people,  they  might  be  less  inclined  to  refer  them  for  specialist 
assessment.  This  warrants  further  investigation  in  the  form  of  a  qualitative 
study.   4 
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“I am thinking about my being black and growing old in Britain. Will 
my old age, I wonder, be a calamitous plunge deeper into the 
underclass, or simply part of the general heritage of the struggling 
old, regardless of race or class?”  
Beryl Gilroy (1994)   16 
1. INTRODUCTION 
 
 
1.1. SCOPE OF THE THESIS 
 
In my thesis, I will describe the study that I conducted during my Medical Research 
Council  (MRC)  research  training  fellowship  in  ‘Health  Service  Research’,  between 
September 2006 and October 2009; comparing the prevalence of dementia between 
older African-Caribbean people and their white counterparts. I will first ‘set the scene’ 
before describing in detail, the background to the study. 
 
Dementia is a national health and social care priority in Britain (section 1.2.4.3). Over 
recent years, there has been growing interest in dementia in Black and Minority Ethnic 
(BME)  people,  as  they  constitute  an  increasing  proportion  of  the  older  population 
(section  1.3.4). T h i s  i s  particularly  so for  black  people o f  A f r i c an  o ri g in ;  because  a 
relatively high prevalence of the disorder has been demonstrated in some community 
studies and because this may be partially related to an excess of vascular risk factors 
that are potentially amenable to preventative measures (section 1.5). Further research 
in this field will help us to understand the aetiology of dementia, identify preventative 
interventions, consider whether these minority groups have equitable access to health 
and social care  and therefore  allow for the planning of culturally sensitive services. 
These  questions  can  be  further  investigated  by  studying  older  African-Caribbean 
people  in  North  London,  where  a  large  number  reside.  Older  members  of  this 
community a r e  p r e d o m i n a n t l y  f i r s t  g e n e r a t i o n  i m m i g r a n t s ,  originally  from  the 
Caribbean, who came to the UK in the 1950s and early 1960s; invited to fill specific 
gaps in the labour force following World War II (section 1.4.2).   
   17 
People  of  African-Caribbean  descent  contribute  a  significant  proportion  of  the  total 
London population, particularly in some Boroughs in the South East, North and North-
West of the capital (section 1.4.4). For example, in the Borough of Haringey where this 
study is set, 11% of the population identified as being African-Caribbean or mixed race 
in the 2001 population census (ONS, 2003). This community is now ageing and many 
of its members have reached retirement, putting them in the age group where there is 
a  significant  risk  of  developing  dementia.  As  this  is  the  first  generation  of  African-
Caribbean people in this country to have reached old age, we know little about their 
needs pertaining to age related illnesses including dementia. Although a small number 
of cross-sectional studies conducted in Britain indicate a possible excess of dementia 
in  this  population,  the  findings  have  so  far  been  inconclusive  (Chapter  2).   I t  is 
therefore important to identify the scale of morbidity, unmet need and to plan for the 
future  if  we  are  to  ensure  access  to  appropriate  care,  given  the  potential  for  large 
numbers of people with dementia in this ethnic group. 
 
In  this  chapter,  I  will  discuss  the  term dementia,  its  different  definitions  and  briefly 
describe the main subtypes, clinical features, diagnostic criteria and risk factors. I will 
then  consider  relevant  epidemiological  aspects  of  the  disorder  including  the 
prevalence, both worldwide, in the UK and at different age groups as a baseline on 
which  to  compare  my  findings.  I  will  then  outline  relevant  reports,  policies  and  the 
recently  published  National  Dementia  Strategy f o r  E n g l a n d .  Next  is  a  section 
describing  health  and  dementia  in  older  BME po p ul a t io n s  in  Britain a n d  t h e n  m o r e  
specifically in the  African-Caribbean  community.  To  complete  the  picture,  I  will also 
consider  aspects  of  dementia  in  other  black  populations  of  African  origin  including 
prevalence  and  risk  factors.  This  is  illustrated  with  examples  from  the  extensive 
African-American literature from the USA and comparisons are made with the British, 
African-Caribbean  population.  Chapter  2 d e s c r i b e s  t h e  s y s t e m a t i c  r e v i e w  t h a t  I  
undertook to identify and synthesise the published literature on the rates of dementia 
and associated risk factors in the African-Caribbean population, living in the UK.   18 
In Chapter 3, I summarise the aims and hypothesis of the study and in Chapter 4, the 
methods employed for a cross-sectional survey that forms the basis of this thesis. As 
well as comparing estimates for the prevalence of dementia in older African-Caribbean 
and  white-British community participants, I examine the  documentation of  dementia 
diagnosis  by  general  practitioners  and  their  rates  of  referral  to  specialist  dementia 
services in the London Borough of Haringey. In Chapter 5, I report the findings from 
the study and describe the statistical analysis and finally in Chapter 6, I discuss the 
implications  and  limitations  of  the  study  followed  by  the  potential  for  further  work, 
before drawing my conclusions in Chapter 7. 
   19 
1.2. DEMENTIA 
 
1.2.1.  Definition and diagnostic criteria 
The word dementia comes from the Latin demens, which translates literally as ‘without 
mind’. The first reference to its common usage was in Blancard’s popular dictionary in 
1726.  There,  it  was  defined  as  ‘the  extinction  of  the  imagination  and  judgement’ 
(Blancard, 1726). The adjective demented however, appeared over 80 years earlier in 
the Oxford English Dictionary of 1644. A more modern dictionary definition of dementia 
would  be  of  ‘a  chronic  or  persistent  disorder  of  the  mental  processes  due  to  brain 
disease or injury’ (Oxford English Dictionary).  
 
There are many slightly different medical definitions of dementia. The recent National 
Dementia Strategy document (DoH, 2009), defined it as: 
 
“..  a  syndrome  which  may  be  caused  by  a  number  of  illnesses  in  which  there  is 
progressive  decline  in  multiple  areas  of  functioning,  including  decline  in  memory, 
reasoning, communication skills and the ability to carry out daily activities. Alongside 
this decline, individuals may develop behavioural and psychological symptoms such as 
depression,  psychosis,  aggression  and  wandering,  which  cause  problems  in 
themselves, which complicate care, and which can occur at any stage of the illness” . 
 
For  clinical  and  research  purposes,  mental  disorders  including  dementia,  can  be 
diagnosed according to sets of criteria stipulated by health or research bodies such as 
the W o r l d  H e a l t h  O r g a n i s a t i o n  (W.H.O,  1992) o r  A m e r i c a n  P s y c h i a t r i c  A s s o c i a t i o n  
(A.P.A, 1994)  (described below). Such criteria are often ‘operationalised’, in that they 
define  categorical  entities  according  to  a  series  of  precise  inclusion  and  exclusion 
statements.  This  allows  for  more  reliable  clinical  diagnosis  and  can  overcome  the 
problem of differences between regional or national classifications (Stengel, 1959).   20 
The  most  widely  accepted  operationalised  diagnostic  research  criteria  for  dementia 
include those set by the two main international diagnostic classification systems; the 
European  based International  Classification  of  Disease, currently in its 10th  edition; 
ICD-10:  diagnostic  criteria  for  research  (W.H.O,  1993a) a n d  t h e  N o r t h  A m e r i c a n  
Diagnostic and Statistical Manual, currently in its fourth, text revised edition; DSM-IV-
TR (A.P.A, 2000). Both sets of criteria have a number of common elements, but also 
some important differences outlined below.  
 
To  diagnose  dementia  according  to  ICD-10,  conditions  in  four  domains  must  be 
fulfilled: 
 
o  Objective  evidence  of  cognitive  decline,  affecting  both  memory  and  other 
cognitive abilities such as judgement or planning. 
o  Symptoms that should be present in the absence of clouding of consciousness. 
o  A  decline  in  emotional  control  or  social  behaviour  to  include  irritability, 
emotional lability, apathy or coarsening of social behaviour. 
o  Cognitive decline should have been present for at least six months. 
 
The ICD-10 criteria stipulate the need for a reliable informant history, which should be 
supplemented, if possible by neuropsychological testing. If the criteria for dementia are 
fulfilled, there is provision to classify this clinically as mild, moderate or severe. 
 
The  DSM-IV  criteria  could  be  considered  broader  than  ICD-10,  in  that  they  don’t 
specifically require an informant history, nor do they stipulate a minimum period for the 
presence  of  symptoms.  However,  like  ICD-10,  they  do  state  that  social  functioning 
must be affected.    21 
Again, four domains must be satisfied to make a diagnosis: 
 
o  The development of multiple cognitive deficits including memory and at least 
one of;  aphasia, apraxia, agnosia or disturbance in executive functioning. 
o  A significant decline in social or occupational functioning. 
o  That the deficits do not occur exclusively during the course of delirium. 
o  That the symptoms are not better accounted for by another psychiatric disorder 
such as depression or schizophrenia. 
 
The term ‘dementia’ alone is broad and implies a clinical syndrome, rather than any 
particular a e t i o l o g y  o r  p a t h o l o g i c a l  p r o c e s s .  T h e r e  a r e  h o w e v e r ,  s p e c i f i c  d e m e n t i a  
types,  synonymously  termed ‘ s u b t y p e s ’  a n d  a  n u m b e r  o f  d i a g n o s t i c  s y s t e m s  a n d  
criteria in use for each one.  Worthy of note, is that the prevalence of each type can 
vary considerably depending on the set of criteria being used. This is discussed further 
in section 1.2.3.1.  
 
   22 
1.2.2.  Dementia subtypes: Clinical features, diagnosis and risk factors. 
A clinical picture of dementia can occur at almost any age and can be caused by a 
number  of  underlying  and  sometimes  overlapping  disease  processes; 
neurodegenerative and vascular being the most common in old age (see table 1.1). 
Although  some  causes  are  potentially  reversible,  those  that  are  primarily 
neurodegenerative  or  due  to  cerebrovascular  disease  are  not,  and  are  usually 
progressive and incurable. The importance of accurate diagnosis is not only to identify 
and  treat  potentially  reversible  causes  of  dementia  (e.g.  hypothyroidism,  B12 
deficiency, syphilis), but for secondary prevention (e.g. treating vascular risk factors), 
symptomatic  management  of  the  condition  (e.g.  cholinesterase  treatment f o r  
Alzheimer’s disease) and to help patients and their family plan for the future. 
 
Table 1.1       Causes & types of dementia   (Foster, 2008) 
AETIOLOGY  EXAMPLES 
Primary 
Neurodegenerative 
Alzheimer’s disease, Dementia with Lewy Bodies, 
Frontotemporal dementia (including Pick’s disease), 
Parkinson’s disease, Multiple Sclerosis, Huntington’s disease 
Vascular  Vascular dementia; including multi-infarct dementia, post 
CVA, small vessel disease  
Infection  HIV/AIDS, Neurosyphilis, Creutzfeldt-Jakob and other Prion 
diseases. 
Toxins/drugs  Alcohol, recreational drugs, heavy metal poisoning,  
Metabolic  Vitamin deficiencies (B12, folate, thiamine), Wilson’s disease,  
Endocrine  Hypothyroidism, Addison’s disease 
Neoplastic  Primary or secondary neoplasms, para-neoplastic syndromes 
(especially bronchial carcinoma) 
 
Throughout  this  thesis,  I  will  be  referring  to  the  most  common  types  of  primary 
dementia found in older people in Britain, namely Alzheimer’s disease (AD), Vascular 
dementia  (VaD),  Dementia  with  Lewy  Bodies  (DLB)  and  Frontotemporal  dementia 
(FTD). Although it is not within the scope of this work to give detailed descriptions, I 
will,  using  Alzheimer’s  disease  as  the  comparator,  summarise  the  main  clinical 
features, diagnostic criteria and risk factors for each type in the following section.   23 
1.2.2.1.  Alzheimer’s disease 
World Alzheimer’s Day, 21
st Septem ber 2006, marked the centennial anniversary of 
Alois Alzheimer’s identification of the destructive condition that bears his name. It was 
in 1906, that Alzheimer identified an 'unusual disease of the cerebral cortex', which had 
affected  a  woman  in  her  early  fifties,  Auguste  Deter,  causing  memory  loss, 
disorientation, hallucinations, aphasia and ultimately her death aged only 55 (Thomas 
and O'Brien, 2001).  His  post  mortem,  histopathological examination  was the first to 
identify the characteristic amyloid plaques and neurofibrillary tangles, now associated 
with the condition (Alzheimer, 1907). Alzheimer’s disease (AD) is now recognised as 
the most common type of dementia, accounting for over 60% of dementia cases in 
Britain  (Knapp,  2007).  It  can  be  characterised  by  so  called  ‘cognitive’ a n d  ‘non-
cognitive’ s y m p t o m s .  T h e  f o r m e r  i n c l u d e  m e m o r y  i m p a i r m e n t  ( i n i t i a l l y  f o r  r e c e n t  
events), aphasia, apraxia, agnosia and executive dysfunction. The latter may include 
psychotic symptoms; delusions and hallucinations (often visual), disturbance in mood; 
depression, anxiety, lability of mood, and other behavioural problems such as apathy, 
agitation, aggression and wandering. It is common for patients to undergo significant 
physical deterioration including weight loss (Cronin-Stubbs et al., 1997). They may also 
exhibit neurological signs such as primitive reflexes relatively early on (Thomas and 
O'Brien, 2001). Later stages are often characterised by incontinence (initially urinary), 
gait  and  balance  abnormalities  and  eventually  dysphagia,  which  invariably  leads  to 
aspiration pneumonia and death. Although it is not uncommon for people with AD to 
die with the disease (from other causes) rather than from it, mortality has been shown 
to be higher than in people without dementia, even when matched for physical illness 
(Paradise et al., 2009b). 
 
As  for  dementia  in  general,  operationalised  criteria  have  been  developed  for  the 
accurate diagnosis of AD. For the purpose of this thesis I will refer to the most widely 
used  of these for  research, namely the ICD-10  diagnostic research criteria (W.H.O, 
1993b),  DSM-IV-TR  (A.P.A,  2000) a n d  N I N C D S -ADRDA  (National  Institute  of   24 
Neurological  and  Communicative  Disorders  and  Stroke  – A l z h e i m e r ’ s  D i s e a s e  a n d  
Related Disorders association) criteria (McKhann et al., 1984). In clinical practice AD is 
essentially  a  diagnosis  of  exclusion;  defined  by  gradual  and  progressive  cognitive 
decline  with features consistent  with core dementia criteria, in the absence of other 
possible causes. Both ICD-10 and DSM-IV are based on this premise (table 1.2) and 
are closely related to the more precise NINCDS-ADRDA research criteria, which has 
three  levels  of  certainty  for  diagnosis;  definite  (requiring  pathological  evidence), 
probable and possible AD (Appendix 3). 
Table 1.2    ICD-10 & DSM-IV diagnostic criteria for Alzheimer’s disease 
A  The general criteria for dementia must be met (section 1.2.1). 
B  The  course  is  characterised  by  insidious  onset  and  progressive  cognitive 
decline. 
C  The cognitive deficits are not due to: 
o  Other CNS conditions that cause progressive deficits in memory 
and cognition e.g. cerebrovascular disease, Parkinson’s disease. 
o  Systemic  conditions  known  to  cause  dementia  e.g. 
hypothyroidism, B12 deficiency, HIV. 
o  Substance induced conditions 
 
Identification of the predictors (risk or protective factors) for dementia is important, in 
that it can add to our knowledge regarding aetiology and pathology of the disorder, 
which  can  then  lead  to  the d e v e l o p m e n t  o f  n e w  t r e a t m e n t s .  A l s o  b y  i d e n t i f y i n g  
predictors,  preventative  interventions  can  be  developed  and  implemented.  If  risk 
factors differ between populations or ethnic groups, such interventions or treatments 
can be tailored to suit the needs of each individual group. With regard to AD, a large 
number  of  risk  factors  have  been  investigated.  The  most  widely  accepted  include 
demographic variables such as age, sex and education. I will discuss these along with 
vascular risks factors and will then briefly comment on the common genetic risk factors. 
Specific risk factors for dementia in African-Caribbean people will be considered further 
in section 1.5 and in the systematic review in Chapter 2.   25 
Age: This is by far the most important risk factor for the development of AD and of 
dementia in general. It has been estimated that both the incidence and prevalence of 
the disorder doubles for every five years increase in age during adult life (Gao et al., 
1998, Jorm et al., 1987, Hofman et al., 1991), although some studies have shown that 
the increase in rate slows down after age 90 (Ritchie and Kildea, 1995). The increase 
in dementia with age is pertinent to this study in that the African-Caribbean population 
in  Britain  has  a  younger  age  profile  than  the  indigenous  white  population  (section 
1.4.4). They would on this basis, be expected to have a lower prevalence of dementia. 
It is therefore necessary, to adjust any estimated differences in dementia prevalence 
between  ethnic  groups  for  age;  a  probable  confounder  of  the  relationship  between 
dementia and ethnicity. 
 
Sex: It is thought that AD is more common in women than men, although there is no 
known  sex  difference  in  the  prevalence o f  d e m e n t i a  o v e r a l l   (Gao  et a l . ,  1 9 9 8 ,  
Ruitenberg et al., 2001). It has been suggested however, that women simply live longer 
than men and are therefore at higher risk of the disorder. Men also have a higher risk 
of developing vascular dementia (section 1.2.2.2) and are less likely to be diagnosed 
with pure AD. Meta-analyses of incidence studies indicate that women are at higher 
risk of AD, particularly in the very old (Gao et al., 1998). It has been suggested that the 
sex difference may be due to postmenopausal changes in oestrogen and one study 
indicated that hormone replacement therapy (HRT) can delay the onset of AD (Kawas 
et al., 1997). Another study only found this effect with prior, but not current use of HRT 
(Zandi  et  al.,  2002).  However,  these  findings  are  controversial  and  have  not  been 
replicated  (Low  and  Anstey,  2006).  There  are  likely  to  be  confounders  of  the 
association between AD and HRT, such as socioeconomic status and education, which 
are known to be strongly related with HRT use (Finley et al., 2001). 
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Education: People of lower intelligence and educational attainment are thought to be at 
significantly higher risk of developing AD (Ott et al., 1999b, Stern et al., 1994). There 
are  two  commonly  cited  explanations  for  this.  The  first  are t h e  brain  reserve  and 
cognitive reserve theories; that people with larger brains and higher premorbid levels of 
intelligence (passive brain reserve) or those that make more use of their brains (active 
cognitive reserve) are better able to compensate for their impairment, hence delaying 
the onset of symptoms (Katzman, 1993, Stern, 2006, Stern, 2009). A recent systematic 
review found evidence that although education delays the onset of symptoms in AD, it 
does not lead to  earlier death after diagnosis (Paradise et al., 2009a).  The second 
explanation relates to cognitive testing, whereby screening instruments are said to be 
educationally  biased,  with  less  educated  people  more  readily screening  positive  for 
cognitive  impairment  (Brayne  and  Calloway,  1990).  The  same  principle  applies  to 
people from different cultural or ethnic groups, and screening instruments for dementia 
have  been  accused  of  being  ‘culturally  biased’,  especially  in  people  who’s  first 
language  is  not  English  (section  4.4.10.1). W h e t h e r  t h e s e  t e s t s  a r e  t r u l y  c u l t u r a l l y  
biased,  or  whether  the  difference  in  performance  relates  more t o  l a n g u a g e  a n d  
education is not always clear, although a number of culturally sensitive screening tests 
have been developed (section 4.4.10.1). 
 
Vascular risk factors: There is good evidence that vascular risk factors and disease, 
including hypertension, diabetes, dyslipidemia and obesity are linked to a higher risk of 
AD and other dementias in later life (Stewart et al., 1999, Stewart, 1998). The results of 
a  recent  study  indicate  that  these  factors  increase  the  risks  differentially  by  sex 
(Hayden et al., 2006). Whether the association with AD is causal is not entirely clear. It 
may be that vascular disease has a direct impact on Alzheimer’s pathology through 
amyloidogenesis s e c o n d a r y  t o  c e r e b r a l  i s c h a e m i a  o r  t h a t  c e r e b r o v a s c u l a r  d i s e a s e  
leads  to  cognitive  impairment  that  unmasks  an  unrelated  AD  at  an  earlier  stage 
(Stewart, 1998). Interestingly, a recent study failed to demonstrate a worse prognosis 
from AD after 18 months in participants with vascular risk factors compared to those   27 
without, except in those who had subsequent cerebrovascular events during follow up 
(Regan et al., 2006). 
 
AD has been shown to be associated with hypertension diagnosed decades before the 
onset  of  clinical  dementia  (Skoog  et  al.,  1996).  Paradoxically,  a  Swedish  cross 
sectional  survey,  demonstrated  that  lower  blood  pressure  (hypotension)  was 
associated with the later stages of AD, as well as other types of dementia (Guo et al., 
1996).  Raised total cholesterol (but not LDLs) has also been shown to be associated 
with AD decades later, with levels falling before the onset of dementia  (Notkola et al., 
1998). Finally, there is evidence that diabetes mellitus is a risk factor both for AD and 
vascular dementia, particularly in poorly controlled patients and those requiring insulin 
(Ott et al., 1999a). These findings have significant implications with regard to primary 
prevention, whereby the careful treatment of hypertension, hypercholesterolemia and 
diabetes  earlier  during  adult  life  may  reduce  the  risk  of  dementia  later  on  (section 
1.2.2.2). 
 
Genetic  risk  factors:   T h e  m a j o r i t y  o f  g e n e t i c  r i s k  s t u d i e s  f o r  d e m e n t i a  h a v e  b e e n  
conducted in  relation to  AD. Approximately  25-50% of people with AD will have an 
affected  first  degree  relative,  and  concordance  in  monozygotic  twins  has  been 
estimated  to  be  40-50%  (Pericak-Vance  and  Haines,  1995).  The  rarer,  early  onset 
familial variant of AD usually has an autosomal dominant mode of inheritance. Three 
susceptibility genes have so far been identified; the amyloid precursor protein (APP) 
gene on chromosome 21, presenilin 1 (PS-1) gene on chromosome 14 and presenilin 2 
(PS-2) gene on chromosome 1. These however, account for less than 2% of AD cases 
overall (Farrer et al., 1997). Worth noting is that people with Down’s syndrome (trisomy 
21), virtually all have pathological features of AD by their 4th decade although they do 
not all develop clinical dementia (Mann et al., 1986). This is presumably due to the 
extra copy of the APP gene on chromosome 21.  
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The more common, late onset AD does not result from a single gene mutation and is 
best considered to be a polygenic, multifactorial condition. The most frequent genetic 
risk factor currently known in this instance is the !4 allelic form of the Apolipoprotein E 
(Apo E) molecule. This plasma protein has roles in lipid transport and tissue repair with 
its  gene  located  on  the  short  arm  of  chromosome  19.  Of  the  three  common 
polymorphisms, the !2 allele is thought to be protective whilst !4 is a risk factor for AD. 
The original finding (Strittmatter et al., 1993) has been replicated in all ethnic groups, 
although the strength of its effect has been shown to be weaker in black people of 
African  descent  (Farrer et  al., 1997,  Morgan  et al., 1998).  The  precise  mechanism 
whereby the apoE4 protein influences the onset of AD is unclear, but those possessing 
the risk allele seem to develop clinical symptoms earlier, and have a heavier amyloid 
burden. The risk of disease is dose-related and age-adjusted odds ratios for AD have 
been estimated at 2.6 for !2/!4 heterozygotes, 3.2 for !3/!4 heterozygotes and 14.9 for 
!4/!4  homozygotes  (Farrer  et  al.,  1997).  It  is  important  however,  to  put  the  risk 
associated with ApoE !4 in context, in that nearly 50% of homozygotes for the allele 
will not have developed AD by age 90 and nearly 70% of people with AD, have no !4 
allele (Henderson et al., 1995).  
 
The association of ApoE with AD is strong and the finding has been readily replicated. 
One main obstacle to identifying novel genetic loci, is that to detect a more modest 
degree  of  association  with  disease,  large  sample  sizes  are  needed.  One  recent 
genome-wide association study of AD, attempted to overcome this by recruiting over 
16,000  participants  (Harold  et  al.  2009).  This  study  replicated  the  association  with 
ApoE but also observed associations at two loci not previously associated with AD; the 
CLU  (also  known  as  APOJ)  gene  on  chromosome  8  and  PICALM  gene  on 
chromosome 11. CLU encodes clusterin, a major brain apolipoprotein. PICALM codes 
for a ubiquitously expressed molecule which is predominantly found in neurones. It is 
involved in an essential step in the intracellular trafficking of proteins and lipids. 
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Other putative risk factors: A number of environmental factors have been put forward 
as possible contributory causes of Alzheimer's disease. Amongst the best known of 
these is aluminium, which has been found in the amyloid plaques and neurofibrillary 
tangles of AD brains at post mortem (Crapper et al., 1973, Crapper et al., 1976). One 
study found a higher incidence of AD in areas of the UK with higher concentrations of 
aluminium  in  the  drinking  water  (Martyn  et  al.,  1989).  However  the  evidence  is 
circumstantial and no causal relationship has yet been proved. As evidence for other 
causes continues to grow, the possible link with aluminium seems increasingly unlikely. 
The role of smoking and dementia has been similarly controversial, with some early 
studies showing a protective effect in AD and others suggesting that it is a probable 
risk  factor  (Ott  et  al.,  1998). A n  a n a l y s i s  o f  t h e  l a r g e  R o t t e r d a m  c o h o r t  f o u n d  t h a t  
current but not previous sm oking is associated w ith AD  and that the e f f e c t  is more 
pronounced in people w ithout the APOE 4
 allele than APOE 4 carriers (Reitz et al., 
2007). 
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1.2.2.2.  Vascular dementia 
The concept of vascular dementia (VaD) as a discrete entity has become increasingly 
controversial  over  recent  years  (Stewart,  2002b). This  is  partly  due  to  the  fact  that 
many risk factors for cerebrovascular disease are also risk factors for AD and that the 
two  so  often  coexist.  According  to  current  diagnostic  criteria,  clear  evidence  of  the 
former, excludes a diagnosis of the latter, although in clinical practice a diagnosis of 
‘mixed dementia’ is becoming increasingly common. Historically the classification has 
changed,  from  terms  such  as  ‘chronic c e re b ra l  h y p o p e r f u s i o n ’  t o  t he  re l a t i ve l y  new  
umbrella term ‘vascular dementia’. This simply refers to any clinical picture of dementia 
which  is  temporally  related  to  underlying  cerebrovascular  pathology.  This  can  be 
further divided into specific sub-types, which according to ICD-10 terminology include: 
vascular dementia of acute onset (usually following a stroke), multi-infarct dementia, 
subcortical vascular dementia, and mixed or unspecified types (W.H.O, 1993a). The 
risk of dementia after clinical stroke is high, particularly when associated with lacunar 
infarcts, those affecting the left cerebral hemisphere or territories of the left posterior or 
left anterior cerebral arteries (Tatemichi et al., 1993). Other rarer syndromes contained 
within this category include ‘Binswanger’s subcortical arteriosclerotic encephalopathy’ 
and  genetic  disorders  such  as  ‘cerebral  autosomal  dominant  arteriopathy  with 
subcortical  infarcts  and  leucoencephalopathy’  (CADASIL)  and  ‘Familial  British 
dementia  with  amyloid  angiopathy’.  The  clinical  picture  of  VaD  varies  considerably, 
depending on the type and area of the brain affected. However, it is likely to result in 
more ‘patchy’ cognitive deficits than that found in AD (Stewart, 2002a).  
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Current diagnostic criteria include those defined by ICD-10 (table 1.3), DSM-IV (table 
1.4)  and  the  National  Institute  of  Neurological  Disorders  and  Stroke ( N I N D S )  /  
Association  Internationale  pour  la  Recherche  et  l'Enseignement  en  Neurosciences 
(AIREN) research criteria (Roman et al., 1993) – (Appendix 3). Diagnosis of VaD is 
notoriously  difficult to  make  and clinical  diagnosis tends to poorly reflect  underlying 
pathology (Stewart, 2002b). The ICD-10 criteria for example, have been shown to be 
being highly selective (Wetterling et al., 1994) and the NINDS-AIREN criteria to have 
high specificity but low sensitivity following post-mortem examination (Holmes et al., 
1999). 
 
Table 1.3    ICD-10 Diagnostic criteria for vascular dementia 
A  The general ICD-10 criteria for dementia must be met. 
B  Deficits in higher cognitive functions are uneven (some functions affected and 
others relatively spared) 
C  Evidence for focal brain damage with at least one of the following: 
o  Unilateral spastic weakness of the limbs 
o  Unilateral increased tendon reflexes 
o  An extensor plantar response 
o  Pseudobulbar palsy 
D  Evidence from the history, examination or tests of significant cerebrovascular 
disease, which may be reasonably judged to be aetiologically related to the 
dementia 
 
 
Table 1.4    DSM-IV diagnostic criteria for vascular dementia 
A  The general DSM-IV criteria for dementia must be met. 
 
B  Focal  neurological  signs  and  symptoms  or  laboratory  evidence  of 
cerebrovascular disease that are aetiologically related to the disturbance must 
be demonstrated. 
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Risk factors for the common forms of VaD include advancing age, male sex, ethnicity 
(section 1.5) and vascular risk factors (Gorelick, 1997, Stewart, 2002a). The vascular 
risks are thought to be the same as those for cerebrovascular disease in general and 
commonly cited factors include hypertension, diabetes, hyperlipidaemia and smoking. 
These  have  received  increasing  interest  over  recent  years,  in  that  vascular  risk  is 
potentially modifiable and there is scope for both primary and secondary preventative 
interventions.  There  may  also  be  the a d d e d  b e n e f i t  o f  r e d u c i n g  t h e  r i s k  o f  o t h e r  
dementias  including  AD  (section  1.2.2.1). T h i s  s e n t i m e n t  h a s  b e e n  c a p t u r e d  i n  t h e  
recent  joint  American  Heart  Association/Alzheimer’s  Association  public  awareness 
campaign (http://www.alz.org/heartbrain), entitled  ‘what’s good for your heart, is good 
for your brain’. 
 
The  most  important  treatable  risk  factor  for  stroke  and  VaD,  and  that  which  has 
received the most attention is hypertension. As for AD, current evidence suggests that 
raised blood pressure in middle age is a predictor for VaD decades later, and its careful 
control early on, may prevent or delay the onset of clinical dementia. One large scale 
controlled  trial,  ‘The  Systolic  Hypertension  in  Europe’  (Syst-Eur)  trial  of 
antihypertensive  treatment  found  a  reduction  in  the  rates  of  stroke  and  dementia 
(Forette et al., 1998). Over a two year period, they demonstrated a 50% reduction in 
the incidence of dementia in participants who were treated. Other putative vascular risk 
factors for VaD include dyslipidaemia, diabetes, ischaemic heart disease and obesity 
(Hayden et al., 2006, Biessels et al., 2006). Worth noting, is that raised low-density-
lipoprotein (LDL) is  an  independent risk factor for VaD but not AD  (Moroney et al., 
1999). The association between smoking and VaD is less clear than with AD and no 
association with past or current smoking was found in the Rotterdam cohort (Reitz et 
al., 2007). 
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1.2.2.3.  Dementia with Lewy Bodies (DLB) 
Although  Frederick  Lewy  (1885-1950)  was  first  to  discover  the  abnormal  protein 
deposits  (Lewy  body  inclusions)  in  1914,  their  association  with  a  characteristic 
dementia  syndrome  was  not  recognised  until  the  1960s a n d  i t  w a s  n o t  c o m monly 
diagnosed until the 1990s. Lew y bodies are the neuronal inclusion bodies generally 
associated with Parkinson’s Disease, where they are found in sub-cortical structures 
including  the  substantia  nigra  and  locus  coeruleus.  In  DLB  they  are  found 
predominantly  in  the  cortex  and  are  also  found  at  relatively  high  rates  in  other 
dementias  and  in  approximately  2%  of  older  people  without  either  dementia  or 
Parkinson’s Disease (Smith et al., 1991). Their role in the pathology of these disorders 
is unclear, as is the relationship between DLB, Parkinson’s disease and Parkinson’s 
dementia. 
 
Because it is a relatively new diagnosis, DLB is not recognised in  ICD-10 or DSM-IV, 
although  it  is b r i e f l y  m e n t i o n e d  i n  t h e  D S M -IV-TR  under  Dementia  Due  to  Other 
General Medical Conditions. Consensus criteria for DLB were first published in 1996 
(McKeith et al., 1996) and later revised in 2005 (McKeith et al., 2005) – (Appendix 3). 
The  core  clinical  features  include  progressive  cognitive  impairment  which  fluctuates 
markedly  over  short  periods  of  time,  well  formed  visual  hallucinations  and 
Parkinsonism.  Other  features,  which  have b e e n  g i v e n  g r e a t e r  p r o m i n e n c e  i n  t h e  
updated criteria, include REM sleep behavioural disorder, severe neuroleptic sensitivity 
and functional neuroimaging changes (reduced striatal dopamine transporter activity). 
Repeated, unexplained falls, delusions and depression are also common. DLB is often 
characterised by a different neuropsychological profile than that in AD, with relatively 
well  preserved  short/medium  term  memory  but  significant  attention  deficits  and 
executive and visuo-spacial dysfunction (McKeith et al., 2005). 
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1.2.2.4.  Frontotemporal dementia (FTD) 
The  term  Frontotemporal  dementia  incorporates  a  spectrum  of  primary 
neurodegenerative disorders predominantly affecting the frontal and temporal lobes. Of 
these conditions, the most commonly described are Frontal lobe degeneration of non-
Alzheimer’s  type  (FLD),  Pick’s  Disease  and  the  dementia  found  in  Motor  Neurone 
Disease (MND). Also included with this group of conditions are progressive non-fluent 
aphasia and semantic dementias. The clinical presentation can sometimes overlap with 
frontal  variants  of  AD  and  in  some  cases,  AD  pathology  is  found  at  post-mortem. 
Although  FTD  is  the  fourth  most  common type  of dementia  overall  (Stevens et al., 
2002), pure Pick’s Disease is relatively rare, and is only found in 1-2 % of dementia 
cases at post-mortem compared to 7.5% for FLD (Gustafson, 1993). 
 
Clinically, FTD presents with significant personality change, executive dysfunction and 
behavioural  abnormalities.  It  tends  to  have  an  insidious  and  relatively  early  onset 
(mean  age  56  +/- 7 . 6  y e a r s )  a n d  a  r e l a t i v e l y  l o n g  d u r a t i o n  (Gustafson,  1993). 
Behavioural and emotional changes are nearly always present, and usually result in 
either lethargy/apathy or disinhibition. The latter can be particularly problematic when 
socially  or  sexually  inappropriate  behaviour  is  exhibited.  This,  when  combined  with 
poor judgement and an inability to plan ahead can lead to devastating complications 
with regard to social relationships, finances and the law. Interestingly, overt psychotic 
symptoms are significantly less common than with AD (Gustafson, 1993). 
 
A number of diagnostic criteria for FTD have been proposed over the past 15 years. 
The f i r s t  w e r e  t h e  L u n d -Manchester  criteria  (Brun  et  al.,  1994). O t h e r s  i n c l u d e  t h e  
consensus  criteria  (Neary  et  al.,  1998) a n d  m o r e  r e c e n t l y ,  t h e  c l i n i c a l l y  o r i e n t a t e d  
McKhann criteria  (McKhann et al., 2001) (Appendix 3). Neither ICD-10 nor DSM-IV 
includes FTD as a separate entity, although they do have diagnostic codes specifically 
for Pick’s Disease.   35 
1.2.3.  Epidemiology of dementia 
 
1.2.3.1.  Studies of dementia frequency – methodological issues 
The frequency of a disease or disorder is most commonly described in terms of point 
prevalence; ‘the proportion of individuals in a population who have the disease at a 
specific instance’ or incidence; ‘the number of new cases of a disease that develop in a 
population of individuals at risk during a specific time interval’ (Hennekens and Buring, 
1987). Prevalence is determined by both the incidence and the duration of survival with 
the disorder. This has practical implications for chronic conditions such as dementia, in 
that  even  a  modest  incidence  can  lead  to  a  high  prevalence  over  the  course  of  a 
lifetime.  This is borne out by the fact that the prevalence of dementia (all subtypes 
combined) almost doubles with every five year increase in age from 30 to 95 (Knapp, 
2007). 
 
There are a number of issues to be considered when designing or interpreting studies 
of  dementia  prevalence.  Prevalence  can  be  determined  in  one  of  two  ways;  case 
register studies and cross sectional surveys. The former is limited by the fact that it can 
only  identify  people  who  are,  or  have  been  known  to  services  with  a  diagnosis  of 
dementia. This would only include a minority of people with dementia, as most do not 
have a formal diagnosis (DoH, 2009). Cross-sectional studies or surveys on the other 
hand,  do  not  just  include  those  in  contact  with  services,  but  screen  a  sample  of 
participants  from  a  defined  population.  Difficulties  can  arise  when  screening  people 
with  low  educational  attainment  (Brayne  and  Calloway,  1990),  learning  disability 
(Strydom  et  al.,  2009) o r  w h o  a r e  n o n -English  speakers  (McCracken  et  al.,  1997). 
Another problem is that the prevalence of dementia tends to vary, depending on the 
diagnostic criteria used. In one study of 1879 elderly Canadians, Erkinjuntii et al. found 
the prevalence of dementia to vary considerably, depending on the diagnostic criteria 
used;  from  3.1%  (ICD-10 criteria) to  29.1% (DSM-III)  (Erkinjuntti et  al., 1997).  It  is 
therefore  difficult to compare prevalence studies directly unless they have used the   36 
same methodology. There are however a large number of dementia prevalence studies 
in the  literature  and  also a number  of  meta-analyses  which have  pooled data from 
similar studies (see section 1.2.3.2). 
 
1.2.3.2.  Global prevalence of dementia 
A  number  of  meta-analyses have pooled  dementia prevalence data from  European 
studies (Hofman et al., 1991, Lobo et al., 2000) and from studies worldwide (Jorm et 
al.,  1987,  Ritchie  and  Kildea,  1995,  Fratiglioni  et  al.,  1999).  Although  prevalence 
estimates vary considerably between individual studies, pooled age-specific rates are 
strikingly similar between the meta-analyses, and there is a clear trend for the rate to 
increase with age. As a guide, dementia prevalence (all types) has been estimated at 
0.7 -1.0% in 60-64 year olds, 2.8 - 4.1% in 70-74 years olds, rising to 11.1 – 13.6% in 
the those aged 80-84 years (Ritchie and Kildea, 1995, Jorm et al., 1987, Hofman et al., 
1991, Fratiglioni et al., 1999). One meta-analysis estimated the prevalence in those 
aged 90-94 to be 33% or more (Ritchie and Kildea, 1995). 
 
Estimates of dementia prevalence vary considerably worldwide, but for many regions, 
evidence from high quality epidemiological studies is lacking; particularly for most of 
Africa, South America and parts of Asia. A key publication in this respect is the Global 
prevalence  of  dementia:  Delphi  consensus  study, w h i c h  aim ed  t o  p r o v id e  dementia 
estimates  separately,  for  each  world  region  (Ferri  et  al.,  2005).  In  this  study,  12 
international  experts  were  provided  with  a  systematic  review  of  the  available  data. 
They were asked to calculate prevalence estimates for each five-year age band in 14 
regions, based on a combination of geography and patterns of mortality. For regions 
where data was scarce, the panel were asked to extrapolate from the existing data and 
give a best estimate. The group response for each region was then summarised as a 
‘mean prevalence estimate’. According to their findings, over 24 million people have 
dementia worldwide and they predicted that this is likely to double every 20 years to 
over 81 million in 2040. There was considerable regional variation in the prevalence of   37 
dementia, with lower rates in less developed regions, such as Africa and South Asia. 
The  authors  suggested  that  this  difference  could  be  due  either  to  methodological 
factors (e.g. under-detection in less developed regions), to lower survival with dementia 
or to lower levels of cardiovascular risk factors in poorer regions. Interestingly, despite 
the  lower  prevalence,  higher  absolute  numbers  of  people  with  dementia  live  in 
developing  countries,  and  this  is  likely  to  increase  significantly  over  the  coming 
decades (table 1.5). 
 
Table 1.5  Worldwide estimates for dementia prevalence & incidence for 2001 
with projections for 2020 and 2040* 
Proportionate increase with dementia 
(%) 
Region  Prevalence (%) 
at age " 60 yrs. 
Annual 
incidence per 
1000 people  2001-2020  2001-2040 
Western Europe 
 
5.4  8.8  43  102 
Eastern Europe 
 
3.8  7.7  51  169 
North America 
 
6.4  10.5  49  172 
Latin America & 
Caribbean 
4.6  9.2  120  393 
North Africa & 
Middle East 
3.6  7.6  95  385 
Western Pacific 
(developed) 
4.3  7.0  99  189 
China & developing 
western Pacific 
4.0  8.0  96  336 
Indonesia, 
Thailand & Sri 
Lanka 
2.7  5.9  100  325 
India & south Asia 
 
1.9  4.3  98  314 
Africa 
 
1.6  3.5  82  235 
Total 
 
3.9  7.5  74  234 
*Adapted from Ferri et. al., 2005 
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According to the Delphi consensus study (above), rates of dementia in Latin America 
and  the  Caribbean  are  similar  to  that  in  Western  Europe,  although  the  absolute 
numbers are likely to rise dramatically by 2040 (table 1.5). More recent publications 
from the region also indicate a prevalence of dementia that is equal to, or higher than 
that in Western Europe or the USA (Llibre Rodriguez et al., 2008b, Figueroa et al., 
2008). One large cross sectional survey of 3,657 people "55, living on the Caribbean 
coast of Venezuela, estimated the overall prevalence of dementia to be 8% (Molero et 
al., 2007). Another estimated the prevalence of DSM-IV dementia in Cubans "65 years 
to be 6.4% (Llibre Rodriguez et al., 2008a) . This ‘hidden epidemic’ has the potential to 
explode in the coming decades, in a region  with limited resources (Maestre, 2008). 
Worth  mentioning  however,  is  that  all  the  available  prevalence  data  from  the 
Caribbean, are from studies conducted in predominantly Hispanic rather than Black-
Caribbean populations (Cuba, Venezuela, Dominican Republic, Puerto Rico). I could 
only identify one small cross sectional survey from the  English speaking  Caribbean 
(Jamaica), which found 2.3% of over 60s to be severely cognitively impaired and 11.8 
% to have questionable cognitive impairment (Eldemire, 1996).    39 
1.2.4.  Dementia in the UK: Demographics, cost, reports and policy. 
 
1.2.4.1.  Demographics 
In  a  similar  Delphi  exercise  as  above,  it  was  estimated  that  in  the  UK  more  than 
700,000 people have dementia (570,000 in England) and with the population ageing, 
this number is likely to double in the next 30 years, to a projected 1.4 million in 2038 
(Knapp,  2007).  Approximately  15,  000  people  with  dementia  are  from  BME  groups 
(DoH, 2009) (section 1.3.4). By far the most common type in the UK is Alzheimer’s 
disease (62%) followed by vascular and mixed dementias (27%) (Knapp, 2007).  
 
 
1.2.4.2.  Financial cost 
People with dementia are heavy consumers, not only of health services, but more so of 
community and residential resources. It has been estimated that in the UK, nearly half 
of older people with cognitive impairment live in institutions, at a cost of £4.6 billion per 
year, 0.6% of the UK gross domestic product (Comas-Herrera, 2005). A more recent 
estimate  puts  this  figure  at  nearer  £6.8  billion  (Knapp,  2007).  Overall,  the  cost  of 
dementia already exceeds that of cancer, heart disease and stroke combined at an 
estimated £17 billion per year (£25,472 per person with dementia), with projected costs 
exceeding £50 billion per year by 2038 (Knapp, 2007). In spite of this, public funding 
for dementia research lags far behind that for other serious medical conditions. This 
may be because people with dementia have relatively low status in western society 
and that there is little kudos given to those working in the field (Warner and Butler, 
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1.2.4.3.  Government policy and the National Dementia Strategy 
The  British government  now  recognising the enormity  of the  problem, has  declared 
dementia to be a ‘National Priority’ for health and social services, and announced its 
National  Dementia  Strategy e ar l y  in  2 00 9 (DoH, 2009). Leading up to this  was the 
publication of a number of influential reports and guidelines, directly by the Department 
of Health and through various public and voluntary sector bodies such as the National 
Institute for Clinical Excellence (NICE), the National Audit Office (NAO), the Healthcare 
Commission and the Audit Commission (table 1.6). 
 
Table 1.6    Dementia reports & publications 
PUBLISHING BODY  YEAR  REPORT 
Department of 
Health 
2001 
 
2005 
 
 
2009 
National Service Framework (NSF) for Older 
People. 
Everybody’s Business – ‘Integrated mental 
health services for older adults: a service 
development guide’. 
Securing Better Mental Health for Older Adults 
National Dementia Strategy. 
 
Audit Commission  2000 
2002 
(revision) 
Forget Me Not: Developing Mental Health 
Services for Older People in England. 
National Institute 
for Clinical 
Excellence 
2001 & 2007 
2006 
NICE guidelines for cholinesterase inhibitors. 
NICE guidelines for dementia. 
National Audit 
Office 
2007  ‘Improving services and support for people with 
dementia’. 
KCL & LSE  2007  Dementia UK report. 
 
King’s Fund  2008  Paying the price. 
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One recurring theme is the need for early and accurate diagnosis of dementia and for 
early intervention. This was first highlighted in the Audit Commission’s ‘Forget Me Not’ 
report in 2000 (Audit-Commission, 2000), and then two years later in ‘Forget me Not 
2002’ (Audit-Commission, 2002). Standard Seven of the ‘National Service Framework 
for Older People’ also advocated a similar policy (DoH, 2001a), as did the National 
Audit Office’s 2007 report, ‘Improving services and support for people with dementia’  
(NAO, 2007). 
 
Despite the recommendation that local health and social services should review their 
arrangements for the early detection of dementia, assessment and access to specialist 
services, there has been criticism that little has changed. Everybody’s Business (DoH, 
2005b),  published  jointly  by  the  Department  of  Health  and  the  Care  Services 
Improvement Partnership (CSIP), did not introduce any new policies, but built on the 
service  models  outlined  in  existing  documents  such  as  the  NSF  for  Older  People 
(above) and Securing Better Mental Health for Older Adults (Philip, 2005). It provides 
guidance  on  how  to  develop  a  range  of  services  from  primary  care,  through  to 
specialist mental health services, as well as residential and day care facilities. There is 
specific  reference  to  memory  assessment  clinics  to  enable t h e  e a r l y  d i a g n o s i s  o f  
dementia and to integrated community mental health teams, whose role includes the 
management  of  people  with  dementia  with  complex  behavioural  and  psychological 
symptoms. Interestingly, it is based on the premise that coordinating services for older 
people  with  mental  health  problems  can  be  difficult,  as  they  tend  to  cut  across 
traditional social care, mental and physical health care boundaries. It states that the 
aim of the guide is to “ensure that older adults with mental health problems and their 
carers have their needs met, wherever they are in the system without encountering 
discrimination or barriers to access”.  
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Expressing  a  similar  sentiment,  is  the  joint  National  Institute  for  Clinical  Excellence 
(NICE)  /  Social  Care  Institute  for  Excellence  (SCIE)  guideline  for  dementia  (NICE, 
2006). It advocates integrated working across agencies and the provision of memory 
assessment services as a single point of referral for the early diagnosis of dementia. 
Also emphasised, is the need for memory clinics to avoid the labels of ‘mental illness’ 
or ‘psychiatry’ to reduce stigma and maximise the uptake of services. 
 
Another influential review highlighting the need for a national dementia strategy, was 
the  National Audit Office ‘Improving services and support for people with dementia’ 
report, published in July 2007 (NAO, 2007). The investigation examined “…what health 
and social care services are available for people with dementia and their unpaid carers 
and whether they are providing effective and good quality support; and the scope for 
better  use  of  resources  against  a  background  of  rising  demand”. T h e  r e p o r t  w a s  
compiled  from  data  provided  by  the  Alzheimer’s  Society  Dementia  UK  report  (see 
below)  and  from  focus  groups,  internet  web  forums  and  surveys  of  people  with 
dementia,  carers  and  professionals.  It  concluded  that  overall,  services  are  not 
delivering value for money to taxpayers or people with dementia and their families. Its 
findings are summarised as follows: 
•  Health and social care services are spending significantly on dementia.  
•  Spending is late – too few people are being diagnosed or being diagnosed early 
enough.  Early  interventions  that  are  known  to  be  cost-effective,  and  which 
would improve quality of life, are not being made widely available. This results 
in spending at a later stage on necessarily more expensive services.  
•  Services in the community, care homes and at the end of life are not delivering 
consistently or cost- effectively against the objective of supporting people to live 
independently as long as possible in the place of their choosing.  
 
Recommendations  included  amongst  others,  more  cross-agency  working,  case 
management and better day care provision for people with dementia.   43 
The ‘ Dementia  UK  report’    (Knapp,  2007),  detailing  the  prevalence  and  cost  of 
dementia, was commissioned by the Alzheimer’s Society and produced jointly by the 
London School of Economics and the Institute of Psychiatry, King’s College London. 
Although not a governmental report, it provides the most comprehensive, up-to-date 
summary of dementia in the UK and gives projections for the future. The document 
concludes with seven key recommendations: 
 
•  To make dementia a national priority. 
•  Increase funding for dementia research. 
•  Improve dementia care skills. 
•  Develop community support. 
•  Guarantee carer support packages. 
•  Hold a national debate on who pays for care. 
•  Develop comprehensive dementia care models. 
 
This report estimated that in total, there are nearly 11,860 people with dementia in the 
UK,  from  BME  communities.  This  however,  is  based  on  the  assumption  that  the 
prevalence in these groups is the same as for the general population and it may be an 
under-estimate.  Although  the  research  group  was  unable  to  calculate  the  projected 
increases in absolute numbers, they were able to predict with confidence, a significant 
increase  in  the  proportion  of BME  older  people with  dementia as compared to the 
general population. This is because the large numbers of people who migrated to the 
UK from the Caribbean, Indian sub-continent and China in the 1950s, 60s and 70s are 
now  entering  old  age  and  are  therefore  at  increased  risk  of  developing  dementia 
(section 1.3.4). 
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A  recent  King’s  Fund  Report  ‘Paying  the  Price:  The  cost  of  mental  health  care  in 
England to 2026’  (McCrone et al., 2008) provided detailed information on the current 
and the projected need for mental health services and the associated costs. This report 
covered all age ranges and included data for dementia and depression, the two most 
prevalent  mental  disorders  in  old  age.  A  particularly  strong  emphasis  was  given  to 
dementia and that dementia is the most costly of all mental disorders with a projected 
cost of £34.8 billion by 2026.  
 
In August 2007, Care Services Minister Ivan Lewis announced a one year programme 
to develop the first ever national dementia strategy and implementation plan. Drawing 
on  evidence  from  a  wide  range  of  reports,  working  group  recommendations  and  a 
series  of  over  50  stakeholder  events  involving  over  4000  people,  a  detailed 
consultation document was published in June 2008 (DoH, 2008). This was a key stage 
in  the  development  of  the  final s t r a t e g y  p a p e r ,  t h a t  w a s  f i n a l l y  p u b l i s h e d  o n  3 r d  
February 2009 (DoH, 2009). The 104 page document, details a 5 year plan to radically 
transform the quality of care for people with dementia and their carers. The current 
government has pledged an additional £150 million investment over the first 2 years, to 
support local services in implementing the plan.   
 
The strategy has three key themes:  
 
•  To improve awareness of dementia, both among the public and professionals. 
•  To promote early and accurate diagnosis and intervention. 
•  To deliver high quality care and support for dementia sufferers and their carers. 
 
These are addressed through 17, specific objectives. Particularly pertinent to this study 
are the first two: 
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•  Objective 1. Improving public and professional awareness and understanding 
of dementia: 
“Public  and  professional  awareness  and  understanding  of  dementia  to  be 
improved  and  the  stigma  associated  with  it  addressed.  This  should  inform 
individuals of the benefit of timely diagnosis and care, promote the prevention 
of  dementia,  and  reduce  social  exclusion  and  discrimination.  It  should 
encourage  behaviour  change  in  terms  of  appropriate  help-seeking  and  help 
provision.” 
 
•  Ojective 2. Good quality diagnosis and intervention for all: 
“All people with dementia to have access to a pathway of care that delivers: a 
rapid and competent specialist assessment; an accurate diagnosis, sensitively 
communicated  to  the  person  with  dementia  and t h e i r  ca r er s ;  a nd  t re a tm en t , 
care and support provided as needed following diagnosis. The system needs to 
have the capacity to see all new cases of dementia in the area.” 
 
The strategy report acknowledges that people from all ethnic backgrounds are affected 
by dementia and that the proportion of sufferers from BME groups are likely to rise 
significantly in the coming years.  There are several other references to minority groups 
throughout the document; for example that BME communities may need targeting in 
respect  to  public  information  campaigns,  and  may  require  ‘a  specifically  tailored 
approach’.  Also  stated  is  that  dementia  services  should  be  inclusive;  ‘working  for 
people of all ages and from all ethnic backgrounds’. 
 
I  discuss  government  policy  in  relation  to  mental  health  in  BME  people  further  in 
section 1.3.5. 
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1.2.5.  Detection and diagnosis of dementia in primary care 
As discussed in the previous section, a number of reports and government policies 
over the past decade, have emphasised the need for early detection and diagnosis of 
dementia in primary care (1.2.4.3). This allow s for access to treatm ent, planning of 
future care and to help individuals and their families come to terms with the prognosis; 
NSF for Older People (DoH, 2001a). The ‘Forget me not 2002’ report points out that 
failing to make an early diagnosis can result in a ‘crisis’ situation for the person with 
dementia and their families (Audit-Commission, 2002). By then it can be too late to set 
up  an  effective  package  of  supportive  care,  resulting  in  premature  residential  care 
home placement or psychiatric in-patient admission.  
 
There are a number of potential barriers to the early detection of dementia and access 
to specialist services. These can be explored using Goldberg and Huxley’s ‘pathway  to 
psychiatric c a r e   model’  (Goldberg  and  Huxley,  1992), w h i c h  s t a t e s  t h a t  t o  receive 
secondary  health  care, s e v e r a l  s e q u e n t i a l  s t a g e s  m u s t  b e  p a s s e d  a n d  p o t e n t i a l  
barriers overcome. The first stage is the appearance and recognition of an illness in the 
community, followed by consultation with the GP, identification and management of the 
illness by the GP, referral to secondary care and identification and management of the 
illness  in  secondary  care.  Factors  relating t o  the  patient,  their  family,  the  GP a nd 
secondary care service can all influence this pathway (Shah and Lindsay, 2005). In the 
following section, I will focus primarily on the patient/family/carer – GP interface. 
 
A significant finding from the Audit Commission’s survey, published in 2001 was that 
only 60% of GPs thought it important to look for signs of dementia or to make an early 
diagnosis (Renshaw et al., 2001). Little had changed in a review two years later (Audit-
Commission,  2002),  and  again  in  2007,  when  the  National  Audit  Office  stated  that 
dementia is poorly recognised and managed in primary care (NAO, 2007). The reasons 
why GPs may fail to recognise or diagnose early dementia are multiple and complex 
(Woods  et al.,  2003, Iliffe and  Wilcox,  2005).  Many  GPs  report  that  they have n o t    47 
received sufficient training, and ‘Forget Me Not 2002’ found that those who did have 
sufficient  training  were  the  ones  most  likely  to  favour  early  diagnosis.  Some  other 
explanations given for GPs not making an early diagnosis include; that they think that 
there  is  little  to  be  gained  in  the  absence o f  a d e q u a t e  s u p p o r t  s e r v i c e s  (Iliffe  and 
Wilcox,  2005),  that  they  find  the  experience  of  explaining  the  diagnosis  to  patients 
difficult (Glosser et al., 1985) and that sometimes they feel that this may do more harm 
than good because the family does not want to be confronted with the diagnosis (De 
Lepeleire et al., 1994). In one qualitative study, GPs stated that they prefer to use a 
‘problem solving’ rather than diagnostic approach, and they argued that “if the early 
changes  of  dementia  don’t  cause  problems,  then  why  not  wait  until  the  situation 
worsens?” (Iliffe and Wilcox, 2005). Following on from these findings have been trials 
of educational interventions and electronic decision support systems, which have been 
shown to improve detection of dementia in primary care (Downs et al., 2006). However, 
despite  some  success,  training  programmes  along  with  the  promotion  of  brief 
screening instruments for cognitive impairment have had limited impact over the past 
decade (Iliffe et al., 2009). It is likely however, that with the high profile of dementia 
following the announcement of the National Dementia Strategy (section 1.2.4.3), that 
GPs will be more aware of the disorder in the future and under increasing pressure 
from their patients or their families to refer them to specialist services. 
 
The  government  has  attempted  to  address  the  issue  of  early  dementia  diagnosis 
through policy, guidelines (section 1.2.4.3) and financial incentives. As part of the new 
general medical services (GMS) contract, implemented in April 2004, GPs have been 
financially rewarded for achieving a number of targets as set out in the Quality and 
Outcomes  Framework  (QOF).  The  2006/2007  revision  included  two, n e w  d e m e n t i a  
‘indicators’; to have set up a register of patients diagnosed with dementia and to have 
carried out a review of their care in the previous 15 months (DoH, 2006). The aim of 
this is to improve the care of vulnerable people with dementia, although currently there 
is no specific incentive to detect or diagnose new cases.   48 
It can be especially difficult for GPs to recognise dementia early on, in people from 
some  BME  groups  (Rait  and  Burns,  1998).  This  may  be  for  a  number  of  reasons 
including  language,  low  levels  of  education/literacy  and  problems  interpreting  rating 
scales or screening tools (Iliffe  et al., 2000). A  recent systematic review also found 
evidence that BME people with dementia tended to be more cognitively impaired at the 
point of referral to diagnostic dementia services in USA and Australia than the majority 
population  (Cooper  et  al.,  2009).  This  seemed  to  be  due  to  later  presentation  to 
services  rather  than  a  cultural  bias  in  screening  instruments  or  differences  in  pre-
morbid levels of education.  
 
The reasons why older people with cognitive impairment and their carers/family may 
fail to seek a diagnosis from their GP, and/or accept help from statutory services are 
equally complex. Commonly, people with dementia may not recognise their symptoms, 
or attribute them to old age (Pollitt, 1996). Their family or carers may similarly fail to 
recognise the symptoms as dementia and may be reluctant to address them; due to 
stigma, or out of respect for their loved one (Antonelli-Incalzi et al., 1992). A recent 
qualitative study found that compared to a minority of white-British participants, most of 
the  South  Asian  and  half  of  the  African-Caribbean  participants  held  a  ‘traditional 
ideology’  of  caring.  This  meant  that  they  ‘conceptualised  caregiving  as  natural, 
expected  and  virtuous’  and  were  less  likely  to  seek  help  from  statutory  services 
(Lawrence et al., 2008). Other factors contributing to patients and family members not 
seeking  help  include:  the  belief  that  nothing  can  be  done;  lack  of  awareness  of 
available services; lack of awareness of access procedures for available services; the 
belief  that  available  services  are  inadequate,  inaccessible  and  culturally  insensitive; 
previous poor experience of services (Shah and Adelman, 2009). Moreover, patients 
may  choose  to  consult  traditional  healers o r  r e s o u r c e s  f r o m  t h e i r  o w n  c o m m u n i t y  
before consulting GPs for their mental disorder.    49 
1.3. OLDER BLACK & MINORITY ETHNIC POPULATIONS IN BRITAIN  
 
1.3.1.  Definitions 
First I will define what is meant by ‘Older Black & Minority Ethnic (BME)’ populations or 
people, but in order to do so, I need to define the terms ethnicity, race and culture and 
then consider what older or elderly means in this context. 
 
The term ethnicity tends to be used interchangeably with race and culture, although 
their meanings are quite distinct. Race, describes physical appearance (Bhopal, 1997) 
and has been used historically to distinguish between groups of people. Although it is 
sometimes understood to imply distinct biological differences, such differences are far 
greater between individuals than between groups or populations. The term is a social 
rather  than  biological  construct  and  not  scientifically  meaningful  or  reliable.  False 
assumptions regarding racial attributes can lead to stereotyping and ultimately to ‘racial 
prejudice’ or ‘racism’ (Smedley and Smedley, 2005),  
 
Culture, refers to “the customs, civilisation and achievements of a particular time or 
people”  (Oxford  English  Dictionary)  and  describes  the  features  that  bind  individuals 
together into a community. Keesing and Strather defined culture as “systems of shared 
ideas, systems of concepts and rules and meanings that underlie and are expressed in 
ways that human beings live” (Keesing and Strathern, 1998). 
 
Ethnicity i s  m o r e  t h a n  j u s t  r a c e  o r  c u l t u r e  a n d  i s  h a r d e r  t o  d e f i n e .  I t  d o e s  i n c l u d e  
components  of  both,  but  combined  with  other  characteristics  such  as  traditions, 
language, religion, spirituality, upbringing, nationality and ancestral place of origin (Rait 
and  Burns,  1997).  Ethnic  identity “includes  a  people’s  sense  of  shared  history  and 
origins,  and  of  a  common  destiny”  (Pool  and  Geissler,  2005).  Importantly it is self-
defined and open to change (Smedley and Smedley, 2005). 
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Although within the United Kingdom, there is a shared British culture, there co-exist, a 
number  of  separate  cultural  and  ethnic  groups;  the  English,  Welsh  and  Scottish 
indigenous groups for example. In addition to the indigenous populations there are a 
number of what have been known as ‘minority ethnic groups’, more recently termed 
‘Black and minority ethnic (BME) groups’. These have been defined as ‘those with a 
cultural  heritage  distinct  from  the  majority  population’  (Manthorpe,  1993),  most 
commonly,  but  not  exclusively  black  people  of  African,  African-Caribbean  or  Asian 
descent. Notably, some other white groups are also considered to be ethnic minorities, 
including  the  Irish  population  in  mainland  Britain  and  certain  other  white  European 
groups. The government document, ‘Delivering Race Equality in Mental Health Care’ 
(DoH,  2005a) d e s c r i b e d  B M E  g r o u p s  a s  ’…  all  people  of  minority  ethnic  status  in 
England. It  does  not  only refer to skin colour  but to  people  of  all  groups  who  may 
experience discrimination and disadvantage’.  
 
The term older people, in this context, relates to people of retirement age i.e. over 60 
or 65 years of age. Although an arbitrary cut-off, this is of some practical value in that 
the prevalence and incidence of dementia is relatively low before the 6
th decade and 
increases  rapidly a f t e r  t h a t  (see  section  1.2.3).  W o r t h  n o t i n g  i s  t h a t  p s y c h i a t r i c  
services in the NHS tend to use 65 years as the cut-off for old age. 
 
1.3.2.  Demographics  
In the 2001 census for England and Wales, just under 8% of the total population (4.6 
million  people)  identified themselves  as coming  from a non-white, ethnic  minority or 
mixed  heritage  background  (ONS,  2003).  Indian  people  were  the  largest  minority 
group,  followed  by  Pakistani  people,  those  of  mixed  ethnic  backgrounds,  African-
Caribbean people, Black African people and Bangladeshi people. Irish people account 
for an additional 1.2% of the population. The remaining minority ethnic groups each 
accounted for less than 0.5 per cent each, but combined accounted for a further 1.4 
per cent of the population.    51 
Just over seven percent of all people aged 65 years of age and above came from BME 
groups, with an estimated total of 531, 909 (Shah, 2007). Conversely, the proportion of 
BME people over the age of 65 years has increased progressively over the decades, 
from 1% in 1981 to 3% in 1991 and 8.2% in 2001 (Shah, 2007). After the indigenous 
white population, those ethnic groups with the highest proportion over 65 years include 
the Irish and African-Caribbean communities (table 1.7).  
 
Many BME communities reside in urban areas and it is thought that London’s elderly 
BME population will have tripled between 1991 and 2011, reaching over 25% of over 
65 year olds in some boroughs (Lowdell et al., 2000) (fig. 1.1). The greatest increase 
will be among those of African-Caribbean origin, with large numbers currently in the 40-
64 year old cohort, soon graduating to the over 65 year range (fig.1.2 and section 1.4). 
 
Table 1.7  Demographic Summary from the 2001 Census  (Shah et al., 2007) 
Ethnic group 
Proportion (%) 
aged over 65 
years 
* Ratio of “young 
old” to “old old” 
Male to female sex 
ratio 
Total Population  15.9  0.74  0.73 
White British  17.1  0.73  0.72 
All BME groups  8.2  -  - 
Irish  24.9  0.82  0.72 
Other white  10.4  0.75  1.08 
Indian  6.6  0.85  0.99 
Pakistani  4.1  0.88  1.24 
Bangladeshi  3.23  0.93  1.96 
Other Asian  5.18  0.86  1.11 
African-Caribbean  10.6  0.89  1.05 
Black African  2.3  0.97  1.05 
Other black  3.18  0.82  0.96 
Chinese  5.13  0.87  0.87 
Other BME groups  2.9  0.83  0.76 
* Defined as 65-79 years and 80 years and above respectively.  52 
Figure.1.1 
 
HARINGEY   53 
Figure 1.2 
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1.3.3.  Socioeconomic and health inequalities 
Ageing is associated with increased vulnerability to both medical and socioeconomic 
adversities  and  older  BME  people  are  at  high  risk  of  exposure  to  established  risk 
factors for  mental illness such as financial strain, poor housing, crime and physical 
disability as well as racism. The combination of old age and ethnic minority status was 
first described as ‘double jeopardy’ (Dowd and Bengtson, 1978). With the addition of 
socioeconomic  deprivation,  this  has  been  referred  to  as  ‘triple  jeopardy’  or  ‘triple 
whammy’ (Norman, 1985, Rait et al., 1996). From these concepts, a model of ‘multiple 
jeopardy’ has been developed to include multiple disadvantage due to ageism, sexism, 
racism,  low  socioeconomic  status  and  poor  access  to  health  and  social  services 
(Boneham, 1989). It is known that in many cases older BME communities are under-
represented  in  their  use  of  secondary  health  care,  although  levels  of  contact  with 
primary  care  and  social  services  are  similar  to,  or  higher  than  the  indigenous 
population (Livingston et al., 2002, Nelson et al., 2004). This inequality in access has 
also been shown to include old age psychiatric and dementia services (Rait and Burns, 
1997, Lindesay et al., 1997, Shah and Dighe-Deo, 1998). One explanation for this is 
that  older  BME  people  do  not  make  use  of  many  statutory  and  voluntary  services 
because  they  perceive  them a s  b e i n g  f o r  t h e  m a j o r i t y  w h i t e  p o p u l a t i o n  a n d  b e i n g  
insensitive  to  their  needs  (Norman,  1985).  Alternatively,  it  may  be  that  General 
Practitioners are less likely to detect some illnesses in BME groups or refer them to 
secondary health services (section 1.2.5). 
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1.3.4.  Dementia in BME populations 
As the common dementias are predominantly diseases of old age, and as the elderly 
BME population in Britain continues to grow, so will the numbers of BME people with 
dementia.  Forward  planning  for  funding  and  development  of  dementia  services  is 
therefore essential, if demand is to be met. One recent study estimated the absolute 
number of cases of dementia in the BME population to be 11, 860 in the UK in 2004 
(Knapp, 2007). Another study estimated the absolute number of cases of dementia to 
be between 7 270 and 10 786 and of depression between 33 559 and 52 980 among 
older BME people (Shah, 2008). It is important to develop mental health services that 
are  accessible  and  culturally  sensitive  to  the  needs  of  all.  This i s  n o w  w i d e l y  
recognised and has been highlighted in a number of influential publications (section 
1.3.5).  
 
As alluded to earlier, people from BME groups are thought to be under-represented in 
their use of specialist dementia services. A report commissioned by London Borough of 
Haringey Social Services and the Alzheimer’s Society found statutory services were 
failing  to  reach  people  with  dementia  and  their  carers  from  certain  BME  groups 
including  the  African-Caribbean,  Indian  Gujarati  and  Irish  communities  (Weir  and 
Wharrad, 1998).  It highlighted the lack of awareness regarding dementia and stigma 
attached to the diagnosis across these ethnic groups. Its recommendations included 
the need for better information on dementia services and how to access them and the 
development  of  multi-ethnic  (rather  than  ethnically  separate),  culturally  sensitive 
services.  It  also  suggested  providing  alternative,  more  open  methods  of  access  to 
services other than through GPs. 
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1.3.5.  Reports and policy   (See publication CR156 - Appendix 2) 
Over  the  last  decade,  the  mental  health  of  BME  people  of  all  ages  has  become  a 
national priority in the UK, as highlighted by the government’s ‘Delivering Race Equality 
in Mental Health Care’ strategy (DoH, 2005a). When coupled to increasing awareness 
regarding dementia and depression in old age, issues pertaining to the mental health of 
older  people  from  BME  groups  have  become  increasingly  prominent.  A  number  of 
reports have been published in relation to mental health in the BME population. These 
can  broadly  be  divided  into  publications  relating  to  BME  people’s  mental  health  in 
general, and those relating to the mental health of older people, with specific mention 
of BME and cultural issues.  
 
Primarily relating to ‘working aged adults’ (18-65 years), the ‘NSF for Mental Health’  
published in 1999 was one of the first governmental policy documents to acknowledge 
disparities between BME groups and the majority white population, in rates of mental 
illness and inequalities in mental health service provision. The report states that mental 
health services should be appropriate to the needs of those who use them and non-
discriminatory. Although not addressing the issues in detail, it did highlight the need for 
a  national  strategy  to  address  the  mental  health  care  needs  of  BME  groups.  This 
initiated the political momentum that led to the government’s ‘Delivering Race Equality’ 
policy. 
 
The NSF for Older People was published by the Department of Health in March 2001 
(DoH, 2001a). It‘s aim  was to set standards for the health and social care of older 
people  by  targeting  a  number  of  key  areas.  Standard  seven  is  concerned  with 
promoting good  mental  health in older people  and specifically  with the treatment of 
dementia  and  depression.  The  standards  for  other  functional  illnesses  such  as 
schizophrenia are not specifically mentioned but are covered by the NSF for Mental 
Health (see above). The document states that: “older people from BME communities 
need  accessible  and  appropriate  mental  health  services”.  It  covers  a  number  of   57 
reasons why this might not be the case, indicating that assessments may be ‘culturally 
biased’ and that assumptions are sometimes made about the willingness of families to 
act as primary carers for their older relatives. Also mentioned is that information about 
services  may  not  be  readily  available  in  an  accessible  form  and  tends  to  rely  on 
translated leaflets and posters. Although the document emphasises that mental health 
services should; “take account of the social and cultural factors affecting recovery and 
support”,  it  makes  few  specific  suggestions  as  to  how  cultural  awareness  might  be 
improved amongst mental health and social care professionals. 
 
In 2003, The National Institute for Mental Health in England (NIMHE) published the 
‘Inside  Outside’ r e p o r t  (Sashidharan,  2003).  This  document  was  one  of  the  first  to 
describe  in  detail,  the  ethnic  mental  health  inequalities  both  inside a n d  outside o f  
services.  Although  this  was  previously  recognised  as  a  problem,  it  had  not  been 
adequately  addressed  by  existing  mental  health  initiatives  such  as  NSF  for  mental 
health  or  NSF  for  older  people.  ‘Inside  Outside’  highlighted  the  need  for  a  national 
strategy to improve the mental health within BME communities and the care offered to 
them by mental health services. It recognised that the task would be complex and that 
progress  and  change  would  be  “dependent  on  an  inclusive  process,  involving 
politicians, policy makers, service providers from both statutory and voluntary sectors, 
service users and carers and most importantly, black and minority ethnic communities 
themselves.” The report went on to outline the key components that should be part of 
the strategy to eliminate mental health inequalities: 
 
•  Ensuring accountability and ownership in relation to black and minority ethnic 
communities. 
•  Developing a culturally capable service. 
•  Setting national standards to improve access, care experience and outcome. 
•  Enhancing the cultural relevance of research and development.   58 
Forget Me  Not, the Audit Commission’s analysis of mental health services for older 
people in England and Wales, was published in 2000 (Audit-Commission, 2000) and 
revised in 2002 (Audit-Commission, 2002). The report is consistent with the principles 
set out in the National Service Frameworks for Mental Health and Older People. It was 
largely welcomed by mental health professionals and helped to alleviate concerns that 
mental health in older people was being neglected by government (Benbow, 2000).  
 
There  is  specific  mention  of  the  needs  of  BME  groups  at  several  points  in  the 
document. Early on, reference is made to studies indicating that the age profile of BME 
groups  differ  from  the  general  population  (mostly  they  are  younger)  and  that  this 
depends on the particular pattern of migration to Britain. It is also states that rates of 
depression and dementia may be higher in some BME groups and it challenges the 
commonly held assumption that minority ethnic and black families “look after their own” 
and  have  less  need  for  services.  Finally  stated,  is  that  when  formal  services  are 
involved;  “they  may  be  insensitive  to  cultural  norms  and  may  threaten  carer’s  well-
being if they do not reinforce the carer’s role in an appropriate manner.”  
 
With  regard  to  day-care,  the  report  states  that;  “Older  people  from  minority  ethnic 
groups need special consideration, to ensure that appropriate services are provided for 
them.” Although the report did not go as far as suggesting separate services, it did 
recommend that this might require a change to the existing provision. Interestingly, it is 
quoted that BME user groups do not generally request separate day centers but ask 
only  for  mainstream  services  to  be  sensitive  to  their  needs  with  regard  to  food, 
language and arrangements for religious practice. 
 
Despite the extensive recommendations in this report, there is little addressing these 
issues  other than suggesting that information for users  and carers is  distributed “in 
languages  and  formats  that  can  be  understood  easily  by  local  people”.  There  is 
virtually no mention of BME groups in the 2002 revision.   59 
In  January  2005,  the  Department  of  Health  published  ‘Delivering  Race  Equality  in 
Mental Health  Care’ (DRE), a five-year action plan for  achieving racial equality and 
tackling  discrimination  in  mental  health  services  in  England  (DoH,  2005a).  The 
document  was  combined  with  the  government’s  response  to  the  recommendations 
made  by  the  independent  inquiry  into  the  death  of  David  Bennett,  a  38  year-old 
African-Caribbean  patient  who  died  in  a  psychiatric  unit  having  been  restrained  by 
staff.  The  DRE  policy  applies  to  all  those  with  BME  status  including those  of Irish, 
Mediterranean and East European origin and covers all age ranges from childhood to 
old age. It is based on three building blocks: 
 
•  More  appropriate  and  responsive  services  – s p e c i f i c a l l y  m e n t i o n i n g  t h e  
improvement  of  clinical  services  for  groups  including  older  people,  asylum 
seekers and children. 
•  Community engagement - aiming to engage communities in planning services 
with the recruitment of new Community Development Workers (CDWs). 
•  Better information – improved m onitoring of ethnicity, better  dissemination  of 
information  and  good  practice  and  a  new  regular  census  of  mental  health 
patients (see ‘count me in census’ below). 
 
The document acknowledges that older people from BME communities face the double 
jeopardy of old age and ethnic minority status, that they can be marginalised in society 
and have specific needs. Potential difficulties around communication and particularly 
written  language  are  highlighted,  as  is  the  need  for  services  to  provide  adequate 
interpretation facilities. It mentions that NHS Primary Care Trusts need to acquire ‘BME 
age-specific  expertise’  in  order  to  develop  culturally  appropriate  and  responsive 
services. This is to be facilitated by NIMHE in collaboration with the voluntary sector 
including Age Concern, Alzheimer’s Society and with the Policy Research Institute on 
Ageing and Ethnicity (PRIAE). 
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As stipulated in the ‘Delivering Race Equality in Mental Health’ action plan, March 2005 
saw the first national mental health ‘Count me in’ census (MHAC, 2008). The census is 
a count of all patients in  mental health and learning disability beds in England and 
Wales on one day and is scheduled annually until 2010. It is a joint initiative between 
the  Healthcare  Commission,  Mental  Health  Act  Commission  (MHAC),  CSIP  and 
NIMHE. The purpose of the census is to obtain reliable data on all mental health in-
patients with regard to their admission and demographics, including ethnicity, language 
and religion. This information is designed to assist healthcare providers in achieving 
the government’s DRE objectives. 
 
Data  published  from  the  first  three  censuses  showed  similar  findings.  In  the  2007 
census, 22% of in-patients were from BME groups although in the general population 
this is less than 10%. Admission rates were particularly high in people from African or 
African-Caribbean decent (9%) and they were more likely than average to have been 
referred  through  the  criminal  justice  system  and  to  have  been  detained  under  the 
Mental Health Act 1983. 
 
One criticism of the 2006 survey was that although one third of the 32 000 patients 
were over 65 years of age, no separate analysis was conducted for this age group 
(Shah and McKenzie, 2007). This was rectified for the 2007 census. The 2007 “Count 
me In “ survey of all psychiatric inpatients on 31
st March 2007 in England and Wales 
estimated that the standardised admission ratio (with the rate for England and Wales 
being the standard) for those aged 65 years and over were: higher in the white Irish, 
other white, other Asian, black Caribbean, black African and other black groups; lower 
in the white British and Chinese groups; and not significantly different in the Indian, 
Pakistani and Bangladeshi groups (Commission for Healthcare Audit and Inspection, 
2007). Similar findings were observed in the 2008 census.   61 
1.4. THE AFRICAN-CARIBBEAN POPULATION IN BRITAIN 
 
In the following section, I will consider in more detail, some aspects relating specifically 
to the African-Caribbean community living in Britain. This will include sub-sections on 
demographics, discrimination and racism, socioeconomic inequalities and health. First, 
it necessary to contextualise these with a brief history of African-Caribbean migration; 
from their origins in West Africa, to the Caribbean where they were taken during the 
slave trade and more recently to their journey back across the Atlantic to Britain. The 
purpose  of  this  section  is  to  ‘set  the  scene’  before  exploring  aspects  of  dementia 
pertaining to populations of African origin in section 1.5 and more specifically to the 
British African-Caribbean population in the systematic review (Chapter 2.) 
 
1.4.1.  Terminology 
The  current  preferred  term  ‘African-Caribbean’ r e f e r s  t o  b l a c k  p e o p l e  o f  C a r i b b e a n  
descent, whose ancestors originated in Africa. It is used interchangeably with ‘Afro-
Caribbean’  and  ‘West Indian’ w h i c h  i s  a  t e rm  st i l l  o f t e n  h ea rd ,  p a r t i cu l ar l y am on g s t 
older  members  of  the  black  and  white  communities  alike.  Official  government 
documents  and  statistics  including  national  census  data  classify  people  as    ‘Black-
Caribbean’ or ‘Black-British’. Confusingly, as immigration from Africa increased in the 
1990s, ‘African-Caribbean’ has also been used (incorrectly) to  include people of purely 
African (but not Caribbean) background. The broader term ‘African and Caribbean’ has 
been coined to refer to people of either heritage . Throughout the rest of this thesis, I 
will use the terms ‘African-Caribbean’ or ‘African and Caribbean’ where appropriate. I 
will also use ‘West Indian’ as a historical term, to refer to inhabitants of the West Indies 
(Caribbean) who may be from any ethnic background (section 1.4.2). 
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1.4.2.  A brief history 
The  Caribbean  is  a  region  consisting  of  the  Caribbean  sea,  it’s  islands  and  the 
surrounding  mainland  coasts.  The  islands  and  reefs,  of  which  there  are  more  than 
7000, are also known as the West Indies. They stretch in a long arc from the southern 
tip  of  Florida  to  the  north-Eastern corner  of the South American  mainland (Ridvan, 
2007). The original inhabitants included the Caribs and Arawaks, w ho w ere virtually 
extinct  within  a century  of  Christopher Columbus’ arrival in 1492. The islands were 
subsequently  colonised  by  European  settlers,  and  by  the  18th  century,  Britain  had 
acquired  much  of  the  territory.  Between  1500  and  the  early  1800s,  the  slave  trade 
satisfied the demand for cheap labour in order to cultivate crops such as tobacco, rice 
and sugarcane.  This  practice involved the trading of goods for  black slaves, mainly 
from  the  West  coast  of  Africa  (Congo,  Ghana,  Nigeria,  Liberia)  and  their  shipment 
under torturous conditions to the Caribbean. Many died from starvation, dehydration or 
disease during the long voyage across the Atlantic.  
 
Although slavery was abolished in 1834, the population of the Caribbean continued to 
grow during the nineteenth century and settlers from India, China and the Middle East 
added  to  the  ethnic  and  cultural  mix  of  the  region.  Despite  this,  the  Anglophone 
territories remained very much part of the British state, and there was no widespread 
drive for independence in most Caribbean islands until the late 20th century. Even by 
the 1950s, most ‘West Indians’, considered themselves to be British and saw England 
as the ‘Mother Land’. Many were fiercely patriotic and volunteered to join the armed 
forces (especially the  RAF) during  World  War II. The numbers  lost in combat  were 
high. However, for the first time young West Indians had the opportunity to visit Britain 
and many chose to return and settle after the war (Phillips & Phillips, 1998).  
 
Historically,  West  Indians  have  been  mobile  and  the  workforce  commonly  took  up 
offers of seasonal employment in the United States and South America, for example 
working on the Panama Canal. The most common destination for emigration before   63 
Britain  was  in  fact  the  USA,  until  strict  anti-immigration  legislation  (The  McCarran-
Walter Immigration Law)  was introduced  in  1952 (Jones,  1985). It  was  only after a 
failed  attempt  to  recruit  European  labour  following  World  War  II,  that  the  British 
government  encouraged  people  from  their  colonies t o  w o r k  i n  t h e  U K .  S e v e r a l  
campaigns actively recruited workers from the Caribbean. The 1948 British Nationality 
Act gave British citizenship to residents of Commonwealth countries and the right to 
settle in Britain (www.opsi.co.uk).  As follow ing the w ar, econom ic conditions in the 
Caribbean were extremely tough, many took up the offer of what they saw as a better 
life in the ‘mother country’ and emigrated to Britain, mainly to fill low paid jobs. They 
included those in manufacturing, public utilities and the health service. 
 
“Five hundred unwanted people, picked up by the trooper Empire Windrush after it had 
roamed the Caribbean, Mexican Gulf , and the Atlantic for 27 days are hoping for a 
new life. They include 430 Jamaican men. And there are 60 Polish women who 
wandered from Siberia, via India, Australia, New Zealand and Africa to Mexico, where 
they embarked in the Empire Windrush. The Jamaicans are fleeing from a land with 
large unemployment. Many of them recognise the futility of their life at home” 
(Daily Express, 21 June 1948). 
 
On  June  22nd  1948  the  famous  Empire  Windrush,  a  captured  German  troop  ship, 
docked in Tilbury docks carrying the first immigrants to the UK from the Caribbean. At 
that  time,  Britain  was  just  beginning  to  recover  from  the  war.  Housing  was  a  huge 
problem  and  stayed  that  way  for  the  next  two  decades  (www.bbc.co.uk/history). 
Although there was plenty of work, African-Caribbean people first clashed with the local 
inhabitants  over  the  issue  of  accommodation.  It  is  estimated  that  during  the  period 
1955-61,  approximately  142,800  people  emigrated  from  Jamaica,  5,000  from 
Barbados, 2,300 from Trinidad & Tobago, 3,500 from British Guyana, 3,500 from the 
Leeward  Islands,  8,200  from  the  Windward  Islands  and  8,700  from  the  remaining 
colonies (Rose, 1969).    64 
By mid-1962, over 300, 000 African-Caribbeans had settled in Britain (Jones, 1985). 
They initially chose to live in the main urban centres such as London and Birmingham 
and  Manchester.  New  legislation  (The  Commonwealth  Immigrants  Act,  1962) 
essentially  blocked  entry  to  Britain  other  than  for  dependants  or  those  with  work 
permits (Jones, 1985). Although there was an initial surge of immigration as people 
came to avoid the ban, this rapidly tailed off to no more than a trickle (Peach, 1998, 
Peach et al., 1988). 
 
1.4.3.  Discrimination and racism 
Since the arrival of the first migrants on the Windrush in 1948, the African-Caribbean 
community has experienced varying degrees of discrimination and racism, sometimes 
extreme. Initially, this was overt and new arrivals found employment and particularly 
housing denied to them on the basis of ‘race’. The jobs that were available to them 
were generally semi-skilled and low paid, often not in keeping with their level of skill or 
education.  This  downward  social  mobility  has  been  well  documented  (Smith,  1977, 
Heath and Ridge, 1983), Housing was in very short supply after the war, and the only 
options  available  to  new  migrants  consisted  of  renting  private  rooms  in  run-down 
areas,  often  at  an  over-inflated  price.  Their  concentration  in  poorer  areas  has  had 
serious consequences for them in terms of health and for their children’s education and 
future employment prospects. Although more subtle, discrimination still operates on a 
number of  levels.  Following the  murder  of teenage Stephen Lawrence in  1993, the 
Macpherson  Report  revealed  what  has  been  termed  ‘institutional  racism’  in  the 
Metropolitan Police Service (Macpherson, 1999). Macpherson defined this term as: 
 
“the  collective  failure  of  an  organisation  to  provide  an  appropriate  and  professional 
service to people because of their colour, culture or ethnic origin, It can be seen or 
detected in processes, attitudes and behaviour which amount to discrimination through 
unwitting  prejudices,  ignorance,  thoughtlessness  and  racist  stereotyping,  which 
disadvantages minority ethnic groups.”   65 
Other  institutions  including  the  education  system  have  similarly  been  accused  of 
racism. The Rampton Report (Rampton, 1981) and the Swann report (Swann, 1985) 
both disclosed that African-Caribbean children performed poorly in schools. By age ten 
many African-Caribbean children had fallen behind the national average and went on 
to achieve lower  examination grades.  This  was  particularly so for  black  males, and 
remains  so  today  (teachernet,  2004). T e a c h e r s  h a v e  b e e n  a c c u s e d  o f  h a v i n g  l o w    
expectations  of  black  children  and  of  not  encouraging  them.  Another  high  profile 
independent enquiry  was commissioned follow ing the death of David Bennett, a 38 
year-old  psychiatric  patient.  This  highlighted  racism  in  mental  health  services  and 
triggered  the  government’s  Delivering  Race  Equality  in  Mental  Health  Care  (DRE) 
action plan (DoH, 2005a). Paradoxically, mental health services have been accused of 
both over-treating black patients in relation to psychosis, (often compulsorily under the 
mental health act) and under-treating them in terms of other mental illnesses, including 
depression  and  dementia  (sections  1.3.3,  1.3.4  &  1.4.5.2).  These  allegations  have 
been  controversial and it is important to view them in relation to the prevalence of 
specific mental disorders in each BME population. 
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1.4.4.  Demographics 
In  the  2001  population  census,  565,  976  people  identified  themselves  as  ‘Black 
Caribbean’ which approximates 1% of the total population (ONS, 2003). In addition to 
this, 0.5% of the population (1% of the London population) were classified as mixed 
race (white & Black Caribbean). At the last census, 61% of African-Caribbean people 
lived in London, accounting for nearly 5% of the London population (ONS, 2003). The 
African-Caribbean population in Britain is ageing and it has a relatively high proportion 
of individuals over the age of 65 years (10.6% in 2001) when compared to other BME 
groups  (table  1.7). I t  a l s o  h a s  a  h i g h e r  p r o p o r t i o n  o f  p e o p l e  w h o  a r e  ‘ y oung  old’ 
compared  to  ‘old  old’ i n  r e l a t i o n  t o  t h e  g e n e r a l  p o p u l a t i o n  (table  1.7). T h i s  a g e  
distribution is in keeping with their pattern of migration i.e. those aged in their twenties, 
who arrived in Britain in the early 1960s are now in their seventies.  
 
The 2001 census also gathered data on ‘country of birth’, with Jamaica the Caribbean 
nation  most commonly recorded (146, 401 people) followed by Barbados (21, 601), 
Trinidad and Tobago (21, 283) and Guyana (20, 872). The remainder reported coming 
from Grenada, Saint Lucia, Montserrat, Saint Vincent, the Grenadines, Dominica, Saint 
Kitts, Nevis, Antigua, Barbuda and Anguilla (ONS, 2003). 
 
There are now African-Caribbean communities throughout the UK, although the largest 
are found in London and Birmingham. In London, African-Caribbean people tend to be 
concentrated in the North (Tottenham, Hackney), North-West (Harlesden, Stonebridge) 
and South-East (Peckham, Brixton, Lewisham) with particularly high percentages (over 
60%) in parts of Brent  (Peach, 1998).  Significant African-Caribbean communities are 
also found in most other major conurbations. Notably, although within these cities, they 
tend to be associated with poorer areas, levels of ‘segregation’ are far less than for 
African-Americans in the USA  and are falling  (Peach, 1998).    67 
1.4.5.  Socioeconomic and health inequalities 
African-Caribbean people in Britain have fared less well than some other BME migrant 
groups economically and are less prosperous than the general population. One large 
survey found that compared to white people, African-Caribbeans were less likely to be 
in professional or managerial socioeconomic classes, more likely to be unemployed or 
in unskilled manual work,  less likely to own their own homes outright (no mortgage) 
and more likely to be living in poverty (Nazroo, 1997b, Modood et al., 1997). At the 
2001 census, Black Caribbean men were still three times more likely, and women twice 
as likely to be unemployed than their white peers (ONS, 2003). 
 
The relationship between lower socioeconomic status and poor health in the general 
population  has  long  been  established.  The  Black  Report c on c l ud ed  t h a t  t h i s  w a s  a 
consequence of the material differences in the standard of living (Black et al., 1980) 
and a  similar sentiment was echoed in the Acheson Report 18 years later (Acheson, 
1998). Interestingly the relationship has been more difficult to demonstrate in migrant 
populations  and  Marmot  et.  al.  found  that  socioeconomic  status  was  unrelated  to 
mortality in some ethnic groups. In his large study, for those born in the Caribbean the 
relationship was reversed, with wealthier African-Caribbeans having a higher mortality 
rate than poorer ones (Marmot et al., 1984a). The reason for this finding is not clear, 
although methodological problems have been suggested (Nazroo, 1999). The British, 
Fourth National Survey of Ethnic Minorities (FNS), a large cross-sectional survey of 
ethnic  minorities  living  in  England  and  Wales  found  conflicting  results  and 
demonstrated  a clear correlation between socioeconomic status  and health for both 
white and African-Caribbean people (Nazroo, 1997b, Modood et al., 1997). Given that 
the African-Caribbean population in Britain fall at the lower end of the socioeconomic 
spectrum, it could therefore be expected that this would adversely affect their health. 
Results of the FNS survey were consistent with this, concluding that African-Caribbean 
people were more likely to rate their health as poor than white people. Worth noting 
however, is that despite perceived poor health, they are known to have lower overall   68 
mortality rates than the general population (Wild and McKeigue, 1997, Marmot et al., 
1984b).  Other  plausible  explanations  for  differences  in  perceived  health  and  actual 
morbidity  when  compared  to  the  general  population  would  be  that  of  cultural  and 
genetic factors and of the direct impact of racism (section 1.4.3). 
 
 
1.4.5.1.  Physical health  
It  has  been  well  documented  that  African-Caribbean  people  in  the  West,  have  an 
increased risk of  hypertension and diabetes (Cooper and Rotimi, 1997, Chaturvedi et 
al.,  1993),  and  that  they  have  higher  rates  of  mortality  from  related  disorders, 
especially cerebrovascular disease (Wild and McKeigue, 1997, Marmot et al., 1984b). 
It has been estimated that they have twice the mortality from stroke and between four 
(in  men)    and  seven  (in  women)  times  the  mortality  from  hypertensive  disease 
compared to the national average (Chaturvedi et al., 1993).  Interestingly in spite of the 
excess of vascular risk factors, they have lower rates of ischaemic heart disease and 
also  have  lower  mortality  from  respiratory  disease  (Marmot et al., 1984b,  Wild and 
McKeigue,  1997).  The  relationship  between  vascular  risk  factors,  cerebrovascular 
disease and dementia in African-Caribbean people will be  discussed further in section 
1.5 and in the systematic review in Chapter 2. 
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1.4.5.2.  Mental Health 
It has been a consistent but contentious finding that African-Caribbean people in Britain 
have    much  higher  rates  of  psychosis  including  schizophrenia,  than  the  general 
population (Harrison et al., 1988, Van Os et al., 1996, Fearon et al., 2006, Fernando, 
1998). They are also thought to present to services with psychotic disorders later, and 
several studies have shown that they were more likely to be detained compulsorily, 
under the Mental Health Act (Morgan et al., 2005, Smaje, 1995). The reasons for this 
are  still  not  entirely  clear,  but  have  included  socioeconomic  disadvantage,  over-
diagnosis by mental health services and racism (Sharpley et al., 2001, Chakraborty et 
al.,  2009).  Studies  investigating  psychosis  and  schizophrenia  in  older  African-
Caribbean people are limited and no consistent differences have been shown to date 
(Livingston and Sembhi, 2003). 
 
It is likely that the rates of depression in African-Caribbean people are similar or slightly 
lower than in other ethnic groups (Bhugra and Ayonrinde, 2004, Lloyd, 1993). The FNS 
however, found an increased relative risk (RR) of 1.5 for depression amongst African-
Caribbean  (all  ages)  as  compared  to  white  people  (Nazroo,  1997a).  Studies  of 
depression in older African-Caribbean people are also inconclusive. Given the excess 
of  cerebro-vascular  disease  in  this  group,  it  is  plausible,  that  they  would  be  at 
increased risk of depression; in keeping with the “vascular hypothesis” of depression. 
Although the association with stroke has been clearly demonstrated, Stewart found no 
such association with vascular risk factors in his South London study (Stewart et al., 
2001a).  Neither McCracken (McCracken et al., 1997) nor Livingston (Livingston et al., 
2001) found significant differences in the prevalence of depression between samples 
including older African-Caribbean people (over 65 years) and a white reference group. 
However, such findings should be interpreted in the context of the screening tool and 
cut-off being used. Notably, it has been shown that community screening instruments 
for depression, validated in white populations underestimate the rates in older African-
Caribbean people (Abas et al., 1998).   70 
1.5. DEMENTIA IN BLACK POPULATIONS OF AFRICAN ORIGIN  
 
Most research on dementia in black populations is from the USA, where a number of 
studies have indicated that older African-American people may be at increased risk of 
developing dementia, with proportionally more vascular dementia when compared to 
the majority white population, (Tang et al., 2001, Demirovic et al., 2003, Krishnan et al., 
2005,  Heyman  et  al.,  1991,  Folstein  et  al.,  1991,  Auchus,  1997).  One  large  study 
comparing community dwelling older African-American people in Indianapolis with a 
sample  in  Ibadan,  Nigeria,  found  more  than  twice  the  incidence  of  dementia  and 
Alzheimer disease in the African-American group (Hendrie et al., 2001).  
 
In  general,  black  people  have  higher  rates  of  hypertension  than  their  white 
counterparts (Lane et al., 2002, Hall, 1999), an increased rate of hypertensive end-
organ disease (Dimsdale, 2000), cardio-vascular disease (Onwuanyi et al., 1998) and 
death  due  to  stroke  (Chaturvedi  et  al.,  1993).  As  hypertension  is  associated  with 
vascular  dementia  as  well  as  Alzheimer’s  disease  (Skoog  and  Gustafson,  2003, 
Stewart, 1998), it seems likely that they may suffer a relative excess of either or both 
dementias.  
 
Other reasons for the excess of dementia in African-American people are less clear 
and a number of analytic studies have been conducted to identify possible risk factors 
that may account for this. For example, diabetes mellitus is common in this population 
(Odugbesan et al., 1989), and it has been investigated as another putative vascular 
risk  factor  for  dementia.  One  study  demonstrating  an  association  between  diabetes 
and  dementia in an elderly African-American sample, found that one third of stroke 
associated  dementia  was  attributable  to  diabetes  (Luchsinger  et  al.,  2001). 
Hypercholesterolaemia  is  also  common  and  possibly  reflects  dietary  intake.  Another 
study found that elevated total cholesterol was associated with AD in a sample of older 
African-American people, but only in those who do not possess the APOE !4 allele   71 
(Evans et al., 2000). Interestingly this highlights the interaction between environmental 
and genetic risk factors for dementia. Also relating to vascular risk and diet was the 
Indianapolis-Ibadan  study  finding  that  not  only  did  the  Nigerian  participants  have 
significantly  less  AD  but  that  they  had  far  fewer  vascular  risk  factors  such  as 
hypertension,  diabetes  and  hypercholesterolaemia.  They  also  happen  to  eat  a  low-
calorie, low-fat diet consisting mainly of cereals, roots and tubers, supplemented with 
small amounts of fish (Hendrie, 2001). Studies of genetic risk factors including the role 
of APOE polymorphisms have been inconclusive, but indicate that the !4 allele may 
have  a  relatively  weak  association  with  AD  in  populations  of  African  origin  when 
compared to Caucasians (Evans et al., 2003, Tang et al., 1998, Farrer et al., 1997).  
 
When compared to the  USA, research on  dementia in  British, black populations is 
limited, and until now, no comprehensive review of the literature was available. These 
populations differ from those in the USA in that generally, the older generation are first 
generation immigrants. The largest of these groups are people of African-Caribbean 
descent. As many have now reached retirement age, they may also be at high risk of 
developing dementia, despite evidence that they are under-represented in their use of 
specialist  health  services  for  their  relative  levels  of  morbidity  (Nelson  et  al.,  2004, 
Boneham et al., 1997) (section 1.3.3). 
 
Although  physically  and  culturally  distinct  in  many  respects,  parallels  can  be  drawn 
between the African-American and British African-Caribbean populations. These may 
be useful, especially when considering risk factors for dementia, some of which may be 
modifiable.  Firstly,  by  definition  both groups  are of  African  descent and have some 
shared physical health characteristics, including an increased risk of hypertension and 
cerebro-vascular disease. Notably however, although rates of coronary artery disease 
are  relatively  high  in  the  African-American  population  with  respect  to  the  white 
population,  this  is  not  so  for  the  African-Caribbean  community  in  Britain,  who  have 
relatively low rates (section 1.4.5.1). Secondly, both groups are considered to be ethnic 
minorities, and have experienced significant social adversity including socioeconomic   72 
deprivation and racism (Modood et al., 1994). In particular, the first of these is known to 
be  associated  with  hypertension  (Diez-Roux  et  al.,  2002).  Sources  of  psychological 
‘stress’ have been hypothesised as a risk factor for other mental illnesses (Herbert, 
1997), although it is not yet clear what effect this may have on the rates of dementia. In 
addition, older British African-Caribbean people who are first generation immigrants will 
have experienced the stresses associated with making a new life in a foreign land. The 
African-American population in contrast, has been established for many generations, 
and the current older generation has not experienced migration first-hand.  
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1.6. SUMMARY 
 
I conclude from this chapter, that there will be large numbers of people with dementia 
in Britain as the population continues to age (1.2.4) and that an increasing proportion 
will come from BME communities (1.3.4). One of these groups to have reached old age 
in large numbers are those people who migrated from the Caribbean in the 1950s and 
early 1960s (1.4). We know little regarding their future health and social care needs 
and  whether  these  will  differ  from  those  of  the  general  population.  The  literature 
suggests that there may be barriers to some older BME people accessing specialist 
health  services,  even  if  registered  with  a  general  practitioner.  There  are  several 
possible explanations for this and good evidence that GPs feel poorly trained in the 
diagnosis of dementia, especially in older BME people (1.2.5). Whether this is so for 
African-Caribbean people is not yet clear and warrants further investigation. 
 
There is now strong evidence from the United States, that some black populations of 
African origin such as African-Americans may be at high risk of developing dementia, 
and that this may be partly due to an interaction between diet, physical and genetic 
factors (1.5). Although some parallels can be drawn with the British African-Caribbean 
population,  there  are  also  many  differences  and  inferences  can  only  be  made  with 
caution.  The  primary  aim  of  the  following  study  is  to  quantify  the  prevalence  of 
dementia in the British African-Caribbean community as compared to the indigenous 
white population. Before I describe the study, it is necessary to explore the relevant UK 
literature in more detail. 
 
In the following chapter I report the findings of a systematic review of the literature, 
relating specifically to aspects of dementia in the older African-Caribbean community in 
Britain, including prevalence and putative risk factors (Chapter 2).   74 
2. SYSTEMATIC REVIEW 
 
A systematic review of the prevalence and covariates of dementia  
or relative cognitive impairment in the older African-Caribbean  
population in Britain  
 
(See publication in Appendix 2) 
 
2.1.  OBJECTIVES 
To synthesise evidence from the literature regarding the prevalence and predictors of 
dementia or relative cognitive impairment in older, African-Caribbean people in Britain, 
as compared to the indigenous white population. 
 
2.2.  METHOD 
2.2.1.  Search Strategy 
I performed an electronic search for all relevant publications in December 2007 using 
the following bibliographic databases: 
 
•  MEDLINE  (1950 -) 
•  EMBASE (1980 -) 
•  PSYCHINFO (1806 -)  
•  CINAHL (1982 -) 
 
Additional  materials  were  identified  from  the  reference  lists  for  each  paper.  Two 
experts in the field were also contacted and asked if they knew of studies not identified 
electronically. 
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2.2.2.  Inclusion Criteria 
Studies reporting the frequency of (incidence or prevalence), or predictors for dementia 
or relative cognitive impairment, that included a sample of people of black, African-
Caribbean origin, living in Britain were included. 
 
2.2.3.  Exclusion criteria 
Qualitative  research,  single  case  studies,  dissertation  abstracts  and  secondary 
research were excluded. 
 
2.2.4.  Search terms 
•  African Caribbean, Afro Caribbean, Black Caribbean, West Indian, Jamaican. 
•  Dementia, Alzheimer’s Disease, Dementia - vascular, Dementia - multi-infarct, 
Dementia  - f r on t o t em p or a l,  Lewy  Body  Disease,  Pick’s  disease  of  the  brain, 
Cognitive impairment. 
 
Both free text and the related thesaurus (MeSH) terms were used for each search. 
 
2.2.5.  Selection method 
I  performed  the  initial  selection  of  studies  for  inclusion  on  the  basis  of  titles  and 
abstracts. Full articles were obtained and read for those appearing to fulfil the inclusion 
criteria. A second selection was then made through consensus, between myself and 
my two supervisors (MB and GL). 
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2.2.6.  Assessment of quality 
Papers meeting our inclusion criteria were randomly assigned and rated independently 
by  two  of  the  three  assessors  (myself  and  MB  or  GL).  In  cases  of  disagreement, 
consensus was reached through discussion.  Prevalence studies were evaluated using 
a standardised checklist (Boyle, 1998) and given a score out of seven (table 2.1). All 
other  studies  were  assigned  a  level  of  evidence  (LE)  grade  based  on  the  Oxford 
Centre  for  Evidence  Based  Medicine  (CEBM)  guidelines  – M a y  2 0 0 1  
(http://www.cebm.net/levels_of_evidence.asp#levels). This rates research on a scale of 
one  to  five,  with  lower  numbers  indicating  higher  quality.  Good  quality  systematic 
reviews and Randomised Controlled Trials (RCT) are level 1, good quality individual 
cohort and RCTs not meeting criteria for level 1 are level 2b and cohort studies not 
meeting these criteria are level 4 (table 2.2). 
 
Table 2.1      Prevalence study quality checklist 
Sampling 
 
 Does the survey design yield a sample of respondents 
representative of a defined target population? 
 
1. Is the target population defined clearly? 
2. Was probability sampling used to identify potential 
respondents? 
3. Do the characteristics of respondents match the target 
population? 
 
Measurement 
 
Do the survey instruments yield reliable and valid measures of 
psychiatric disorder and other key concepts? 
 
4. Are the data collection methods standardised? 
5. Are the survey instruments reliable? 
6. Are the survey instruments valid? 
 
Analysis 
 
Were special features of the sampling design accounted for in 
the analysis? 
 
7. Do the reports include confidence intervals for statistical 
estimates? 
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Table 2.2      Oxford CEBM levels of evidence. 
1a  Systematic review (with homogeneity) of prospective cohort studies or 
RCTs. 
1b  Prospective cohort study with good (>80%) follow up, or individual RCTs. 
1c  All or none case series 
2a  Systematic review (with homogeneity) of 2b and better studies. 
2b  Individual cohort study or low quality RCTs. 
2c  Ecological studies. 
3a  Systematic review (with homogeneity) of case-control studies 
3b  Individual case-control study. 
4  Poor quality (not meeting above criteria) cohort and case-control studies. 
Case-series. 
5  Expert opinion without explicit critical appraisal, or based on physiology, 
bench research or ‘first principles’. 
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2.3. RESULTS 
 
The  electronic  searches  identified  178  references  from  MEDLINE,  183  FROM 
EMBASE, 254 from PSYCHINFO and 160 from CINAHL. The majority were excluded 
from the title and abstract, leaving 26 papers for the second selection. Of these, 11 
primary studies were included in the review.  
 
2.3.1.  Prevalence studies  
Three  studies  investigated  the  prevalence  of  dementia  in  samples  of  older  African-
Caribbean people, one of these being a mixed sample of Black African and African-
Caribbean  people  (Livingston  et  al.,  2001).  No  studies  measuring  the  incidence  of 
dementia w e r e  f o u n d ,  a l t h o u g h  a  s e r i e s  o f  l o n g i t u d i n a l  s t u d i e s  l o o k e d  a t  c o g n i t i v e  
decline  over a three-year  period and  associated risk factors (table 2.3).  Two of the 
larger studies were designed to examine both dementia and depression in a variety of 
BME groups. T h e  f i r s t  o f  t h e s e  s e t  i n  L i v e r p o o l ,  s c r e e n e d  4 1 8  c o m m u n i t y  d w e l l i n g  
people aged 65 years and over from a number of ethnic backgrounds (McCracken et 
al.,  1997).  BME  participants  were identified from  multiple sources, including  Family 
Health  Services  Authority  lists,  community  lists,  ‘snowballing’  (obtaining  further 
contacts  via  participants)  and  a  door-to-door  survey.  The  computerised  Geriatric 
Mental State Examination algorithm - GMS-AGECAT (Copeland et al., 1986) was used 
to make the diagnosis of dementia. Comparison was made with a reference sample 
from a previous study (MRC ALPHA study). A dementia prevalence of between 2% 
and  9%  was found among the  English-speaking BME  groups  with 8% (8/98) in the 
African-Caribbean  participants.  Although  this  was  higher  than  that  in  the  white 
reference  sample  (3%),  the  absolute  numbers  with  dementia  were  small  and  the 
authors concluded that there was no significant difference between any of the English 
speaking BME groups and the indigenous white population. They did however find a 
higher  rate  of  dementia  in  non-English  speaking  participants  and  questioned  the 
validity of this diagnosis amongst people who do not speak the dominant language.   79 
 
The Islington Study surveyed 1085 people also aged over 65, from a range of ethnic 
backgrounds, in an inner city borough of North London (Livingston et al., 2001). The 
investigators  used  a  shortened  version  of  the  Comprehensive  Assessment  and 
Referral Evaluation; Short-CARE (Gurland et al., 1984) to elicit psychiatric symptoms 
and diagnoses. Participants were recruited using the gold standard method of ‘door 
knocking’; visiting every household within randomly selected enumeration districts. Of 
all  the  African  and  African-Caribbean  people  surveyed,  17.3%  (17/98)  screened 
positive for dementia, as compared to 10% (67/667) of the white, British respondents, 
despite the former being significantly younger. This study was limited by the fact that all 
the African and African-Caribbean participants were analysed together as one group, 
regardless of their country of origin. In addition, absolute numbers screening positive 
for dementia were small. 
 
One small pilot study did specifically aim to compare the risk of dementia in a sample 
of African-Caribbean older people with that in a white control group (Richards et al., 
2000).  On  this  occasion,  45  African-Caribbean  and  an  equal  number  of  age  and 
gender matched white community residents were recruited by household enumeration 
of an inner city, South London electoral ward. The participants were screened with the 
Mini Mental State Examination; MMSE (Folstein et al., 1975) and followed up with a 
comprehensive diagnostic interview if they screened positive. From the data gathered, 
an independent psychiatrist rated 22% (9/45) of the African-Caribbean participants as 
cognitively impaired (but not ‘demented’) and 34% (14/45) as ‘demented’ as compared 
to  9%  (4/45)  and  4%  (2/45)  respectively,  of  the  white  comparison  group.  The 
investigators concluded that the African-Caribbean participants were at far higher risk 
of dementia, even after controlling for educational and occupational factors. They could 
not however, exclude residual confounding by socioeconomic status or the effects of 
‘cultural test bias’. Other major limitations of this study were the small sample size and 
relatively high refusal rate in both groups.   80 
 
Table 2.3      Studies reporting the prevalence of dementia or relative cognitive impairment. 
 
 
STUDY  TARGET 
POPULATION 
TARGET 
POPULATION 
WELL 
DEFINED? 
 
PROBABILITY 
SAMPLING 
USED? 
 
SAMPLE 
MATCH 
TARGET 
POP. ? 
 
SAMPLE 
SIZE 
DATA 
COLLECTION 
METHOD 
STANDARDISED 
 
SCREENING 
INSTRUMENT 
VALID ? 
 
INSTRUMENT 
RELIABLE? 
PREVALENCE  OF 
DEMENTIA 
(95% CI) 
VALIDITY 
SCORE 
(OUT OF 7) 
 
McCraken  
1997 
 
 
BME elders 
aged >65 
living in a 
defined, 
inner-city area 
of Liverpool. 
 
YES  NO  NO  418 total 
100 A-C  YES 
YES 
 
(but cultural 
validity 
uncertain) 
YES 
8% (4-15%) in 
A-C sample. 
 
3% (2-4%) in 
reference sample. 
(Difference not 
significant.) 
5 
 
Richards  
2000 
 
A-C and white 
community 
residents 
aged >65 
living in an 
inner, South 
London 
Borough. 
 
YES  YES  Unknown  45 A-C 
45 white  YES 
YES 
 
(but cultural 
validity 
uncertain) 
YES 
34% A-C sample 
 
4% white sample 
 
OR 8.3 (2.9-24) 
5 
 
Livingston 
2001 
 
 
 
 
 
 
Community 
dwelling 
residents 
aged >65 
living in an 
inner city 
North London 
borough.  
 
YES  YES  YES 
1085 total 
 
98 African/ 
A-C 
YES 
YES 
 
(but cultural 
validity 
uncertain) 
YES 
17.3% in African/  
A-C sample 
 
10% in white 
sample. 
 
RR 1.72 (1.1-2.0) 
7   81 
2.3.2.  Association/risk factor studies         
Eight  studies  were  identified,  investigating t h e  a s s o c i a t i o n  b e t w e e n  a  n u m b e r  o f  
potential  risk  factors  and  dementia  or  cognitive  impairment  in  African-Caribbean 
participants (table 2.4). 
 
2.3.2.1.  Cardiovascular risk factors 
A small follow up to the Islington study investigated the association between dementia 
subtype  and  country  of  origin  (Stevens  et  al.,  2004).  Of  the  72  people  in  whom  a 
dementia  diagnosis  was  made,  47  were  born  in  the  UK  and  10  in  Africa  or  the 
Caribbean.  The  combined  African/African-Caribbean  group  had  nearly  double  the 
proportion of vascular dementia as compared to UK born comparisons, depending on 
the  diagnostic system used. Interestingly, eight  of the ten  African/African-Caribbean 
people diagnosed with dementia were hypertensive at the time of interview, of which 
four  were  not  diagnosed,  or  were  presumed  to  have  had  their  hypertension 
inadequately  treated.  Three  conclusions  were  drawn  from  this  study;  that  vascular 
dementia may be overrepresented in older people of African and/or Caribbean origin, 
that these populations are more likely to have hypertension that is either undiagnosed 
or poorly treated and that this in turn is a risk factor for dementia. Again, this study was 
limited by small numbers and the grouping of African and Caribbean people together.  
 
In  a  series  of  seven  publications,  Stewart  and  his  colleagues  investigated  the 
association between a number of physical risk factors and relative cognitive impairment 
and cognitive decline in a cohort of African-Caribbean, South London residents. The 
sample was identified from primary care registration lists and participants were aged 
between 55 and 75 years. At baseline, participants were simultaneously screened for 
cognitive impairment and vascular risk factors by means of eleven psychometric tests 
and a physical examination. Blood samples were taken where possible and used to 
measure further potential biological risk factors. Participants were classified as having 
‘relative cognitive impairment’, either if they scored below the 30
th percentile on six or   82 
more tests or below the 10
th percentile on four or more tests.  Of the 278 participants, 
79 (28%) were classified as having relative cognitive impairment. The remainder of the 
sample were classified as ‘unimpaired’. The two groups were compared in terms of 
potential risk factors. Attempts to follow up the original cohort were then made after 
three  years  and  data  was  collected  on  cognitive  decline  from  baseline  for  further 
analysis.  
 
The first of these analyses investigated the association of cognitive impairment (CI) 
with a number of vascular risk factors (Stewart et al., 2001b). A key finding was that the 
associations  detected  were  modified  by  educational  level.  Whereas  hypertension, 
diabetes and raised triglycerides were found to be significant risk factors for CI in those 
of lower educational level, low fibrinogen, high cholesterol and manual occupation were 
risk  factors  in  those  with  normal/high  levels  of  education.  Physical  exercise  was 
negatively associated with CI.  
 
In a three-year follow-up study of the same community sample, cognitive decline from 
baseline was strongly associated with ageing but not directly with other vascular risk 
factors.  However,  the  age  related  decline  was  significantly  stronger  in  those  with 
diabetes and weaker in those reporting vigorous exercise at baseline (Stewart et al., 
2003). 
 
2.3.2.2.  Genetics 
The  only  genetics  studies  found  in  a  British  African-Caribbean  sample  were  further 
analyses of Stewart’s original cohort data. They investigated the association between 
Apolipoprotein  E  genotype  and  early  CI  (Stewart  et  al.,  2001c) a n d  A n g i o t e n s i n  I  
converting enzyme (ACE) genotype and cognitive decline (Stewart et al., 2004). In the 
first paper, APOE genotype was determined for 202 participants. Although APOE !4 
genotype has been established as an important risk factor for Alzheimer dementia in 
Caucasian and Japanese populations, its role in people of African origin is less clear.   83 
In this analysis, CI was negatively associated with APOE !2 allele and positively, but 
more weakly with the APOE !4 allele. The effect of both alleles was greater after the 
age of 70 years and greatest in those with hypertension, diabetes and lower levels of 
educational attainment. In the second paper, ACE genotype was determined in 148 
older  African-Caribbean  participants  and  the  association  with  cognitive  decline  over 
three years investigated (Stewart et al., 2004). It is thought that the insertion/deletion 
polymorphism of the ACE gene can influence the risk of cerebrovascular disease in 
white populations although any association with cognitive decline or dementia remains 
controversial. Although no direct relationship was found between ACE genotype and 
cognitive decline in this sample, an interaction  was demonstrated  with the ACE  DD 
genotype,  strengthening  the  association  between  age  and  cognitive  decline  when 
compared to the ID/II genotype. 
 
 
2.3.2.3.  Inflammatory markers 
There  is  growing  interest  in  the  role  of  inflammatory  processes  in  the  pathology  of 
cognitive  decline  and  subsequent  dementia.  In  an a n a lysis  of  Stewart’s  cohort, 
Jordanova et al. investigated the association between three inflammatory markers and 
cognitive decline in 216 older African-Caribbean participants (Jordanova et al., 2007). 
After  adjusting  for  potential  confounders,  raised  plasma  interleukin-6  (IL-6)  was 
associated with cognitive decline over three years. No associations were found for C-
reactive protein (CRP) or serum amyloid A (SAA). The authors concluded that as IL-6 
predicts cognitive decline in this population, cytokines may mediate cognitive decline 
via specific causal pathways.  
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2.3.2.4.  Plasma Homocysteine 
Moderately raised plasma homocysteine has been associated with both cardiovascular 
and cerebrovascular disease (Hankey and Eikelboom, 1999) and as such, this could 
be considered as a risk factor for cognitive decline and dementia. In this secondary 
analysis, Stewart et al. compared measurements of plasma homocysteine with relative 
CI  in  248  older  African-Caribbean  participants  (Stewart  et  al.,  2002).  They  found 
homocysteine levels in the highest quartile to be associated with CI (OR 2.5; 95% CI 
1.33-4.69) but this was only significant in those with low educational attainment. 
 
 
2.3.2.5.  Leg length 
Adult leg length has been used as a marker for early life environment and is related to 
childhood nutritional status. It is recognised that these factors may influence health in 
later life and shorter leg length has been related to a number of disorders including 
dementia in a Korean population (Kim et al., 2003). Mak et al. carried out a secondary 
analysis  of  Stewart’s  data  on  203  older  African-Caribbean  people  in  South  London 
(Mak et al., 2006). Relative CI at baseline and subsequent cognitive decline over three 
years was compared with leg length (iliac crest to lateral malleolus). The investigators 
found that shorter leg length (the lowest quartile) was associated with CI but not with 
cognitive decline. Although statistically significant, this finding was strongly mediated 
by previous occupational status.   85 
 
 
Table 2.4  Studies reporting predictors of dementia or cognitive impairment in an African-Caribbean sample of people 
 
STUDY  RISK FACTOR(S)  OUTCOME 
MEASURE 
STUDY SAMPLE   FACTORS ASSOCIATED WITH DEMENTIA 
OR C.I 
LEVEL OF 
EVIDENCE 
Stewart, R  
2001 
Vascular risk factors  Cognitive 
impairment 
278 participants aged 
55-75, born in the 
Caribbean. 
(28% with relative C.I) 
Hypertention, diabetes & raised triglycerides in 
those with low education. Low fibrinogen 
(negative association) & raised cholesterol in 
those with normal/high education. 
4 
Stewart, R 
2001 
Apolipoprotein E 
Genotype 
Cognitive 
impairment 
202 participants aged 
55-75, born in the 
Caribbean. 
(28% with relative C.I) 
APOE !4 – weakly association 
APOE !2 – negative association 
Effects increased after age 70 
 
4 
Stewart, R 
2002 
Plasma 
Homocysteine 
Cognitive 
impairment 
248 participants aged 
55-75, born in the 
Caribbean. 
(27% with relative C.I) 
Raised plasma homocysteine was significantly 
associated with C.I (OR 2.5; 95%CI 1.33-4.69) 
but only in those with low education.  4 
Stewart, R 
2003 
Age & vascular risk 
factors 
Cognitive decline 
over 3 years 
207 participants aged 
55-75, born in the 
Caribbean. 
 
Cognitive decline strongly associated with age. 
Association strengthened further in people with 
diabetes and weakened in those reporting 
vigorous physical exercise. 
 
4 
Stevens, T 
2004 
Hypertension  Dementia  98 participants from 
Africa or the Caribbean 
(from a larger sample of 
1085 aged >65). 
Undiagnosed or poorly treated hypertension is 
associated with an increased risk of dementia. 
Excess in vascular subtype in A-Cs.  4 
Stewart, R 
2004 
ACE genotype  Cognitive decline 
over 3 years 
148 participants aged 
55-75, born in the 
Caribbean. 
No direct association found but ACE DD 
genotype strengthened the association between 
increasing age and cognitive decline (effect 
modification). 
 
4 
Mak, Z 
2006 
Leg length  Cognitive 
impairment and 
cognitive decline 
over 3 years 
203 participants aged 
55-75, born in the 
Caribbean. 
Shorter leg length (lowest quartile) was 
significantly associated with cognitive 
impairment at baseline but not cognitive decline.  4 
Jordanova, V 
2007 
Markers of 
inflammation 
Cognitive decline 
over 3 years 
216 participants aged 
55-75, born in the 
Caribbean. 
Raised levels of IL-6 were associated with 
cognitive decline. No association was found for 
CRP or SAA.  4   86 
2.4. DISCUSSION 
In this, the first systematic review  of the literature  on dementia in the older,  British 
African-Caribbean population, I strikingly found only three small studies that report the 
prevalence  of  dementia.  Thus,  although  it  seems  likely,  it  cannot  be  shown 
conclusively  that  dementia  is  increased  in  this  population.  Two  studies  recruited 
participants of African-Caribbean origin and one study, a mixed sample of black African 
and African-Caribbean people. All have small numbers and use screening instruments 
of uncertain cultural validity. The study with the highest prevalence of dementia had the 
smallest numbers, and that with the lowest prevalence did not compare two groups 
recruited at the same time. The latter also used a snowballing technique that may have 
led to a biased estimation of the illness. Notably, all three studies found a higher rate of 
dementia in the ‘black’ population but the rate varied widely between 8% and 34%. The 
study with the highest validity score found a prevalence of 17% and this may therefore 
be the most plausible estimation.  One study indicated that there may be higher rates 
of  vascular  dementia  in  particular,  and  that  this  may  be  associated  with  poorly 
controlled hypertension but this study is too small to draw any conclusion other than 
that further investigation is merited.  
 
Relative CI and cognitive decline (but not dementia) in this population has been studied 
extensively  by  one  group,  who  found  that  that  APOE  !4  genotype  and  shorter  leg 
length  were  associated  with  cognitive  impairment  and  raised  IL-6  with  cognitive 
decline.  Physical e x e r c i s e  w a s  f o u n d  t o  b e  p r o t e c t i v e .  T h e  l i n k s  b e t w e e n  
cardiovascular risk factors and cognitive impairment were less clear and were strongly 
modified  by  education.  Interestingly,  the  most  plausible  of  these,  hypertension  and 
diabetes were only risk factors in the least educated participants. Vascular risk factors 
were not found to be directly linked to cognitive decline from baseline but to modify the 
strong association with ageing. None of the risk factor studies we identified, scored at 
the higher levels of evidence according to the Oxford CEBM criteria.  
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2.5. LIMITATIONS 
Only  two  experts  responded  to  my  request  for  information  regarding  additional 
unpublished  work,  and  none  was  identified.  My  systematic  review  therefore  only 
included  published  research  which  is  inevitably  biased  towards  positive  findings 
(publication  bias).  As  research  in  this  field  is  limited  and  the  number  of  published 
studies small, I employed broad inclusion criteria. The result of this was that the studies 
identified were heterogeneous in design, making direct comparison difficult. All of the 
prevalence studies reviewed were limited by small sample sizes and used screening 
tools of uncertain cultural validity. The association studies all fell into category 4 of the 
Oxford  CEBM  level  of  evidence,  indicating  poor  quality  evidence.  It  was  therefore 
difficult to draw any definitive conclusions from these. 
 
 
2.6.  CONCLUSIONS 
I  conclude  from  this  review  that  further  investigations  are  needed,  to  confirm  an 
increased rate of dementia in the British African-Caribbean population, to estimate its 
magnitude,  to  further  investigate  predictors  and  ultimately  to  identify  preventative 
interventions. Initially a much larger cross sectional survey would be helpful. Ideally this 
would  achieve  a  high  response  rate,  would  include  the  use  of  a  culturally  valid 
screening  instrument  in  an  epidemiologically  representative  population  and  would 
include  a  white comparison group.  Further,  higher quality longitudinal studies  would 
also be desirable and this is discussed further in Chapter 6.   88 
3. AIMS & HYPOTHESES 
 
As discussed in Chapter One, there is very little in the published literature regarding 
the prevalence  of dementia in African-Caribbean  people,  either  in  the  Caribbean  or 
elsewhere in the world, but a relative wealth of data regarding the African-American 
community in the United States. The latter indicates that older African-American people 
are at increased risk of developing dementia when compared to the white majority, or 
to B l a c k  p e o p l e  l i v i n g  i n  A f r i c a  ( section  1.5).  Although  distinct  both  physically  and 
culturally, comparisons can be  made  with the African-Caribbean population  living in 
Britain. I hypothesised that there may be common risk factors, potentially increasing 
the  prevalence  of  dementia  in  both  groups  relative  to  their  white  counterparts.  The 
most plausible explanation relates to vascular risk, whereby both African-American and 
British African-Caribbean people have a predisposition to hypertension, diabetes and 
subsequent cerebrovascular disease. As there is now consistent evidence that these 
factors are associated with both vascular dementia and Alzheimer’s disease (section 
1.2.2), it is a plausible that it may account for an overall excess of dementia in both 
groups. This warrants further investigation as there may be potential for both primary 
and secondary preventative interventions.  
 
Also explored in Chapter  One w ere health and socio-demographic characteristics of 
the ageing BME population in Britain. Notably, an increasing number are reaching the 
age group that puts them at risk of dementia. As the majority of first generation African-
Caribbean  people  migrated  to  Britain  in  the  1950s  and  early  1960s,  they  are  now 
reaching o l d  a g e  i n  l a r g e  n u m b e r s .  If  they  are  at  increased  risk  of  dementia  as 
hypothesised, their health and social care needs will be substantial, and services need 
to plan for this. Available evidence suggests that general practitioners may be failing to 
diagnose dementia early enough in this population and that they are less likely to be 
referred on to specialist services for assessment. 
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In Chapter Two, I concluded from my systematic review, that there may be an excess 
of dementia in the African-Caribbean compared to the white-British population in the 
UK, but the evidence was of poor quality and the findings inconclusive. Of the three 
studies identified, none was powered with the primary aim of measuring and comparing 
the  prevalence  of  dementia  between  an  African-Caribbean  and  a  white  reference 
sample  of  older  people.  None  had  used  culturally  adapted  screening  or  diagnostic 
instruments, making the validity of the screening process questionable. The prevalence 
estimates  for  dementia  also  varied  widely  for  the  black  groups  from  8%  to  34%.  I 
concluded that it was necessary to determine definitively whether the prevalence of 
dementia  is  higher  in  British  African-Caribbean  as  compared  to  the  majority  white 
population and if so by how much. 
 
3.1. HYPOTHESES 
 
3.1.1.  Primary Hypothesis 
 
•  The point prevalence of dementia (all types) is higher in the African-Caribbean 
than the white-British older population. 
 
3.1.2.  Secondary hypothesis 
 
•  Dementia  in  older  African-Caribbean  people  is  under-recognised  in  primary 
care (according to their medical records) and the rate of referral to specialist 
dementia services is lower than that for the white-British population. 
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3.2. AIMS 
 
The general aim of this research is to enhance our knowledge with regard to dementia; 
its prevalence, risk factors and access to specialist care, in older African-Caribbean 
people living in Britain.  
 
3.2.1.  Primary aim 
 
•  To test the primary hypothesis that the prevalence of dementia is higher in the 
African-Caribbean, compared to the white British-born older population, using 
General Practice lists in the London Borough of Haringey as a sampling frames. 
 
3.2.2.  Secondary aims 
 
•  To compare the diagnosis of dementia between African-Caribbean and white-
British people, in relation to demographic and vascular risk factors. 
•  To investigate levels of documentation regarding dementia and rates of referral 
for specialist assessment in primary care and to compare them between the two 
ethnic groups. 
•  To explore the distribution of dementia subtypes between these groups. 
•  To further test the performance of the culturally valid, African-Caribbean version 
of the MMSE as compared to the standard version. 
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4. METHODS 
4.1. STUDY DESIGN 
The study design is of a two-stage cross sectional prevalence study and a  medical 
notes survey. 
 
4.2. ETHICS COMMITTEE & R&D APPROVAL 
Ethical approval was obtained separately for the pilot and the main study. Approval for 
the  pilot  study  was  granted  by  the  Moorefield  &  Whittington  Research  Ethics 
Committee (REC) on 19
th May 2004, and for the main study by Camden & Islington 
Community REC on 15
th November 2006 (Appendix 4). 
 
The  main  ethical  issues  addressed  by  the  two  committees  are  discussed  in  the 
relevant sections as indicated below, but in summary included: 
 
•  Issues  pertaining  to  data  protection  &  privacy;  specifically  that  potential 
participants should be invited to take part by their GP in the first instance, and 
that they should be able to ‘opt out’ of the study before being contacted by a 
researcher (section 4.4.8.2). 
•  The issue of obtaining valid informed consent from people who lack the mental 
capacity through cognitive impairment / dementia (section 4.4.8.3).  
•  Printed i n f o r m a t i o n  a n d  l e t t e r s  s h o u l d  b e  i n  l a r g e  c l e a r  p r i n t  a n d  a c c e s s i b l e  
language (section 4.4.8.2). 
 
The  final  project  was  registered  with  the  UCL  research  and  development  (R&D) 
department and with the local data protection coordinator at the Department of Mental 
Health  Sciences  (UCL),  Royal  Free  Campus.  I  also  obtained  an  honorary  contract 
from Haringey teaching Primary Care Trust (PCT) enabling me to approach patients 
registered with GPs throughout the borough.   92 
4.3. PILOT STUDY 
In this section I will describe a small pilot study, which I conducted between June 2004 
and  July  2005.  This  was  completed  prior  to  my  starting  an M R C  r e s e a r c h  t r a i n i n g  
fellowship and formed part of my grant application. The aims of the pilot were primarily 
to test the feasibility of the selection and recruitment process in a primary care setting, 
and to refine the screening tool for use in African-Caribbean participants.  The findings 
were used to inform the development of the final method for the study. 
 
4.3.1.  Pilot study method 
Just one GP practice  was recruited for the  pilot study and  a sample  of 29 African-
Caribbean volunteers aged 60 years and over were screened for cognitive impairment 
using  an  African-Caribbean  version  of  the  Mini  Mental  State  Examination  – M M S E  
(Rait et al., 2000). Validated specifically for use in older African-Caribbean people in 
Britain, it was designed to be less culturally and educationally biased than the standard 
MMSE (Folstein et al., 1975). I decided on a cut-off of <26 as screening positive for 
dementia  as  this  gave  an  acceptable  level  of  sensitivity  and  specificity  (section 
4.4.10.1). N o  w h i t e  c o m p a r i s o n  g r o u p  w a s  r e c r u i t e d  i n  t h i s  i n s t a n c e .  A t  t h e  t i m e ,  
approximately  60%  of  patients  had  been  coded  for  ethnicity  on  the  GP  practice 
electronic database. With this information alone, it was possible to identify a significant 
proportion,  but  not  all  of  the  African-Caribbean  patients  aged  60  years  and  over. 
Potential  participants  were  sent  a  letter  directly  from  their  GP,  on  practice  headed 
paper,  inviting  them  to  take  part  in  the  study.  I  subsequently  contacted  them  by 
telephone, and if they agreed, made an appointment to interview them at their own 
home. Each interview lasted for 30-45 minutes during which written, informed consent 
was obtained, and a simple demographic questionnaire was administered (Appendix 5) 
along with the MMSE screening tool. I had intended that those screening positive for 
dementia  would  undergo  a  structured  diagnostic  interview; T h e  C a m b r i d g e  M e n t a l  
Disorders of the Elderly Examination – CAMDEX (Roth et al., 1986) (section 4.4.11.) 
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4.3.2.  Pilot study findings 
In total, 69 African-Caribbean GP patients over 60 years of age were identified from the 
single practice list. Of the total, 20 (29%)  were  not contactable by telephone and a 
further  15  (22%)  declined.  Reasons  for  not  making  contact  included:  no  phone, 
unobtainable phone number, no answer, had moved house, was out of the country or 
died.  Although  34  (69%)  of  those  contactable a g r e e d  t o  t a k e  p a r t ,  o n l y  2 9  ( 5 9 % )  
completed  the  screening  process,  the  remainder  having  changed  their  mind  either 
before or during the interview. Of those screened, just one (3.4%) screened positive for 
cognitive  impairment.  Unfortunately  the  participant  refused  further  testing  and  no 
formal diagnostic interview was performed. The full diagnostic interview derived from 
the  CAMDEX  (4.4.11)  was  piloted  for  acceptability  separately  in  a  small  purposive 
sample  of  patients,  immediately  prior  to  the  main  study.  These  participants  were 
recruited from patients of the local old age psychiatry service. 
 
In summary, the main findings from the pilot study were as follows: 
 
•  Identification  and  recruitment  of  African-Caribbean  participants  was f e a s i b l e  
through existing ethnic coding of practice lists. However, it became apparent 
that ethnic coding alone would not identify a sufficient proportion of African-
Caribbean patients, and that this might also result in a biased sample; those 
having  attended  the  GP  practice  recently  were  more  likely  to  be  coded fo r 
ethnicity by receptionists than non-attenders. It was anticipated that additional 
methods to identify potential participants would be employed in the main study 
(section 4.4.8.1).  
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•  The overall response rate (42%) was moderately low. Part of the difficulty was 
that the contact details for some patients were incorrect or incomplete. Also, 
during the pilot study it  was  only possible to contact people during  working 
hours. I had expected that these difficulties would be largely overcome in the 
main study where more time and resources would be available to pursue all 
potential participants (section 4.4.8.2.) 
 
•  The screening questionnaire and interview were quick and easy to administer 
and  acceptable  to  participants,  who  generally  scored  highly.  The  low 
prevalence of dementia in this pilot was accounted for by the small, biased and 
unrepresentative sample. 
 
•  The  full,  unmodified  CAMDEX  interview  &  CAMCOG  cognitive  assessment 
was  found  to  be  time  consuming  and  some  components  potentially 
educationally or culturally biased. This led to the development of a m odified 
diagnostic interview (section 4.4.11) 
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4.4. CROSS SECTIONAL SURVEY 
 
4.4.1.  Study location 
The Borough of Haringey in North London was chosen as the setting for this study, 
primarily  because  it  has  a  large  and  well-established  African-Caribbean  population 
(table 4.1 & figure 1.2). The area is also accessible to the research team base and 
links had been established with Haringey Teaching Primary Care NHS Trust (tPCT), 
and  with  Barnet,  Enfield  and  Haringey  (BEH)  Mental  Health  NHS  Trust.  There  is 
evidence that statutory services in  Haringey have been failing to reach people with 
dementia from certain BME groups, including the African-Caribbean community (Weir 
and Wharrad, 1998). The local mental health and primary care NHS trusts were keen 
to address this problem, and have been key collaborators with this study. 
 
Geographically, the borough of Haringey covers an area of more than 11 square miles 
in  North  London,  bordering  clockwise  from  the  North:  Enfield,  Waltham  Forest, 
Hackney, Islington, Camden and Barnet (www.haringey.gov.uk). Socioeconomically it 
is  an  extremely  diverse  borough  and  it  ranks  as  the  fifth  most  deprived  in  London 
(www.haringey.gov.uk). It spreads from the affluent suburbs of Highgate, Muswell Hill 
and  Crouch  End  in  the  West,  to  the  much  poorer  areas  of  Tottenham  and  Lower 
Edmonton  in  the  East.  The  latter  contain  some  of  the  most  deprived  wards  in  the 
country.  According  to  ONS  (Office  for  National  Statistics)  estimates,  the  total 
population  for  mid  2007  was  224,700,  3%  of  the  total  London  population 
(www.haringey.gov.uk).  It  has  an  equal  male  to  female  ratio  and  an  age  structure 
similar to other London boroughs, although the east of the borough tends to have more 
young people and the west more older people (www.haringey.gov.uk). Its residents are 
ethnically diverse with approximately half coming from BME communities (table 4.1). In 
fact, it has the 6
th highest proportion of BME people in London after Brent, Newham, 
Tower Hamlets, Hackney and Ealing (www.haringey.gov.uk). 
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Table 4.1  Ethnic composition of London Borough of Haringey (ONS 2003, 2007) 
Ethnicity  2001 Census data 
for Haringey 
 
2005 Estimates for 
Haringey 
2001 Census data - 
National average  
White British  45.3%  47.6%  87.0% 
Black Caribbean  9.5%  8.3%  1.1% 
Mixed white and 
Black Caribbean  
1.5%  1.4%  0.5% 
       
White Irish  4.3%  3.6%  1.3% 
Other White  16.0%  14.1%  2.7% 
Asian  6.7%  7.6%  4.6% 
Black African  9.2%  9.1%  1.0% 
Other Black  1.4%  1.3%  0.2% 
Other Mixed   3.1%  3.3%  0.8% 
Other  3.0%  3.7%  0.8% 
ONS estimates for mid-2005 
(http://www.london.gov.uk/gla/publications/factsandfigures/dmag-update-20-2007-
ons-ethnic-group-estimates.pdf) 
 
 
 
The  first  large-scale  immigration  into  Haringey,  was  of  the  African-Caribbean 
community who arrived in the late 1950s and early 1960s. This was followed by the 
Cypriot,  Turkish  and  Asian  communities.  More  recently,  the  ethnic  mix  has  been 
increased, with people migrating from Africa in the late 1980s/1990s and from Central 
and Eastern Europe, particularly since the expansion of the EU in the last decade. In 
fact,  in  2001,  Haringey  had  the  third  largest  proportion  of  ‘other  white’  residents  in 
London (16%), with 31% of these born in Central/Eastern Europe (including Turkey) 
(www.haringey.gov.uk). 
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Although  Haringey’s population of African-Caribbean  residents  rose  slightly  between 
the 1991 and 2001 censuses, their number might now be falling. It was last estimated, 
that in mid-2005, approximately 18,700 (8.3%) people were of black, Caribbean origin, 
which represents a decrease from the 2001 census estimate of 20, 570 (9.5%) (ONS 
2003, 2007). In contrast, the population of 3, 200 (1.4%) people of mixed white/black-
Caribbean  heritage  has  remained  relatively  stable  (ONS,  2007).  With  specific 
relevance to this study, is that at least 3, 400 African-Caribbean people aged over 60 
years reside in the borough (ONS, 2003). As the profile of this community begins to 
age, the relative number of older residents is likely to rise substantially. This is likely to 
have  significant  implications  regarding  the  provision  of  culturally  appropriate  health 
care and social services.  
 
 
4.4.2.  Study Setting 
As the aim of this study was to survey a sample of people from the general population, 
I  chose  a  community  setting.  Participants  were  identified  from  individual  General 
Practice lists and interviewed primarily in their own homes. 
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4.4.3.  Study & reference populations 
 
4.4.3.1.  Study population 
The study (target) population includes all people aged 60 years and over, who are of 
black, African-Caribbean origin, and who migrated to Britain from a Caribbean island or 
Guyana  (on  the  North-East  coast  of  South  America).  Although  not  technically  a 
Caribbean island, culturally Guyana associates primarily with other English-speaking 
Caribbean countries such as Jamaica, or Trinidad and Tobago. I chose the age of 60 
years, rather than the conventional cut-off of 65, primarily because a previous study 
(Livingston et al., 2001) suggested that older people of African/African-Caribbean origin 
might  develop  dementia  at  a  significantly  younger  age  than  the  indigenous  white 
population. I felt it was important that these people were included.  All such people who 
permanently reside in the Haringey area, whether living in their own homes or in 24-
hour residential care, were included in the study.  
 
 
4.4.3.2.  Reference population 
I chose the reference population to include people aged 60 years and over, who are 
white and consider themselves to be British. This included people born throughout the 
British Isles. In practice, the majority of the white participants were born in London and 
considered  themselves  to  be  English.  As  for  the  study  population,  all  permanent 
residents of Haringey were included. 
 
   99 
4.4.4.  Sampling frame 
In order to identify participants, General Practices were recruited and their patient lists 
used  as sampling frames.  These lists are  relatively accessible  and the patients  are 
representative of the general population. It is known that  approximately 98% of the 
general population are registered with a General Practitioner and that even in inner-city 
areas, the rates of registration for BME groups are at least as high as for the white 
population (Johnson et al., 1983, Richards, 1996). Practices are now expected to code 
their patients for self-assigned ethnicity and since April 2001, they have been using, as 
a National Standard, a set of 16 codes to record ethnicity (DoH, 2001b). The codes are 
identical to those used in the 2001 ONS census and are grouped under five headings : 
White;  Mixed;  Asian  or  Asian  British;  Black  or  Black  British;  and  Chinese  or  other 
ethnic group. Although the level of completion varies between practices, this coding, in 
addition to other methods allowed for the identification of participants (section 4.4.8.1). 
 
 
4.4.5.  Sampling method 
I  used  single  stage,  cluster  sampling  to  obtain  a  representative  sample  of  African-
Caribbean  people  from  across  Haringey.  This  was  achieved  by  simple  random 
sampling of all GP practices from across the borough (see details below). From each 
participating practice, all eligible African-Caribbean patients that were identified, who 
were 60 years or over, were invited to participate in the study. This method has the 
advantages of producing an equally weighted, random sample of participants, and of 
being  practical  to  perform.  As  there  were  many  more  potential  white,  British  than 
African-Caribbean  participants,  they  were  randomly  selected  from  the  same  GP 
practice lists until an equal number had been recruited. Randomisation was achieved 
by  selecting  alternate  white-British  names  until  the  numbers  of  African-Caribbean 
participants had been matched. 
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General Practices were identified with the assistance of the primary care trust and of 
the North Central London Research Consortium (NoCLOR). I sent a random selection 
of  practices  a  letter  and  information  sheet  asking  for  their  involvement.  This  was 
followed up with a telephone call to the practice manager. As expected, only a small 
proportion of practices agreed to participate and the sampling process was repeated 
until  the  required  number  had  been  recruited  (see  4.4.7). T h e  r e c r u i t m e n t  o f  
subsequent GP practices was ongoing, and ran in parallel with the recruitment of study 
participants. Experience from a feasibility study had suggested that the implementation 
of the project would require minimal input from each practice once recruited, both in 
terms of staff-time or costs. The project itself was also unlikely to generate a significant 
excess of clinical work for GPs and it was of potential benefit to their patients.  
 
 
4.4.6.  Inclusion & exclusion criteria 
All patients from each practice who were selected and who fulfilled the inclusion criteria 
were encouraged to participate. Minimising refusals was essential, in order to reduce 
participation b i a s .  T h i s  i s  k n o w n  t o  b e  p o t e n t i a l l y  p r o b l e m a t i c ,  especially i n  c r o s s  
sectional studies where a minimum response rate of 70% would be considered to be 
acceptable, providing the demographic profiles of responders are similar to those of the 
non-responders (Boyle, 1998). Exclusion criteria have also been kept to a minimum in 
order to preserve generalisability of the findings.  
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4.4.6.1.  Study sample. 
Inclusion Criteria:  
•  All  General  Practice  patients  aged  60  years  and  over  and  who  identified 
themselves  as  being  African-Caribbean,  Afro-Caribbean,  Black-Caribbean, 
Caribbean  or  West  Indian  and  who  were  born  on  a  Caribbean  island  or  in 
Guyana.  
•  All those living in any community setting including their own home, that of a 
relative,  friend  or  in  24  hour  residential  care  in  the  Haringey  area.  Potential 
participants,  registered  with  one  of  the  participating  General  Practices,  who 
lived  nearby,  but  in  a  neighbouring  borough  (usually  Enfield)  were  also 
included.  
•  Those  with,  or  without  existing  cognitive  impairment  or  dementia,  whether 
diagnosed or not. 
 
 
Exclusion Criteria:  
•  People  younger  than  60  years  or  those  not  born  on  a  Caribbean  island  or 
Guyana.  As  such,  second  generation  people  of  African-Caribbean  descent 
were excluded for clarity, and to facilitate the identification of study subjects. In 
any case, it was thought to be unlikely that second generation migrants over 60 
would be encountered. 
•  Non-English speakers were excluded, as no interpreters were available for the 
study. 
•  Those with a known moderate or severe intellectual (learning) disability, as the 
screening tool for cognitive impairment had not been validated in this group. 
•  Those who were hospitalised long term, considered too physically or mentally 
ill, and those too frail to participate were excluded from the study. 
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4.4.6.2.  Reference Sample 
Adults  aged  60  years  and  over,  living  in  the  Haringey  area,  but  who  identified 
themselves as being white-British and who were born in the British Isles were randomly 
selected to participate (4.4.5). Those of other European descent were excluded. Other 
than ethnicity, inclusion and exclusion criteria were the same as for the study sample. 
 
 
4.4.7.  Sample size 
The systematic review (Chapter 2) indicated that in the African-Caribbean population in 
Britain, the prevalence of dementia in those aged 65 years and over is likely to fall 
somewhere  between  8%  and  34%,  with  17%  the  most  plausible  estimate.  A 
conservative  estimate  for  a  younger,  60  years  and  over  group  might  therefore 
approximate  10-15%,  whilst  that  in  the  general,  white  population  is  known  to  be 
approximately  5%  (Ferri  et  al.,  2005).  Such  a  difference,  if  detected w o u l d  b e  
considered significant in terms of its impact  on  health and social care  planning.  To 
detect a difference between 5% and 15% with a power of 90% and at a significance 
level of 5% (p" 0.05), it was calculated that a sample of 207 people (STATA statistical 
software  package,  version  9)  would  need  to  be  screened  in  each  group.  Given  a 
response rate of 70% based on previous similar surveys (60%-90%), it was expected 
that approximately 300 people would need to be contacted in each group (600 in total). 
Based on the  pilot study, where 69 older  African-Caribbean  patients  were  identified 
from a total practice list of 6000, of which 80% were contactable, it was expected that 
approximately 6 similarly sized practices would need to be recruited.   103 
4.4.8.  Identification & recruitment of participants 
 
4.4.8.1.  Identification 
One of the major difficulties often encountered in epidemiological research with BME 
communities is the challenge of identifying potential participants. This is particularly so 
for the African-Caribbean community, as unlike some other BME groups (e.g. South 
Asians), their  names  are often indistinguishable from  those of the  white  population. 
Also,  until  recently,  data  on  ethnicity  or  country  of  birth  has  not  been  routinely 
collected.  Previous  investigators  have  used  a  number  of  methods  to  identify  their 
subjects including recall by GP practice staff, ‘snowballing’ (identification by existing 
participants), electoral and census lists and ‘direct household enumeration’ (Richards, 
1996). Although comprehensive, household enumeration (door-knocking) is considered 
by  many  to  be  the  ‘gold  standard’,  this  method  is  labour  intensive,  lengthy  and 
considered unacceptable by some Research Ethics Committees (RECs). In Stewart’s 
comparison of this approach with primary care sampling, they estimated that African-
Caribbean  participants  identified  by  practice  staff,  included  72%  of  the  potentially 
eligible population  whilst only 8% of those contacted  were not eligible (Stewart and 
Richards,  2002).  They  also  found  that  compared  to  household  enumeration,  the 
primary care sample was similar on most demographic measures. However, although 
highly specific and moderately sensitive, this approach is vulnerable to ‘use of service’ 
bias.  
 
In  this  study,  all  patients  60  years  and  over,  coded  for  as  African-Caribbean  (or 
equivalent), were identified primarily by searching each practice’s electronic database. 
Most practices recruited for this study use the EMIS™ software, which encompasses a 
provision for generating lists of patients with pre-defined parameters (e.g. age, gender, 
ethnicity).  In  practices  where  ethnic  coding  was  unavailable  or  incomplete, 
identification of potential participants was supplemented with the help of practice staff 
(receptionists,  practice  nurses  &  GPs),  who  manually  identified  African-Caribbean   104 
patients from  a hard copy of the patient list. Similar combinations  of  methods  have 
been used successfully in other studies (Rait et al., 2000) with the aim of achieving the 
highest detection rate possible. The white-British comparison group was identified in 
the same way as the study group, but by searching for those coded as white-British (or 
equivalent).  As  there  tended  to  be  at  least  twice  as  many  white-British as African-
Caribbean patients on each practice list, the former were randomly selected (section 
4.4.5). 
 
4.4.8.2.  Recruitment 
All potential participants were sent a standard letter from their GP on surgery headed 
paper,  (Appendix 6) i n t ro du c i ng  t he  s t ud y  an d  a s k ing  whether  they  would  consider 
participating. This initial letter was brief and written in clear, simple language. It stated 
that a researcher would be contacting them by telephone within two weeks, to discuss 
the  study.  They  were  given  the  choice  to  ‘opt-out’  at  this  stage  by  telephoning  a 
dedicated number and leaving a message or by writing to me, or their surgery, in which 
case they were not contacted further. Between one and two weeks after the first letter 
was sent, potential participants were telephoned to discuss the study and to offer an 
appointment to meet with myself or a research assistant at a venue of their choice. 
This would normally be at the participant’s home or that of a friend or family member. 
Occasionally,  participants  chose  to  be  seen  at  a  day  centre  or  in  the  academic 
department. Participants were not seen in GP surgeries so as not to burden practice 
reception staff and due to space limitations. They were encouraged to invite a family 
member or friend to the interview. Following the telephone call, a detailed information 
sheet (Appendix 7) and letter, confirming the appointment date, time and venue was 
sent.  If  potential  participants  were  not  contactable  on  the  first  occasion,  they  were 
telephoned  several  times,  including  evenings  and  weekends  to  establish  contact. 
Answer  machine  messages  were  left  when  it  was  felt  appropriate.  Unobtainable 
telephone  numbers  were  checked  online  (www.thephonebook.bt.com  and 
www.192.com). If contact was still not made, details were checked with practice staff.   105 
4.4.8.3.  Obtaining Informed consent 
At the first screening appointment, participants and their relative or carer were given 
the opportunity to ask questions regarding the study. The investigator then carefully 
explained any points in the information sheet that had not been understood. Written 
consent was obtained directly from the participant where possible (Appendix 7). When 
it was apparent that the participant did not have the mental capacity to give informed 
consent (e.g. through cognitive impairment), approval  was sought from a relative or 
carer and when not available, from a professional such as their GP*. If it was thought 
that the study would be in any way detrimental to the participant, or if the consent could 
not  be  obtained  as  stipulated,  no  further  action  was  taken  and  the  subject  was 
excluded  from  the  study.  For  those  who  were  able  to  give  verbal  but  not  written 
consent, a relative or carer was asked to witness this and to provide a signature (when 
available).  For  those  with  sensory  impairment,  such  as  blindness  or  deafness, 
assistance  was  made  available  to  facilitate  their  participation  in  the  consenting 
procedure. 
 
*  Although  the  recruitment  for  this  study  was  completed  before  October  2008 a n d  
therefore did not fall under the jurisdiction of the Mental Capacity Act 2005, the same 
principles were adhered to. The act clearly outlines how and when incapacitated adults 
can be recruited into research, specifically stipulating that: 
 
“Carers or nominated third parties must be consulted and agree that the person would 
want to join an approved research project. If the person shows any signs of resistance 
or indicates in any way that he or she does not wish to take part, the person must be 
withdrawn from the project immediately. “ (DoH, 2007). 
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4.4.9.  Interviewers 
Although the author conducted the majority (72%) of the screening interviews (n=314) 
and  all  of t h e  d i a g n o s t i c  s t a g e  a s s e s s m e n t s  ( n = 4 8 ) ,  a  s m a l l  t e a m  o f  r e s e a r c h  
assistants (RAs) was recruited to assist. None of the RAs was involved for the duration 
of the study and recruitment was staggered, with a maximum of two or three helping at 
any  one  time.  The  team  consisted  of  junior  psychiatrists  at  various  stages  of  their 
training,  and  departmental,  non-medical  research  assistants  (RAs).  All  had  some 
previous experience of  interviewing patients or  members  of the general public.  The 
team was composed of: 
Psychiatric trainee doctors: 
•  SP - SHO (Senior House Officer)  
•  MG  - SHO  
•  AR  - SpR (Specialist Registrar) 
•  AP  - SpR 
Departmental Research Assistants: 
•  GH – RA with an undergraduate psychology degree 
•  SB – RA with an undergraduate psychology degree 
•  KS – RA with an undergraduate psychology degree 
 
The psychiatric trainees volunteered their  help in order to gain research experience 
whilst  the  RAs  were  from  the  local  DeNDRoN  (Dementias  &  Neurodegenerative 
Diseases Research Network) team. Each member was provided with an induction pack 
and training for the study. They initially joined me during research visits and observed a 
minimum  of  three  screening  interviews  before  conducting  an  interview  themselves 
under observation.  The psychiatrists who were considerably more experienced than 
the  non-medical  departmental  RAs  subsequently  arranged  their  own  interviews  and 
performed  them  alone.  The  departmental  RAs  were  given  pre-arranged  interview 
appointments a s  t h e y  w e r e  u n a b l e  t o  a c h i e v e  h i g h  e n o u g h  r e c r u i t m e n t  r a t e s ,  
presumably due to their relative inexperience and non-medical status.   107 
4.4.10. Stage 1 - Screening interview 
The screening interviews were performed between March 2007 and October 2008. The 
interview took between 20 and 45 minutes to complete, depending on the participant. It 
comprised  of  the  consent  procedure  as  described,  a  brief  questionnaire  containing 
basic  personal  and  demographic  details,  blood  pressure  reading  and  the  cognitive 
screening test. Information was collected directly from the participant, or from a relative 
or carer for those with evidence of significant cognitive impairment (Appendix 8). The 
questionnaire included questions on: 
 
Age – Completed years 
Sex – Male/Female 
Self-assigned ethnicity – White-British, African-Caribbean, Other - Specified 
Country of birth – Specified  
Years in the UK – Completed years from migration to UK (where applicable) 
Marital status – Single, married/partnership, divorced/separated, widowed, co-habiting 
Living with – Spouse/partner, other family, friend/carer, alone, residential care-home 
Years of education – Years in full-time education from primary level 
Home ownership – Yes/No (previous home ownership if in residential care home) 
Socioeconomic classification – based on current or last employment  
 
Two measures of social and economic status were included; the self coded version of 
the National Statistics Socioeconomic Classification – NS-SEC (Appendix 9) and home 
ownership (Yes or No). The NS-SEC is a measure based on a combination of current 
or previous employment type and supervisory/managerial status. An algorithm gives a 
numerical score from 1 (professionals, managers and employers) to 5 (manual workers 
with no supervisory responsibility). It was decided to include data on home ownership, 
as a single measure of socioeconomic status based on employment could introduce 
bias, as the African-Caribbean community were invited to migrate to the UK specifically 
to fill lower status jobs.    108 
4.4.10.1.  The screening questionnaire 
It is well documented that screening tests tend to over estimate the levels of cognitive 
impairment and dementia in people from BME groups (Parker and Philp, 2004). This is 
thought to be due to a number of factors including language, education, literacy and 
cultural differences.  For example, Fillenbaum et al. found that using the Mini-Mental 
State  Examination  (MMSE),  42%  of  black  participants  falsely  screened  positive  for 
cognitive  impairment  compared  to  only  6%  of  white  participants  (Fillenbaum  et  al., 
1990).  Because of this phenomenon, I decided to identify and use a culturally adapted 
version of the Mini Mental State Examination (MMSE) in the African-Caribbean group. 
The original MMSE (Folstein et al., 1975) is probably the most commonly used and 
extensively studied of the brief dementia screening tests. It covers several areas of 
higher  cognitive  functioning  including  orientation,  attention,  registration,  recall, 
language (reading and writing) and visual construction. The test is scored out of 30, 
and in clinical practice <25 is the usual cut-off for possible dementia. However, one 
study  found  the  optimal  MMSE  cut-off  to  be  <26,  with  a  sensitivity  of  74%,  and 
specificity of 100% (Monsch et al., 1995). Alternatively, due to its education bias, some 
have proposed a cut-off of <27 in high school educated individuals and <25 in those 
with  no  high  school  education.  Even  so,  it  has  been  criticised  as  being  strongly 
culturally, as well as educationally biased and it performs poorly in some BME groups, 
usually  over-predicting  dementia.  This  tends  to  be  worse  in  non-English  speaking 
groups,  despite  its  translation  into  several  Asian  languages.  Its  widespread  use  is 
probably  due  to  the  fact  that  it  is  quick  and  easy  to  administer  (10  minutes),  is 
acceptable  to  most  participants,  and  is  widely  recognised  both  in  primary,  and 
secondary care.  
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African-Caribbean  versions  of  the  MMSE  and  the  shorter  Abbreviated  Mental  Test 
(AMT) were developed by Rait et al. (Rait et al., 2000) – (Appendix 10).  The original 
screening tools were culturally adapted with the assistance of a community group of 
African-Caribbean  volunteers,  alongside  an  academic  group  of  health  professionals. 
The  modified  screening  tools  were  subsequently  validated  in  a  sample  of  130 
community  residents f r o m  i n n e r  c i t y  M a n c h e s t e r .  O n  d i r e c t  c o m p a r i s o n  w i t h  a  
diagnostic  computerised  interview,  the  GMS-AGECAT  (Copeland  et  al.,  1986),  the 
MMSE showed a high correlation (r= -0.47. p<0.001). With a cut-off of <26 the MMSE 
demonstrated 83% sensitivity (95%CI 76-91) and 78% specificity (95%CI 69-86), which 
was  thought  to  be  adequate  for  our  study.  Although  a  higher  cut-off  would  have 
increased the sensitivity, the significantly higher numbers of participants requiring full 
diagnostic interview and of false positives was considered to be impractical, given the 
limited resources for this study.  This version of the MMSE with the same cut-off was 
also used in the pilot study for our project,  where it was found to be  acceptable to 
participants. 
 
In  the  white  reference  group,  a  standardised  version  of  the  Mini  Mental  State 
Examination (Molloy et al., 1991) was employed (Appendix 10). This was developed in 
an attempt to improve on the objectivity and intra/inter-rater reliability of the original 
MMSE. It is particularly useful in studies with more than one researcher, which is why I 
chose it in this instance. With the same components as the original test, this version 
comes w i t h  s p e c i f i c  i n s t r u c t i o n s  o n  h o w  t o  s c o r e  e a c h  q u e s t i o n  a n d  p r o v i d e s  
examples. It has been shown to score similarly on measures of validity and reliability to 
that of the African-Caribbean version when used in the general white population, and 
the same cut-off of <26 was used in this study. 
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In order to directly compare the performance of the standard and African-Caribbean 
versions of the MMSE in our own study sample, I decided to administer both screening 
tests simultaneously to all participants. As the two versions contain a high proportion of 
shared  questions,  this  was  best  achieved  by  combining  them  into  one,  extended 
version of the MMSE, from which two scores could be obtained (Appendix 10). This 
was done in such a way that all the questions were included and the time for delayed 
recall in each test was preserved. This new, combined test was then piloted before use 
in  the  main  study  and  inter-rater  reliability  calculated  between  researchers.  African-
Caribbean  participants  were  subsequently  scored  on  their  performance  on  the 
culturally  adapted  version  whilst  white  participants  were  scored  on  the  standard 
version.  An  exception  was  made  for  those  white  participants  with  poor  literacy,  in 
whom the less educationally biased African-Caribbean version was used. In this test, 
there  is  no  requirement  to  spell  (as  in  ‘spell  WORLD  backwards’)  or  to  write  a 
sentence, although the instruction ‘CLOSE YOUR EYES’ was retained. Screening in 
those  with  visual  impairment  was  achieved  by  omitting  the  sight  dependent 
components  and  linear  transformation  of  the  scores  to  estimate  the  equivalent,  full 
MMSE score as described by (Reischies and Geiselmann, 1997) and (Busse et al., 
2002). 
 
4.4.10.2.  Blood Pressure Measurement 
Blood pressure was measured after 5 minutes of sitting, both at the start and at the end 
of the interview with an automated BP monitor. The lowest value was used.  If the first 
reading was high (systolic >140mm Hg or diastolic >90mm Hg) the blood pressure was 
repeated twice over the next 15 minutes and a mean value taken. This allowed for the 
objective screening for hypertension in participants according to British Hypertension 
Society recommendations (www.bhsoc.org). However, the limitation of a one-off blood 
pressure screen are recognised and discussed further in section 6.5.7.2. 
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4.4.11. Stage 2 - Diagnostic Interview 
Those  screening  positive  on  the  MMSE  (<26) at the initial stage  were  asked for a 
second,  structured  diagnostic  interview.  Due  to  the  limited  time  available  for  the 
screening interviews, this was generally held at a later date. A family member, friend or 
carer was invited to attend, and as before, the interview took place at a time and venue 
of the participant’s choice. I conducted all the diagnostic interviews myself, although a 
research assistant was present if they had conducted the original screening test. The 
interview  took  between  60  and  120  minutes  depending  on  the  number  of  test 
components completed. 
 
A number of structured diagnostic schedules have been developed, which allow for the 
generation of formal dementia diagnoses according to operational diagnostic criteria. 
However, unlike the screening tool, none was found to have been validated specifically 
for use in the British African-Caribbean population. I therefore decided that one of the 
most  commonly  used  and  acceptable  interview  schedules,  the  Cambridge  Mental 
Disorders of the Elderly Examination (Revised) – CAMDEX-R (Roth et al., 1986) would 
be  modified  for  use  in  this  study.  The  full  CAMDEX-R in t e r v iew  com p r i s e s s e ve r a l 
sections  including  an  informant  history,  medical  and  drug  history,  laboratory 
investigations, interviewers observations, a brief physical examination and a cognitive 
assessment  – t he  C AM C O G .  A l t ho ug h a ll  t he se  c om p on en t s  w e r e re t a i ne d f o r t h e 
study, a small number of questions were modified or removed, as they were thought to 
be  redundant,  or  culturally/educationally  dependent.  These  changes  are  justified,  in 
that the data generated by the modified interview retained enough information, to allow 
for the diagnosis of dementia and sub-types according to the operational diagnostic 
criteria  chosen  for  the  study.  Guided  by  a  tick  box  proforma  (Appendix 1 1 ),  the 
modified diagnostic interview comprised eight sections: 
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A. Physical Health Questions: 
•  Cardio-vascular risk factors 
•  History of cerebro-vascular disease 
•  Neurological symptoms 
•  General health 
•  Drugs & alcohol history 
•  Family history of physical illness 
 
B. Mental Health Questions: 
•  Psychiatric History 
•  Current mood & related symptoms 
•  Psychotic symptoms 
C. Cognitive Functioning Questions: 
•  Memory problems 
•  General Mental Functioning 
•  Personality change 
•  Delirium/Clouding 
•  Everyday activities/Level of functioning 
D. Current Medication 
E. Relevant Physical Investigations (if known) 
F. Brief Physical Examination 
G. Cognitive Examination – CAMCOG 
H. Interviewer Observations 
 
4.4.11.1.  The Informant history 
Questions from the modified CAMDEX-R were asked to the participant, informant or 
both, where relevant. Whereas information on physical health could be obtained easily 
elsewhere, this  was  often the only opportunity to gather  a clear history of cognitive 
decline  and  assess  the  current  level  of  social  functioning.    As  informants  were  not 
always available, it was sometimes not feasible to complete the assessment during the 
interview. In these circumstances, as much detail as possible was obtained from the 
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This  included  speaking  to  relatives,  friends,  neighbours,  paid  carers  and  other 
professionals,  such  as  wardens  and  residential  home  staff  outside  of  the  interview 
setting (with consent). General practice records were also scrutinised for evidence of 
cognitive decline, as were any records held by the local old age psychiatric service. For 
some participants, exhaustive investigations were required, in order to obtain enough 
information to make a definitive diagnosis. 
 
4.4.11.2.  Cognitive Assessment 
The  CAMCOG  was  designed  to  be  administered  in  conjunction  with  the  other 
CAMDEX-R c o m p o n e n t s .  I t  c o m p r i s e s  s e c t i o n s  that a s s e s s  a  n u m b e r  o f  c o g n i t i v e  
domains  including:  orientation,  perception,  language,  memory  (recall,  recent  and 
remote memory), attention/concentration, calculation, praxis and executive functioning. 
It also incorporates questions from the MMSE and can generate an independent score 
for this. In its complete form, it has a maximum of 106 points, with a cut-off of 79/80 for 
dementia. It has an estimated sensitivity of 93% and a specificity of 96% (Roth et al., 
1986). As mentioned previously, the CAMDEX-R although widely used, has not been 
validated or adapted for use in any specific cultural or ethnic group. When designing 
the diagnostic interview, I decided along with my supervisors that a small number of 
questions were potentially either culturally or educationally biased. I removed them for 
the purpose of this study. These included some questions testing executive functioning 
(200b  –  visual  reasoning)  and  the  retrieval o f  r e m o t e  m e m o r y :  ( 1 6 6  – 1 7 1 ) ;  f o r  
example: 
 
When did the First World War begin? 
What was Mae West famous for? 
Who was the famous flyer whose son was kidnapped? 
What is Yoko Ono famous for? 
Who was the first woman Prime Minister of India? 
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The questions generating the MMSE score were redundant and also omitted. As the 
total  score  no  longer  totalled  106,  the  cut-off  of  79/80  was  not  used  to  guide  the 
diagnostic procedure. Instead, performance in specific cognitive domains were used to 
supplement the clinical information and informant history in making the final diagnosis, 
in accordance with standardised criteria (4.4.12) 
 
4.4.11.3.  Medical History & Physical examination 
The medical history assessed risk factors for dementia, focusing heavily on cerebro-
vascular  disease  and  its  determinants,  such  as  diabetes,  hypertension  and  stroke. 
Prescribed  and  taken  medications  were  recorded;  in  particular  anti-hypertensives, 
diabetic  treatment  and  psychotropic  drugs.  The  medical  history  was  later 
supplemented  by  information  obtained  directly  from  the  participant’s  primary  care 
notes,  with  written  permission  (Consent  form  -  Appendix 7 ).  This  was  accessible 
electronically at each of the G.P. surgeries. Recent pathology results, neuroimaging 
reports (when available) and other relevant physical investigations were also obtained 
in  this  way.  Although  desirable,  it  was  beyond  the  scope  of  this  study  to  request 
additional investigations in the form of blood tests or neuroimaging. 
 
A brief, but structured physical examination was conducted to elicit any physical signs 
associated with dementia and to identify other physical disease that may account for 
cognitive impairment. As for the medical history the examination focussed largely on 
evidence of cardio-vascular and cerebro-vascular disease, and also looked for other 
neurological  and  endocrine  disorders  (e.g.  thyroid  disease)  and  sensory  deficits.  A 
comprehensive physical examination was rarely possible, due to the home setting and 
the  fact  that  it  would  have  been  inappropriate  to  ask  participants  to  undress, 
particularly when unaccompanied.  
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4.4.12. Diagnostic procedure 
Data collected from both the screening and  diagnostic interviews  were collated and 
summarised  in  a  standardised  format  (Appendix 1 2 ).  Any  identifiable  participant 
information  was  removed  from  the  original  interview  proforma.  These  were  then 
copied,  and  compiled  into  packs,  with  a  summary  sheet  for  each  of  the  diagnostic 
raters.  Typically,  batches  of  5-10  interview  packs  were  rated  at  meetings  between 
myself and the two raters (my PhD supervisors; both academic old age psychiatrists). 
‘Blind’ to the ethnicity of each participant, the raters judged whether a formal diagnosis 
of  dementia  could  be  made,  according  to  ICD-10 Research  Diagnostic  Criteria  and 
DSM-IV-TR  criteria (section  1.2.1).  They  also  included  a  clinical  rating  of  dementia 
(mild,  moderate  or  severe)  based  on  ICD-10  criteria, a n d  s p e c i f i e d  t h e  d e m e n t i a  
subtype(s) according to the following diagnostic criteria: 
 
Alzheimer’s Dementia – ICD-10, DSM-IV & NINCDS-ADRDA (McKhann et al., 1984) 
Vascular Dementia – ICD-10, DSM-IV & NINDS-AIREN (Roman et al., 1993) 
Lewy Body Dementia (DLB) - Revised DLB Consortium Criteria (McKeith et al., 2005) 
 
Frontotemporal Dementia (FTD) – Consensus criteria (McKhann et al., 2001)  
Other dementia – specified 
 
Diagnoses  were  made  independently  by  each  rater,  with  the  aid  of  a  specially 
developed diagnostic checklist (Appendix 12) and recorded, before comparing with the 
other rater. In instances where raters did not agree, consensus was reached through 
discussion.  It  was  possible  for  participants  to  meet  the  criteria  for  more  than  one 
subtype of dementia unless one precluded the diagnosis of another e.g. a diagnosis of 
vascular dementia would excluded an ICD-10 diagnosis of Alzheimer’s disease.  
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4.5. MEDICAL NOTES SURVEY 
 
As discussed in Chapter One, the importance of early detection of dementia in primary 
care is strongly emphasised in a number of governmental reports, guidelines and in the 
National Dementia Strategy (section 1.2.4.3). Financial incentives in the form of QOF 
indicators  also  encourage  General  Practices  to  set  up  a  dementia  register  and  to 
review the patients on it at regular intervals (section 1.2.5). The advantage of the new 
QOF related dementia registers to this study is that they were used as a preliminary 
guide  to  the  level  of  detection  of  dementia  in  each  general  practice  recruited. 
Participants from each practice, who screened positive for cognitive impairment, were 
initially  checked  for  their  inclusion  on  the  dementia  register,  if  in  operation.  Their 
individual medical records were then scrutinised for: 
 
1.  Mention of cognitive impairment; in terms of forgetfulness, confusion, behavioural 
change or functional deterioration. 
2.  Mention of, or formal diagnosis of ‘dementia’. 
3.  Referral to mental health, social or voluntary services in relation to any of the above 
problems. 
4.  Pharmacological  treatment  received  in  relation  to  a  diagnosis  of  dementia  or 
cognitive impairment (e.g. cholinesterase inhibitors for AD). 
 
For  most  participants,  their  medical  records  were available in electronic format and 
were easily accessible. Electronic records were scrutinised for the previous five years, 
or from first registration with the practice if sooner. For each participant, documentation 
of  dementia  in  the  medical  records  was  compared  with  the  standardised  diagnosis 
generated through the study. The rates of dementia diagnosis and referral to dementia 
services were subsequently compared between the two study groups.   117 
4.6 STATISTICAL ANALYSIS 
 
I used SPSS version 16.0 for Mac (SPSS inc 2007) to analyse the data. Two-tailed 
tests were used throughout. Although multiple univariate analyses were conducted, a 
level of 5% (p<0.05) was taken as significant, only to identify those variables to include 
in the multivariate analysis. For univariate tests, parametric statistics were used where 
the data approximated a normal distribution (where Pearson’s skewness statistic was 
less than +/- 1.0) (Miles and Shevlin, 2001). Chi squared (Chi
2) or Fisher’s exact tests 
were  performed  to  compare  proportions  (binary  data),  and  independent  t-tests  or 
Mann-Whitney U tests to compare central values (continuous data), where appropriate. 
Classical  stratification  and  binary  logistic  regression  techniques  were  used  for 
multivariate  analyses.  Variables  chosen  for  the  final  analyses  included  those  under 
investigation  (i.e.  dementia  status  and  ethnic  group)  and  potential  confounders  as 
identified from the univariate analyses. 
 
 
4.6.1. Cross sectional analysis 
Initially, the recruitment rate and reasons for non-participation were explored. In order 
to assess for selection bias, I compared the age, sex and ethnic distribution between 
potential participants who were contactable and those who were not. I repeated this 
analysis for those who agreed to participate and those who declined. I then performed 
univariate  analyses  to  compare  the  white-British  and  African-Caribbean  groups,  in 
terms  of  their  main  demographic  characteristics  including  age,  sex,  marital  status, 
years  of  education,  home  ownership  and  self  assigned  socioeconomic  status ( N S -
SEC).  
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 4.6.1.1. Screening stage 
I compared the MMSE scores (range, central value, spread) between ethnic groups on 
their  respective, culturally appropriate versions. I then calculated and compared the 
crude  prevalence  of  screening  positive  for  cognitive  impairment.  To  investigate  the 
performance (cultural/educational) of the two MMSE versions, I calculated the crude 
prevalence of screening positive for each group on each test, separately.  
 
Rates  of  measured a n d  r e p o r t e d  ( t r e a t e d )  h y p e r t e n s i o n  w e r e  c o m p a r e d  b e t w e e n  
ethnic  groups,  separately.  I  also  compared  rates  of  measured  hypertension  with 
reported  hypertension,  in  order  to  estimate  the  frequency  of  untreated  and 
inadequately treated hypertension. The proportions of both were compared between 
ethnic groups. 
 
I subsequently performed univariate analyses to explore the relationship between  a 
number of demographic/health variables and screening status. These included age, 
sex,  years  of  education,  home  ownership,  socioeconomic  status,  reported  and 
measured  blood  pressure.  From  the  univariate  analyses  that  reached  statistical 
significance (p<0.05), the most plausible confounders or effect modifiers of the crude 
association between ethnicity and screening status were identified. Where appropriate 
(for  continuous  data),  potential  confounders  were  transformed  into  categorical  data. 
Classical  stratification  techniques  were  then  employed  to  control  for  potential 
confounding and to identify effect modification of the primary association. Finally, all 
potential confounders were entered into a logistic regression model using a stepwise 
approach, with screening status as the dependent variable. I entered ethnicity on step 
one and all other variables that reached statistical significance on univariate analysis 
on subsequent steps, in order to assess their effect on the model individually. I then re-
examined  the  primary  association  between  screening  status  and  ethnicity  when 
controlled for potential confounders.   119 
4.6.1.2. Diagnostic stage 
I  first  identified  those  participants  who  had  dropped  out  of  the  study  or  failed  to 
complete the diagnostic interview, and compared them by ethnic group.  I then further 
investigated each component of the diagnostic interview for the degree of completion 
by participants. The crude prevalence of dementia (any criteria) was calculated and 
compared between ethnic groups. This analysis was performed for participants, both 
with and without MCI and including and excluding those in residential care homes. I 
then explored frequency of dementia by severity (mild, moderate or severe) and then 
by subtype, according to each standardised diagnostic criterion. 
 
As  for  screening  status  (described  above),  univariate  analyses  were  conducted  to 
explore  the  relationship  between  dementia  diagnosis  and  a  number  of  potential 
covariates. From these, potential confounders of the relationship between ethnicity and 
dementia  were  identified.  These  were  further  investigated,  first  using  classical 
stratification  and  then  logistic  regression  techniques,  with  dementia  status  as  the 
dependent variable. As the numbers of participants with dementia were relatively small, 
variables for which data was missing in more than 20% of participants (with dementia) 
were excluded from the final multivariate analysis, otherwise data was imputed, using 
SPSS software. 
 
4.6.2.  Medical notes survey 
Of the participants with dementia, the proportions that had a formal diagnosis recorded 
in the primary care records were compared between ethnic groups, and any difference 
analysed. I then examined the medical note entries in more detail, in regard to mention 
of  cognitive  impairment,  dementia,  dementia  subtype,  referral  and  pharmacological 
treatment. Statistically significant differences between the groups were tested, using 
univariate analyses.   120 
5. RESULTS 
 
5.1. CROSS SECTIONAL SURVEY RESULTS 
5.1.1.  Recruitment rates 
Of the 14 Haringey, General Practices I approached through NoCLoR, eight expressed 
an initial interest and five participated in the study. The remainder either declined, or 
did not respond. Four of the participating practices were in the suburb of Tottenham, 
and one in Hornsey (table 5.1). 
 
Table 5.1      General Practices Recruited 
NAME  LOCATION  PARTICIPANTS 
SELECTED 
 
PARTICIPANTS 
CONTACTABLE 
(%) 
 
NUMBER 
PARTICIPATED 
(%)* 
 
Westbury 
Avenue 
Surgery 
 
Hornsey  8  8 (100)  3 (37.5%) 
 
Charlton House 
Medical Centre 
 
Tottenham  306  249 (81.4)  155 (62.2%) 
 
Park Road 
Surgery 
 
Hornsey  72  49 (68.1)  32 (65.3%) 
 
Somerset 
Garden Family 
Healthcare 
Centre 
 
Tottenham  283  210 (74.2)  130 (61.9%) 
 
Lawrence 
House Medical 
Centre 
 
Tottenham  227  170 (74.9)  116 (68.2%) 
Total  896  686 (76.6) 
 
436 (63.6%) 
 
* % of those contactable and eligible to take part   121 
In total, the names of 1,617 potential participants were obtained, of which 896 were 
selected for inclusion in the study. This included all 460 people who were coded for, or 
identified  by general practice staff as being African-Caribbean (or equivalent) and a 
random sample of 436 people who were coded for, or identified as being white-British 
(or  equivalent).  The final  number randomly selected for the  white-British group was 
smaller, because a higher proportion were contactable than for the African-Caribbean 
group. One hundred and seventy three (19.3%) people were not contactable by phone 
for  a  number  of  reasons  including;  no/wrong/unobtainable  telephone  number  61 
(6.8%), no answer after several attempts 77 (8.6%), moved away/ no longer with the 
same general practitioner/in hospital/dead 35 (3.9%). Further enquiry revealed that 18 
(2%) people coded for as African-Caribbean were of other ethnicities; all came from 
South Asia or Africa. They were excluded from the study along with a further 19 people 
who  did  not  meet  the  inclusion  criteria  for  other  reasons  (intellectual  disability, 
hospitalisation,  acutely  ill).  In  total,  723  potential  participants  were  contacted  by 
telephone and of them, 686 met the inclusion criteria. Although 456 agreed to meet 
with a  researcher,  20 cancelled  or did  not keep their  appointment, leaving 436  who 
completed the screening interview (63.6% of those contacted and eligible). As planned, 
half were white-British (218) and half were African-Caribbean (218). The majority of 
participants (96.5%) lived in their own homes or with family; the remainder living in one 
of two residential care homes (fig. 5.1). 
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Figure 5.1      Summary of Recruitment 
 
 
 
896 Potential Participants selected 
 
 
686 Contactable & eligible 
 
 
456 Agreed to meet 
 
 
 
436 Completed screening interview 
 
         
 
218 White-British      218 African-Caribbean 
 
           
19 screen positive (8.72%)    32 screen positive (14.68%) 
 
             
 
15 have dementia        21 have dementia 
6.88% crude prevalence      9.63% crude prevalence 
 
 
 
No phone or 
unobtainable  
number =  61 
No answer = 77 
Moved away, 
hospitalised/died = 35 
Not eligible = 37 
 
n=210 
 
DNA or 
Cancelled 
n=20 
Declined n=230 
 
Refused 
further testing 
or lost to 
follow-up. 
n=5   123 
 
5.1.2  Contactable versus not contactable 
A  higher  proportion  of  white-British  people  were  contactable  (85.9%)  than  African-
Caribbean people (80.6%), (Chi
2=4.213; p=0.040; OR 1.471, 95%CI 1.016 to 2.129) 
and  a  higher  proportion  of  females  (86.8%)  were  contactable  than  males  (78.7%), 
(Chi
2=9.474; p=0.002; OR 0.563, 95%CI 0.389 to 0.84). Those contacted (mean age 
72.9  years;  SD  8.3)  were  on  average  3.1  years  older  than  those  who  were  not 
contactable  (mean  age  69.8  years;  SD  7.4)  (t=4.104;  p<0.001).  In  those  not 
contactable,  there  was  no  age  difference  (t=0.240;  p=0.810) o r  s e x  d i f f e r e n c e  
(Chi
2=1.596; p=0.207)  between ethnic groups. 
 
5.1.3  Participants versus those who declined  
Although  the  participation  rate  was  higher  in  the  African-Caribbean  group,  218/320 
(68.1%)  than  in  the  white-British  group  218/346  (63.0%),  this  was  not  statistically 
different (Chi
2=1.927; p=0.165). Participants were also similar to those who declined in 
terms  of  sex  and  age;  260/436  (59.6%)  of  participants  were  female  compared  to 
128/230  (55.7%)  of  non-participants ( C h i
2=0.981;  p=0.322);  the  mean  age  of 
participants  was  72.8  years  (SD  8.0)  compared  to  73.1  years  (SD  8.9)  in  non-
participants, (t= -0.421; p=0.674). 
 
5.1.4  Participant demographic data 
5.1.4.1 Country of Birth 
As  well  as  the  United  Kingdom  and  Ireland,  participants  reported  coming  from  11 
Caribbean islands and Guyana. Of the 216 African-Caribbean participants on whom I 
had  data,  the  majority  were  born  in  Jamaica  120  (55.6%)  followed  by  Trinidad  19 
(8.8%),  Barbados  16  (7.4%)  and  Guyana  11  (5.1%).  Others  reported  coming  from 
Antigua,  St  Vincent,  St  Lucia,  St  Kitts,  Nevis,  Montserrat,  Grenada  and  Dominica. 
Notably, none of the potential African-Caribbean participants I approached was born in 
the UK.    124 
5.1.4.2 Age 
The age range for participants (n=436) was 60 to 99 years (skewness statistics 0.691), 
with a mean age of 72.8 years (SD 8.005), (fig. 5.2). 
 
Figure 5.2    Age distribution of all participants. 
 
 
 
The mean age for white-British participants was 73.7 years compared to 71.8 years in 
the African-Caribbean sample. The  mean difference of 1.9 years (95%CI 0.4 – 3.4) 
was significant (t=2.528; p=0.012). When I explored the age distribution for each ethnic 
group (see table 5.2), I found that 58/218 (26.6%) of white-British participants were 
over the age of 80 and 10/218 (4.6%) over 90 years, whereas these proportions were 
only 28/218 (12.8%) and 2/218 (0.9%) respectively for African-Caribbean participants. 
Notably, a high proportion of African-Caribbean people fell into the 65-69 & 70-74 year 
age bands.  The difference in age structure between the two ethnic groups was highly 
significant (Chi
2=2.47; p=0.001).    125 
 
Table 5.2      Age distribution by ethnic group 
5-year age-bands 
Ethnicity 
60-64  65-69  70-74  75-79  80-84  85-89  90-94  95-99 
Total 
White-
British (%) 
32 
(14.7) 
59 
(27.1) 
35 
(16.1) 
34 
(15.6) 
25 
(11.5) 
23 
(10.6) 
6  
(2.8) 
4  
(1.8) 
218   
(100) 
African-
Caribbean 
 (%) 
28 
(12.8) 
59 
(27.1) 
67 
(30.7) 
36 
(16.5) 
18 
(8.3) 
8  
(3.7) 
2  
(0.9) 
0  
(0.0) 
218   
(100) 
Total  
(%) 
60 
(13.8) 
118 
(27.1) 
102 
(23.4) 
70 
(16.1) 
43 
(9.9) 
31 
(7.1) 
8  
(1.8) 
4  
(0.9) 
436  
(100) 
 
 
5.1.4.3 Sex 
Of the whole sample, the majority were female (table 5.3). There was no significant 
difference in the proportion of females between the white-British and African-Caribbean 
participants (Chi2=0.152; p=0.696). 
 
Table 5.3        Sex distribution by ethnic group 
Ethnic group  Male (%)  Female (%)  Total (%) 
White-British (%)  90 (41.3)  128 (58.7)  218 (100) 
African-Caribbean (%)  86 (39.4)  132 (60.6)  218 (100) 
Total (%)  176 (40.4)  260 (59.6)  436 (100) 
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5.1.4.4 Marital status 
Information on marital status was available on 424/436 (97%) of participants. Of these, 
180 (42.4%) were married or cohabiting (table 5.4). This proportion was higher in the 
African-Caribbean group 100/212 (47.2%) than the white-British group 80/211 (37.9%) 
and  the  difference  approached  statistical  significance  (Chi
2=3.705;  p=0.054).  The 
white-British  participants  were  nearly  twice  as  likely  to  be  widowed  (Chi
2=2.35; 
p<0.001). 
 
Table 5.4      Marital status by ethnic group. 
  White-British (%)  African-Caribbean (%)  Total (%) 
Married  76 (35.9)  95 (44.8)  171 (40.3) 
Partner/Cohabiting  4 (1.9)  5 (2.3)  9 (2.1) 
Single  28 (13.2)  16 (7.5)  44 (10.4) 
Divorced  28 (13.2)  44 (20.8)  72 (17.0) 
Separated  3 (1.4)  12 (5.7)  15 (3.5) 
Widowed  73 (34.4)  40 (18.9)  113 (26.7) 
Total  212 (100)  212 (100)  424 (100) 
 
 
5.1.4.5 Years of education 
Data were available on 370/436 (84.9%) of participants (see figure 5.3). Time spent in 
full-time  education  ranged  from  five  to  23  years  (skewness  statistic  2.00).  Of  all 
participants, the median value was 10.0 years (interquartile range 9-11 years). There 
was no difference in these values between ethnic groups. 
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5.1.4.6 Home Ownership 
Data on home ownership was available on 421/436 (96.6%) of participants (table 5.5). 
The majority either owned, or had previously owned their own homes. The proportion 
of home ownership was considerably lower in the white-British group than the African-
Caribbean group (Chi
2=1.56; p<0.001; OR 0.458, 95%CI 0.310 – 0.677).  
 
 
Table 5.5      Home ownership by ethnic group. 
Home ownership   White-British (%)  African-Caribbean (%)  Total (%) 
YES  88 (41.7)  128 (61.0)  216 (51.3) 
NO  123 (58.3)  82 (39.0)  205 (48.7) 
Total  211 (100)  210 (100)  421 (100) 
 
 
 
5.1.4.7 Self assigned socioeconomic status 
Data on  NS-SEC was available on 414/436 (95.0%) of participants (table 5.6). The 
majority  (61.7%)  fell  into  groups 4  a n d  5  i n d i c a t i n g  l o w e r  s o c i o e c o n o m i c  s t a t u s  
according to current or previous occupation. When I compared socioeconomic status 
by ethnicity, I found that a higher proportion of African-Caribbean participants (74.7%) 
fell into NS-SEC categories four and five than white-British participants (55.3%) (table 
5.6).  This  overall  difference  in  NS-SEC  distribution  was  statistically  significant 
(Chi
2=2.07; p<0.001). 
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Table 5.6        NS-SEC by ethnic group. 
 
Ethnic Group (%) 
 
White-British  African-
Caribbean 
Total (%) 
1  36 (17.3)  28 (13.6)  64 (15.5) 
2  49 (23.6)  22 (10.7)  71 (17.1) 
3  8 (3.8)  2 (1.0)  10 (2.4) 
4  36 (17.3)  53 (25.7)  89 (21.5) 
5  79 (38.0)  101 (49.0)  180 (43.5) 
Socioeconomic 
status 1-5 
Total  208 (100)  206 (100)  414 (100) 
 
 
5.1.5  Stage 1 – Screening interview 
A total of 436 participants (218 white-British and 218 African-Caribbean) completed the 
screening interview. 
 
5.1.5.1 Performance on the MMSE 
The  scores  ranged  from  zero  to  30  on  both  the  standard  and  African-Caribbean 
versions  of  the  MMSE  (skewness  statistics  -3.305  and  -4.029  respectively).  The 
median values for the ethnic groups combined were 28 (interquartile range 26-29) for 
the  standard  version  and  29  (interquartile  range  27-30)  for  the  African-Caribbean 
version. Overall, the African-Caribbean participants performed less well on both tests 
than their white-British peers. The difference in performance between ethnic groups on 
both tests was statistically significant; Mann-Whitney U scores = 15060.5 (p<0.001) 
and 19065.0 (p=0.004) for the Standard and African-Caribbean versions respectively. 
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5.1.5.2 Screen positives 
 
A total of 51/436 (11.7%) participants screened positive for cognitive impairment (<26 
on  their r e s p e c t i v e ,  c u l t u r a l l y  a p p r o p r i a t e  v e r s i o n s  o f  t h e  M M S E ) ,  ( t a b l e  5 . 7 ) .  T h e  
difference in proportions screening positive between the two ethnic groups approached 
statistical significance (Chi
2=3.753; p=0.053), with an estimated MH Odds Ratio of 1.80 
(95%CI 1.00 to 3.29). 
 
Table 5.7    Screening status by ethnic group.* 
  White-British  African-Caribbean  Total 
Screen Negative  199 (91.3)  186 (85.3)  385 (88.3) 
Screen positive  19 (8.7)  32 (14.7)  51 (11.7) 
Total  218 (100)  218 (100)  436 (100) 
* With a cut-off of < 26 on the culturally appropriate version of the MMSE. 
 
When  I  analysed  the  participants’  performance  on  each  of  the  MMSE  versions 
separately,  the  difference  was  more  striking.  Both  groups  performed  better  on  their 
respective, culturally appropriate versions. This effect was far more pronounced in the 
African-Caribbean participants of whom more than 28% would have screened positive 
on the standard MMSE (with the same cutoff) compared to just 8.7% of white-British 
participants (Chi
2=2.74; p<0.001) (table 5.8).  
 
Table 5.8  Participants screening positives (%) according to MMSE version. 
Participants  Standard MMSE (%)  African-Caribbean MMSE (%) 
White-British  19 (8.7)  21 (9.6) 
African-Caribbean  62 (28.4)  32 (14.7) 
Total screen positives  81 (18.6)  53 (12.2) 
 
*Numbers in bold indicate the respective, culturally appropriate MMSE. 
 
 
   130 
5.1.5.3 Blood pressure  
During the screening interviews, blood pressure measurements were taken on 361/436 
(82.8%) participants (methods section 4.4.10.2). The diastolic values ranged from 48 to 
114  (mean  83;  SD  11.3;  skewness  -0.041)  and  the  systolic  values  from  93  to  206 
(mean 146; SD 19.3; skewness 0.367). 
 
When  adhering  to  British  Hypertension  Society  guidelines,  240/361  (66.5%)  of  all 
participants were considered to be hypertensive at the time of the screening interview. 
When compared by ethnic group  113/180 (62.8%)  of  white-British participants  were 
hypertensive  compared  to  127/181  (70.2%)  of  African-Caribbean  participants.  This 
difference was not statistically significant (Chi
2=2.211; p=0.137). 
 
Of  the  324  participants  who  knew  their  existing  hypertension  status,  205  (63.27%) 
reported  taking  treatment  for  high  blood  pressure.  Significantly  fewer  white-British 
participants  89/163  (54.6%)  reported  taking  treatment  than  African-Caribbean 
participants 116/161 (72.0%); (Chi
2=1.06; p=0.001; OR 0.47, 95%CI 0.29-0.74)). 
 
I collected complete data on 317 participants with regard to both reported (treated) and 
measured hypertension (see table  5.9). Overall, 141/199  (70.9%) of those reporting 
treatment with an antihypertensive, were hypertensive as measured at the screening 
interview. There was no significant difference between the two ethnic groups in this 
respect  (Chi
2=0.423;  p=0.515).  Conversely,  72/213  (33.8%)  of  participants  with 
measured hypertension reported having no treatment for this and significantly fewer 
were white-British (50.7%) than African-Caribbean (77.8%) (Chi
2=8.591; p=0.003; OR 
3.41, 95%CI 1.47-7.88).   131 
Table 5.9    Treated and measured hypertension by ethnic group. 
Hypertension (reported/treated)  Ethnic 
Group 
Hypertension 
(measured)  Yes (%)  No (%) 
TOTAL 
White-
British 
Yes  63 (73.3) *  37 (50.7) ***  100 (62.9) 
  No  23 (26.7) **  36 (49.3)****  59 (37.1) 
  Sub-total  86 (100)  73 (100)  159 (100) 
         
African-
Caribbean 
Yes  78 (69.0) *  35 (77.8) ***  113 (71.5) 
  No  35 (31.0)**  10 (22.2)****  45 (28.5) 
  Sub-total  113 (100)  45 (100)  158 (100) 
         
TOTAL    199  118  317 
* Inadequately treated hypertension ** Adequately treated hypertension  
*** Undiagnosed hypertension **** No hypertension 
 
 
5.1.6  Covariates relating to screening status. 
All univariate analyses were performed in relation to culturally specific MMSE scores. 
These  associations  were  further  explored  to  identify  potential  confounders  of  the 
relationship between ethnicity and screening status. 
 
5.1.6.1 Age 
The mean age in those screening positive was significantly higher at 80.8 years (SD 
9.3) compared to 71.7 years (SD 7.2) in those screening negative; mean difference 9.1 
years (95%CI 6.91 to 11.28 years; t= -8.179; p< 0.001).  
 
5.1.6.2 Sex 
There was no significant difference in screening status by sex; 21/176 (11.9%) males 
screened positive verses 30/260 (11.5%) females (Chi
2=0.16; p=0.9).    132 
5.1.6.3 Years of education 
The median duration of full time education was significantly lower in those screening 
positive at 9 years (interquartile range 8-10) compared to 10 years (interquartile range 
9-11) in those screening negative (Mann-Whitney U score 3895.0 ; p<0.001). 
 
5.1.6.4 Home ownership 
There  was  no  significant  difference  in  screening  status  when  compared  by h o m e  
ownership;  21/216  (9.7%)  of  home  owners  screened  positive,  compared  to  26/205 
(12.7%) not owning their own home (Chi
2=0.930; p=0.335). 
 
5.1.6.5 Self assigned socioeconomic status 
Of the 414 participants on whom I had data, 229/370 (61.9%) of participants screening 
negative  were assigned to NS-SEC  groups  4  and 5 compared to 40/44 (9 0 . 9% )  o f 
those screening positive (table 5.10). The difference in distribution of screen positives 
and negatives between the NS-SEC groups 1 to 5 was found to be highly significant 
(Chi
2=2.71; p<0.001). 
 
Table 5.10      Screening status by NS-SEC 
Screening Status (%)   
Screen negative  Screen positive 
Total (%) 
1  63 (17.0)  1 (2.3)  64 (15.5) 
2  70 (18.9)  1 (2.3)  71 (17.1) 
3  8 (2.2)  2 (4.5)  10 (2.4) 
4  83 (22.4)  6 (13.6)  89 (21.5) 
Socioeconomic 
class  
5  146 (39.5)  34 (77.3)  180 (43.5) 
Total  370 (100)  44 (100)  414 (100) 
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5.1.6.6 Blood Pressure 
Of the participants screening positive from whom I collected data, significantly more 
reported  existing  (treated)  hypertension  compared  to  those  screening  negative 
(Chi
2=5.065; p=0.024). The estimated MH odds ratio was 0.45 (95%CI 0.22 to 0.91), 
(table 5.11).  
 
 
Table 5.11    Screening status by reported (treated) hypertension 
  Reported 
hypertension 
No reported 
hypertension 
 
Total 
Screen negative (%)  167 (60.7)  108 (39.3)  275 (100) 
Screen positive (%)  38 (77.6)  11 (22.4)  49 (100) 
Total (%)  205 (63.3)  119 (36.7)  324 (100) 
 
There was no significant difference in the rates of measured hypertension in relation to 
screening status (Chi
2=0.007; p= 0.935), (table 5.12). 
 
 
Table 5.12      Screening status by measured hypertension 
  Hypertension  No hypertension  Total 
Screen negative (%)  105 (33.4)  209 (66.6)  314 (100) 
Screen positive (%)  16 (34.0)  31 (66.0)  47 (100) 
Total (%)  121 (33.5)  240 (66.5)  361 (100) 
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5.1.7  Controlling for potential confounders 
The only variables potentially confounding the association between screening positive 
and African-Caribbean ethnicity are age and self reported socioeconomic status (NS-
SEC). Age is most likely to be a negative confounder in this instance; controlling for it 
strengthening  the  association.  Conversely,  socioeconomic  status  is  likely  to  be  a 
positive confounder. Controlling for this would be expected to weaken the association. 
 
5.1.7.1 Controlling for Age 
When stratified by ten-year age bands, the association between screening status and 
ethnicity was strengthened and highly significant (pooled MH OR 3.53; 95%CI 1.68 to 
7.43; p=0.001), (table 5.13). 
 
5.1.7.2 Controlling for Socioeconomic status 
When  stratified  by  socioeconomic  status,  the  association  between  screening  status 
and ethnicity was weakened, and not significant (pooled OR 1.45; 95%CI 0.74 to 2.84; 
p=0.282), (table 5.14). 
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Table 5.13  Screening status by ethnic group, stratified by 10-year age bands 
 
ETHNIC GROUP (%) 
10 YEAR AGE BANDS  WHITE – UK 
AFRICAN-
CARIBBEAN  TOTAL (%) 
SCREEN 
NEGATIVE 
91 (100)  81 (93.1)  172 (96.6) 
SCREEN 
+/-  SCREEN 
POSITIVE 
0 (0)  6 (6.9)  6 (3.4) 
60-69 
TOTAL  91 (100)  87 (100)  178 (100) 
SCREEN 
NEGATIVE  64 (92.8)  91 (88.1)  155 (90.1) 
SCREEN 
+/-  SCREEN 
POSITIVE 
5 (7.2)  12 (11.7)  17 (9.9) 
70-79 
TOTAL  69 (100)  103 (100)  172 (100) 
SCREEN 
NEGATIVE  40 (83.3)  14 (53.8)  54 (73.0) 
SCREEN 
+/-  SCREEN 
POSITIVE  8 (16.7)  12 (46.2)  20 (27.0) 
80-89 
TOTAL  48 (100)  26 (100)  74 (100) 
SCREEN 
NEGATIVE 
4 (40.0)  0 (0)  4 (33.3) 
SCREEN 
+/-  SCREEN 
POSITIVE  6 (60.0)  2 (100)  8 (66.7) 
90-99 
TOTAL  10 (100)  2 (100)  12 (100) 
 
 
 
10 Year Age 
Bands 
Pearson’s Chi
2 
Value 
Significance (p)  Fisher’s Exact 
Test (p) * 
60-69  -  -  0.120 
70-79  0.900  0.343  - 
80-89  7.435  0.006  - 
90-99  -  -  0.515 
*Exact test score given when cells have values less than 5. 
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Table 5.14    Screening status by ethnic group, stratified by NS-SEC 
 
ETHNIC GROUP 
SOCIOECONOMIC STATUS 1-5  WHITE – UK 
(%) 
AFRICAN-
CARIBBEAN 
(%) 
TOTAL (%) 
SCREEN NEGATIVE  35 (97.2)  28 (100)  63 (98.4)  SCREEN 
+/-  SCREEN POSITIVE  1 (2.8)  0 (0)  1 (1.6)  1 
TOTAL  36 (100)  28 (100)  64 (100) 
SCREEN NEGATIVE  48 (98.0)  22 (100)  70 (98.6)  SCREEN 
+/-  SCREEN POSITIVE  1 (2.0)  0 (0)  1 (1.4)  2 
TOTAL  49 (100)  22 (100)  71 (100) 
SCREEN NEGATIVE  7 (87.5)  1 (50.0)  8 (80)  SCREEN 
+/-  SCREEN POSITIVE  1 (12.5)  1 (50.0)  2 (20)  3 
TOTAL  8 (100)  2 (100)  10 (100) 
SCREEN NEGATIVE  35 (97.2)  48 (90.6)  83 (93.3)  SCREEN 
+/-  SCREEN POSITIVE  1 (2.8)  5 (9.4)  6 (6.7)  4 
TOTAL  36 (100)  53 (100)  89 (100) 
SCREEN NEGATIVE  66 (83.5)  80 (79.2)  146 (81.1)  SCREEN 
+/-  SCREEN POSITIVE  13 (16.5)  21 (20.8)  34 (18.9)  5 
TOTAL  79 (100)  101 (100)  180 (100) 
 
 
 
NS-SEC  Pearson’s Chi
2 
Value  Significance (p)  Fisher’s Exact Test 
(p) * 
1  -  -  1.000 
2  -  -  1.000 
3  -  -  0.378 
4  -  -  0.395 
5  0.544  0.461  - 
*Exact test score given when cells have values less than 5.   137 
5.1.8  Multivariate analysis 
The association between screening status and ethnicity was investigated further, by 
controlling for both age and socioeconomic status (NS-SEC) simultaneously. Stepwise 
logistic regression modelling was used (table 5.15). In step 3, data was imputed for the 
22 participants on whom NS-SEC was missing. 
 
Table 5.15    Logistic regression model 
 
Variables not in the Equation 
  Score  df  Sig. 
Ethnicity  3.753  1  0.053 
Overall 
Statistics 
3.753  1  0.053 
 
Step 1 
 
95% CI 
    B  S.E.  Wald  df  Sig. 
Exp(B) 
  Lower  Upper 
Ethnicity  0.589  0.307  3.678  1  0.055  1.802  0.987  3.289 
Step 1 
Constant  -2.938  0.517  32.292  1  0.000  0.053  -  - 
 Variable entered on step 1: Ethnicity.           
 
Step 2 
 
95% CI 
    B  S.E.  Wald  df  Sig. 
Exp(B) 
  Lower  Upper 
Ethnicity  1.373  0.380  13.074  1  0.000  3.948  1.876  8.312 
Age  0.164  0.023  48.857  1  0.000  1.178  1.125  1.234  Step 2 
Constant  -1.66  2.195  57.737  1  0.000  0.000  -  - 
 Variable entered on step 2: Age.           
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Step 3 
 
95%CI 
    B  S.E.  Wald  df  Sig. 
Exp(B) 
3.558  Lower  Upper 
Ethnicity  1.269  0.394  10.362  1  0.001  3.558  1.643  7.705 
Age  0.166  0.025  44.245  1  0.000  1.181  1.125  1.241 
NSSEC   0.627  0.182  11.832  4  0.001  1.872  1.310  2.676 
Step 3
* 
Constant  -1.93  2.556  57.037  1  0.000  0.000  -  - 
Variable entered on step 3 : NS-SEC.           
 
 
On step one of the regression analysis, the relationship between screening status and 
ethnicity was not statistically significant. When controlled for by age, the association 
was strengthened and highly significant (step 2). Controlling for NS-SEC added little to 
the model (step 3).   139 
5.1.9  Stage 2 – Diagnostic Interview  
Of  the  participants  who  screened  positive  for  cognitive  impairment,  46/51  (90.2%) 
completed  enough  of  the  diagnostic  interview  for  us  to  make  a  diagnosis.  Of  the 
remaining  five,  three  refused  to  participate  further  (all  African-Caribbean)  and  two 
lacked sufficient information (one white-British, one African-Caribbean). 
 
In  total,  21/46  (45.7%)  completed  all  components  of  the  diagnostic  interview;  33 
(71.7%)  completed  the  informant  history/medical  questionnaire,  22  (47.8%)  the 
CAMCOG and 40 (87%) the physical examination. I obtained information from primary 
care  medical  notes  on  45  (97.8%), an d  physical  investigations/neuroimaging  on  35 
(76.1%). Although not all participants had completed all sections of the interview, we 
had enough information to diagnose dementia in 36 people (15 white-British and 21 
African-Caribbean)  and  mild  cognitive  impairment  (MCI)  in  a  further  five  (two  white-
British and three African-Caribbean). The remaining five participants did not meet the 
criteria for either diagnosis (one white-British and four African-Caribbean); and w ere 
‘false positives’ on the screening interview. 
 
5.1.9.1 Crude dementia prevalence 
The crude prevalence of dementia (excluding MCI), according to at least one set of 
diagnostic criteria was 15/218 (6.9%) in the white-British group and 21/218 (9.6%) in 
the African-Caribbean group. This weak association between dementia and ethnicity 
(OR 1.44; 95%CI 0.72 to 2.88) was not statistically significant (Chi
2=1.090, p=0.296). 
When participants with MCI were included, the prevalence increased to 17/218 (7.80%) 
in  the  white-British  group  and  24/218  (11.01%)  in  the  African-Caribbean  group 
(Chi
2=1.319,  p=0.251).  If  those  in  residential  care  homes  were  excluded,  the  crude 
prevalence  of  dementia  in  the  two  groups  (excluding  MCI)  was  10/200  (5.0%)  and 
16/205 (7.8%) respectively (Chi
2=1.326; p=0.250). 
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5.1.9.2 Dementia severity 
The  severity  of  dementia  was  most  frequently  ‘mild’,  followed  by  ‘moderate’  and 
‘severe’ respectively (table 5.16). The frequency of ‘mild’ and ‘moderate’ dementia was 
higher  in  the  White-British group and of ‘severe’ dementia in the African-Caribbean 
group. However, there was no statistically significant difference between the two ethnic 
groups in the distribution of dementia severity overall (Chi
2=0.630; p=0.730). 
 
Table 5.16  Dementia severity by ethnic group (any criteria) 
 
Dementia severity   Total  
Ethnic group 
Mild  Moderate  Severe   
White – British (%)  7 (46.7)  6 (40.0)  2 (13.3)  15 (100) 
African-Caribbean (%)  9 (42.9)  7 (33.3)  5 (23.8)  21 (100) 
Total (%)  16 (44.4)  13 (36.1)  7 (19.4)  36 (100) 
 
 
5.1.9.3 Dementia subtype 
Of  the  36  participants  that  were  diagnosed  with  dementia,  26/36  (72.2%)  met  the 
criteria for ICD-10 and 34/36 (94.4%) for DSM-IV TR diagnosis (see table 5.17). Six did 
not meet the criteria for any of the dementia subtypes and were classified as ‘dementia 
unspecified’.  A  further  six  met  the  criteria  for  more  than  one  subtype.  The  most 
common diagnosis was that of Alzheimer’s dementia, followed by vascular dementia 
and unspecified dementia. Only two participants were diagnosed with Frontotemporal 
dementia and one with possible Lewy Body dementia. These three participants were 
also  given  a  differential  diagnosis  of  Alzheimer’s  dementia.  A  marginally  higher 
proportion of White-British participants were diagnosed with Alzheimer’s dementia than 
African-Caribbean participants, who were significantly more likely to be diagnosed with 
vascular (or mixed vascular/Alzheimer’s) dementia (Chi
2=4.593; p=0.032).   141 
Table 5.17      Dementia subtype by ethnic group 
Ethnic group (%)* 
  Dementia 
Subtype  Specific Criteria 
White-
British 
African-
Caribbean  Combined 
ICD-10  10 (66.7)  16 (76.2)  26 (72.2) 
DSM-IV TR  15 (100.0)  19 (90.5)  34 (94.4)  Any dementia 
Either criteria  15 (100)  21 (100)  36 (100) 
         
ICD-10  6 (40.0)  8 (38.1)  14 (38.9) 
DSM-IV  10 (66.7)  10 (47.6)  20 (55.6) 
NINCDS-ADRDA:       
Possible  4 (26.7)  7 (33.3)  11 (30.6) 
Probable  7 (46.7)  7 (33.3)  14 (38.9) 
Alzheimer’s 
Dementia 
Any criteria  11 (73.3)  14 (66.7)  25 (69.4) 
         
ICD-10  0 (0)  1 (4.8)  1 (2.8) 
DSM-IV  0 (0)  3 (14.3)  3 (8.3) 
NINDS-AIREN:       
Possible  1 (6.7)  8 (38.1)  9 (25) 
Probable  0 (0)  0 (0)  (0) 
Vascular  
Dementia 
Any criteria  1 (6.7)  9 (42.9)  10 (27.8) 
         
DLB consensus:       
Possible  0 (0)  1 (4.8)  1 (2.8)  Lewy Body 
Dementia 
Probable  0 (0)  0 (0)  0 (0) 
  Any criteria  0 (0)  1 (4.8)  1 (2.8) 
         
Fronto- 
temporal 
Dementia 
Consensus criteria  0 (0)  2 (9.5)  2 (5.6) 
         
Unspecified 
Dementias 
 
  4 (26.7)  2 (9.5)  6 (16.7) 
* Percentage of all participants diagnosed with dementia in each ethnic group respectively.   142 
5.1.10  Covariates relating to dementia diagnosis 
 
5.1.10.1  Age 
The mean age of those with dementia was 82.3 years (S.D. 7.3) verses 71.9 years (SD 
8.9) in those without dementia; mean difference 10.4 years (95%CI 7.8 – 13.0) ; (t = 
7.976; p<0.001). The mean age of African-Caribbean participants with dementia (79.1 
years; SD 8.7) was significantly less than for white-British participants with dementia 
(86.9 years; SD 7.4); (t=2.839; p=0.008). 
 
5.1.10.2  Sex 
There was no difference in the likelihood of a dementia diagnosis according to sex; 
16/176 (9.1%) male participants were diagnosed with dementia compared to 20/260 
(7.7%) females (Chi
2=0.271; p=0.603). There was no difference in the sex distribution 
for participants with dementia between ethnic groups (Chi
2 = 2.520; p=0.112). 
 
5.1.10.3  Years of education 
Those  with dementia had less full time  education  (9 years; interquartile range  9-10 
years)  than  those  without  (10  years;  interquartile  range  9-11)  (Mann  Whitney  U= 
2690.0;  p=0.001).  There  was  no  difference  in  the  median  duration  of  education  for 
those with dementia between ethnic groups (Mann Whitney U= 74.0; p=0.852). 
 
5.1.10.4  Home ownership 
There  was no difference in the likelihood  of dementia diagnosis according to home 
ownership; 16/216 (7.4%) of home owners were diagnosed with dementia compared to 
16/205 (7.8%) of those not owning their own home (Chi
2=0.024; p=0.878). 
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5.1.10.5  Self assigned socioeconomic status (NS-SEC) 
Data for NS-SEC was available on 385/400 (96%) of participants without dementia but 
only  29/36  (81%)  of  those  with  dementia.  Of  the  latter  group,  27/29  (93.1%)  were 
assigned to NS-SEC groups 4 and 5, compared to 242/385 (62.9%) of those without 
dementia (table 5.18). Conversely, there was just one participant (3.4%) with dementia 
in  NS-SEC  groups  one  and  two  compared  to  134/385  (34.8%)  of  those  without 
dementia. This difference in distribution was highly significant (Chi
2=1.44; p=0.006). 
 
Table 5.18      Dementia status by NS-SEC 
 
Dementia Status 
NS-SEC 
Dementia (%)  No dementia (%) 
Total (%) 
1  1 (3.4)  63 (16.4)  64 (15.5) 
2  0 (0)  71 (18.4)  71 (17.1) 
3  1 (3.4)  9 (2.3)  10 (2.4) 
4  6 (20.7)  83 (21.6)  89 (21.5) 
5  21 (72.4)  159 (41.3)  180 (43.5) 
Total  29 (100)  385 (100)  414 (100) 
 
 
5.1.10.6  Blood Pressure 
A  higher  proportion  of  participants  diagnosed  with  dementia  reported  treated 
hypertension  than  those  without  dementia  (table  5.19),  but  the  difference  was  not 
significant (Chi
2=1.123; p=0.289).  Interestingly, proportionally more African-Caribbean 
participants  with  dementia  reported  treated  hypertension  than  their  White-British 
counterparts,  but  the  difference  between  the  ethnic  groups  was  not  statistically 
significant (p = 0.361). 
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Table 5.19    Dementia status by reported (treated) hypertension 
  Reported 
hypertension 
No reported 
hypertension 
Total 
Dementia (%)  25 (71.4)  10 (28.6)  35 (100) 
No dementia (%)  180 (62.3)  109 (37.7)  289 (100) 
Total (%)  205 (63.3)  119 (36.7)  324 (100) 
 
All  but  three  participants,  who  underwent  the  diagnostic  interview,  had  their  blood 
pressure measured. For those with dementia, the mean systolic value was 146 (SD 20; 
skewness 0.356) and the mean diastolic value was 79 (SD 14; skewness 0.038). There 
was no difference in the rates of measured hypertension between those with dementia 
and those without dementia (Chi2 = 0.001; p = 0.981), (table 5.20). 
 
Table 5.20      Dementia status by measured hypertension 
  Hypertension  No hypertension  Total 
Dementia (%) 
  22 (66.7)  11 (33.3)  33 (100) 
No Dementia 
(%) 
218 (66.5)  110 (33.5)  328 (100) 
Total (%) 
  240 (66.5)  121 (33.5)  361 (100) 
 
 
5.1.11  Controlling for potential confounders 
As for screening status, the only two variables plausibly confounding the association 
between dementia and ethnic group are age and socioeconomic status (NS-SEC). 
 
5.1.11.1  Controlling for Age 
When stratified by ten-year age bands, the association between dementia status and 
ethnic  group  was strengthened significantly (Pooled  MH OR  2.938; 95%CI 1.254 to 
6.882; p = 0.013), (table 5.21). 
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 Table 5.21  Dementia status by ethnic group, stratified by 10-year age bands 
 
ETHNIC GROUP 
10 YEAR AGE BANDS  WHITE – 
BRITISH (%) 
AFRICAN-
CARIBBEAN 
(%) 
TOTAL (%) 
DEMENTIA   0 (0)  3 (3.4)  3 (1.7)  DEMENTIA 
STATUS  NO DEMENTIA   91 (100)  84 (96.6)  175 (98.3) 
60-
69 
TOTAL  91 (100)  87 (100)  178 (100) 
DEMENTIA   3 (4.3)  8 (7.8)  11 (6.4)  DEMENTIA 
STATUS  NO DEMENTIA   66 (95.7)  95 (92.2)  161 (93.6) 
70-
79 
TOTAL (%)  69 (100)  103 (100)  172 (100) 
DEMENTIA   7 (14.6)  8 (30.8)  15 (20.3)  DEMENTIA 
STATUS  NO DEMENTIA   41 (85.4)  18 (69.2)  59 (79.7) 
80-
89 
TOTAL (%)  48 (100)  26 (100)  74 (100) 
DEMENTIA   5 (50.5)  2 (100)  7 (58.8)  DEMENTIA 
STATUS  NO DEMENTIA   5 (50.0)  0 (0)  5 (41.7) 
90-
99 
TOTAL   10 (100)  2 (100)  12 (100) 
 
10 Year Age 
Bands 
Pearson’s Chi2 
Value 
Significance (p) 
Fisher’s Exact Test  
(p)* 
60-69  -  -  0.115 
70-79  -  -  0.529 
80-89  2.734  0.098  - 
90-99  -  -  0.470 
*Exact test score given when cells have values less than 5. 
 
5.1.11.2  Controlling for Socioeconomic status (NS-SEC)  
When  stratified  by  socioeconomic  status ( N S -SEC  1-5),  the  association  between 
dementia status and ethnic group was weakened, and was not statistically significant 
(Pooled MH OR 1.00; 95% CI 0.46 to 2.20; p=0.998), (table 5.22). This analysis was 
however, only performed on the 414 participants on whom NS-SEC data was available 
(data was missing on 19% of those with dementia and 4% without dementia).   146 
Table 5.22   Diagnostic status by ethnic group, stratified by NS-SEC 
 
ETHNIC GROUP 
SOCIOECONOMIC STATUS 1-5 
WHITE - 
BRITISH 
AFRICAN-
CARIBBEAN  TOTAL 
DEMENTIA (%)  1 (2.8)  0 (0)  1 (1.6)  DEMENTIA 
STATUS  NO DEMENTIA (%)  35 (97.2)  28 (100)  63 (98.4)  1 
TOTAL (%)  36 (100)  28 (100)  64 (100) 
DEMENTIA (%)  0 (0)  0 (0)  0 (0)  DEMENTIA 
STATUS  NO DEMENTIA (%)  49 (100)  22 (100)  71 (100)  2 
TOTAL (%)  49 (100)  22 (100)  71 (100) 
DEMENTIA (%)  1 (12.5)  0 (0)  1 (10)  DEMENTIA 
STATUS  NO DEMENTIA (%)  7 (87.5)  2 (100)  9 (90)  3 
TOTAL (%)  8  2  10 
DEMENTIA (%)  1 (2.8)  5 (9.4)  6 (6.7)  DEMENTIA 
STATUS  NO DEMENTIA (%)  35 (97.2)  48 (90.6)  83 (93.3)  4 
TOTAL (%)  36 (100)  53 (100)  89 (100) 
DEMENTIA (%)  10 (12.7)  11 (10.9)  21 (11.7)  DEMENTIA 
STATUS  NO DEMENTIA (%)  69 (87.3)  90 (89.1)  159 (88.3)  5 
TOTAL (%)  79 (100)  101 (100)  180 (100) 
 
 
NS-SEC 
Pearson’s Chi2 
Value 
Significance (p) 
Fisher’s Exact Test 
(p)* 
1  0.790  0.374  1.000 
2  -  -  - 
3  0.278  0.598  1.000 
4  1.511  0.219  0.395 
5  0.134  0.714  0.816 
*Exact test score given when cells have values less than 5. 
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5.1.12  Multivariate analysis 
The  logistic  regression  analysis  included  all  436  participants  and  demonstrated  a 
strong association between dementia and African-Caribbean ethnicity, when controlled 
for age (table 5.23 – step 2). Data on NS-SEC was imputed for the 22 participants for 
whom  this  was  missing.  When  adjusted  for  both  age  and  NS-SEC,  the  association 
between dementia and ethnicity was weaker but remained statistically significant (table 
5.23 – step 3). 
 
Table 5.23    Logistic regression model  
 
Variables not in the Equation 
  Score  df  Sig. (p) 
Ethnicity  1.090  1  0.296 
 
 
 
Step 1 
95.0% C.I.for 
EXP(B)    B  S.E.  Wald  df  Sig. (p)  Exp(B) 
Lower  Upper 
Ethnicity  0.366  0.353  1.081  1  0.299  1.443  0.723  2.879 
Constant  -2.972  0.582  26.044  1  0.000  0.051     
Variables entered on step 1: 
Ethnicity. 
         
 
 
Step 2 
95.0% C.I.for EXP(B)    B  S.E.  Wald  df  Sig. (p)  Exp(B) 
Lower  Upper 
Ethnicity  1.217  0.435  7.851  1  0.005  3.379  1.442  7.918 
Age  0.178  0.027  42.318  1  0.000  1.195  1.132  1.261 
Constant  -1.802  2.582  48.735  1  0.000  0.000  -  - 
Variables entered on step 2: Age.   
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Step 3 
95.0% C.I.for EXP(B)    B  S.E.  Wald  df  Sig. (p)  Exp(B) 
Lower  Upper 
Ethnicity  1.120  0.444  6.361  1  0.012  3.066  1.284  7.322 
Age  0.179  0.029  39.096  1  0.000  1.196  1.131  1.265 
NS-SEC  0.491  0.195  6.372  1  0.012  1.634  1.116  2.393 
Constant  -1.991  2.881  47.953  1  0.000  0.000  -  - 
Variables entered on step 3:  
NS-SEC   
 
 
5.2  MEDICAL NOTES SURVEY 
 
The primary care medical notes were examined for participants who screened positive 
for cognitive impairment. Of those that we diagnosed with dementia, 15/36 (41.7%) had 
a formal diagnosis of dementia and a further 5/36 (13.9%) had cognitive impairment (or 
similar) recorded in their notes (table 5.24). Only 13/36 (36.1%) had been referred for 
specialist dementia assessment; ten to local old age psychiatric services and three to a 
neurologist  (Dementia  Research  Centre,  Institute  of  Neurology,  Queen’s S q u a r e ). 
There was mention of pharmacological treatment with a cholinesterase inhibitor in five 
participants (13.9%); one white-British, four African-Caribbean.  
 
Although more African-Caribbean (52.4%) than white-British participants (26.7%) had a 
formal  diagnosis  of  dementia  documented  in  the  notes,  this  was  not  significantly 
different (Fisher’s Exact Test; p=0.176). Nor was there a significant difference if the 
less specific records of ‘memory problem’ or ‘cognitive impairment’ were included in the 
analysis (Chi
2=0.823; p=0.364).  
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For all participants with dementia (recognised and unrecognised), marginally more of 
the  white-British  group  (40%)  had  been  referred  on  to  specialist  services  for 
assessment  than  the  African-Caribbean  group  (33.3%),  but  the  difference  was  not 
significant (Chi
2= 0.169; p=0.681). This analysis was repeated for the 20 participants 
for whom cognitive impairment or dementia was recorded in the notes. Although 6/7 
(85.7%) of white-British participants had been referred compared to only 7/13 (53.8%) 
of  African-Caribbean  participants,  the  difference  was  not  significant  (Fisher’s  Exact 
Test; p=0.329). 
 
 
Table 5.24  Record of dementia diagnosis & referral, by ethnic group 
 
Documentation  White-British (%)  African-Caribbean (%)  Total (%) 
* Screening 
instrument used 
 
6 (40.0)  7 (33.3)  13 (36.1) 
       
** Cognitive 
impairment 
 
3 (20.0)  2 (9.5)  5 (13.9) 
*** Dementia 
 
4 (26.7)  11 (52.4)  15 (41.7) 
Sub-total with 
recorded diagnosis 
 
7 (46.7)  13 (61.9)  20 (55.6) 
       
Referral for 
assessment 
 
6 (40.0)  7(33.3)  13 (36.1) 
Anti-dementia drug 
prescribed 
 
1 (6.7)  4 (19.0)  5 (13.9) 
       
Total  15 (100)  21 (100)  36 (100) 
 
*    Screening instrument score recorded e.g. MMSE, AMT 
**  Memory problem/Cognitive impairment recorded (not dementia). 
*** Formal diagnosis of dementia recorded.  
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6. DISCUSSION 
 
This is the first epidemiologically representative cross-sectional study set in the UK, 
powered with the primary aim of measuring and comparing the prevalence of dementia 
between a sample of older African-Caribbean and white-British people. It is therefore 
the largest study of dementia in the older, British African-Caribbean population. It is 
also  the  first  prevalence  study  to  have  employed  a  culturally  sensitive  screening 
instrument for cognitive impairment in the African-Caribbean group. Recruitment to the 
study  was  successful  in  that  the  anticipated  sample  size  was  reached,  and  the 
response rate achieved was comparable to similar studies. The findings supported the 
primary  hypothesis  that  the  prevalence  of  dementia  is  higher  in  older  African-
Caribbean  than  white-British  people.  Before  discussing  this  in  detail,  I  have 
summarised the other main results as follows: 
 
 
Demographics 
•  The mean age of African-Caribbean participants was significantly lower than that 
for white-British participants and the age structure of the populations differed.  
•  There was no difference in sex ratio between ethnic groups. 
•  There was no significant difference in duration of education between ethnic groups. 
•  Significantly  more  African-Caribbean  participants  fell  into  lower  socioeconomic 
groups as defined by their previous occupation (NS-SEC), although a significantly 
higher proportion were home-owners. 
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Screening phase 
•  More  African-Caribbean  than  white-British  participants  screened  positive  for 
cognitive impairment (14.7% vs. 8.7%) and this was significant when controlled for 
age and socioeconomic status. 
•  Both  ethnic  groups  performed  better  on  their  respective,  culturally  appropriate 
versions of the Mini Mental State Examination (MMSE). 
•  African-Caribbean participants had significantly more hypertension than the white 
reference group (both treated and untreated). 
•   A  history  of  hypertension  was  associated  with  screening  positive  for  cognitive 
impairment. 
•  Two  thirds  of  participants  were  hypertensive  as  measured  at  the  screening 
interview, but this proportion was not significantly different between the two groups. 
 
Diagnostic phase 
•  Thirty six participants met at least one set of diagnostic criteria for dementia and 
another five met our criteria for mild cognitive impairment (MCI). 
•  When adjusted for age and socioeconomic status, the prevalence of dementia was 
significantly higher in the African-Caribbean than the white-British group (9.6% vs. 
6.9%).  
•  African-Caribbean participants with dementia were significantly younger than white-
British participants with dementia (mean difference 7.8 years). 
•  A diagnosis of dementia was associated with increasing age, lower socioeconomic 
status and fewer years of education. 
•  The  most  frequently  diagnosed  dementia  subtype  was  Alzheimer’s  disease, 
followed by Vascular dementia, unspecified dementia, Dementia with Lewy Bodies 
and Frontotemporal dementia, according to at least one set of diagnostic criteria. 
•  Marginally more white-British participants were diagnosed with Alzheimer’s disease 
and  significantly  more  African-Caribbean  participants  with  vascular  dementia, 
according to at least one set of diagnostic criteria.   152 
 
Medical notes survey 
•  Of all the participants diagnosed with dementia, 42% had dementia and a further 
14% had cognitive impairment recorded in their electronic primary care records. 
•  26.7% of white-British and 52.4% of African-Caribbean participants with dementia, 
had  this  documented  in  their  medical  notes,  although  the  difference  was  not 
significant. 
•  Fewer African-Caribbean (54%) than white-British participants (86%) with cognitive 
impairment or dementia, recognised/documented by their General Practitioner had 
been referred for specialist assessment, although the difference was not significant.   153 
6.1. CROSS-SECTIONAL SURVEY FINDINGS 
 
6.1.1.  Demographics 
Fifty  six  percent  of  the  African-Caribbean  participants  came  from  Jamaica  and  the 
remainder from other Caribbean islands or Guyana. This figure is close to the 2001 
census  estimate  of  61%  for  Haringey’s  Caribbean-born  residents  born  in  Jamaica, 
(www.haringey.gov.uk) and is one indicator that my sample may be representative of 
the target population (section 6.5.2). All of the African-Caribbean people I identified had 
migrated to Britain directly from the Caribbean rather than elsewhere, and none was 
born in the UK. This was expected, and suggests that there are few, if any second 
generation African-Caribbean people aged above 60 year living in the borough.  
 
Compared to those born in Britain, African-Caribbean participants were on average two 
years younger, with relatively few people aged over 80 years. This finding is consistent 
with previous studies (Livingston et al., 2001, McCracken et al., 1997, Richards et al., 
2000) and on their pattern of migration; based on the mean duration in Britain (study 
participants) being 46 years and assuming that  most were in their twenties or thirties 
when they arrived. This age difference had a significant effect on the prevalence of 
dementia, and its role as a confounder is discussed later (section 6.5.6.3). The fact that 
more African-Caribbean participants were married or cohabiting and that nearly twice 
the number of white-British participants were widowed might also be partly explained 
by the latter group being older.  
 
Worth noting is that there was no difference in sex distribution between the two ethnic 
groups. Sixty percent of all participants were female, compared to 56% of over 60 year 
olds in  Haringey at the 2001 census (http://www.statistics.gov.uk/census). T h i s m a y 
also indicate that my sample reasonably matches the target population. 
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No potential participants were excluded on the basis of language, as all spoke English 
fluently. Importantly, there was no difference in the number of years spent in full-time 
education  between  ethnic  groups  (median  value  10  years)  and  the  duration  was 
strikingly similar to that found in the Islington study (Livingston et al., 2001). Language 
and  education  are  therefore  unlikely  to  have  influenced  performance  on  cognitive 
testing differentially between groups.  
 
The significance of socioeconomic status in this instance was far less clear than for 
age,  and  I  obtained  conflicting  results  from  my  two  measures.  Whereas  African-
Caribbean participants were nearly 50% more likely to own their own homes than white 
participants, the majority fell into the lowest socioeconomic groups according to current 
or  previous  occupation.  Socioeconomic  status a c c o r d i n g  t o  o c c u p a t i o n  ( N S -SEC), 
although not a risk factor for dementia per se, might be considered to be  a ‘proxy’ for 
other covariates such as educational level, general health, smoking or diet. However, 
this  may  be  less  meaningful  for  many  African-Caribbean  people,  who  migrated  to 
Britain  to  fill  relatively  unskilled  jobs  for  their  level  of  education  and  social  status 
(section 1.4.2). The role of NS-SEC as a potential confounder is discussed further in 
section 6.5.6.3. 
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6.1.2.  Screening for cognitive impairment  
African-Caribbean participants performed significantly less well on both versions of the 
MMSE than their white-British peers in terms of the median score.  They did however 
score significantly better on the culturally sensitive ‘African-Caribbean’ version, whilst 
white-British  participants  did  marginally  better  on  the  ‘Standard’  version.  This  is 
consistent  with  the  notion  that  the  African-Caribbean  version  is  ‘culturally  specific’ 
rather than just being easier, or less educationally biased. This finding supports one of 
the  secondary  aims  of  my  study,  in  that  it  provides  more  evidence  for  use  of  the 
African-Caribbean  version  of  the  MMSE  as  a  valid  screening  instrument  in  this 
population as opposed to the standard version and may be useful in routine clinical 
practice. 
 
Using  the  same  cut-off  of  <26  as  the  definition  of  screening  positive  for  cognitive 
impairment,  considerably  more  African-Caribbean  than  white  participants  screened 
positive as measured by either version of the MMSE. Strikingly, had I only screened 
with  the  standard  version,  over  28%  of  African-Caribbean  participants  would  have 
failed  the  test  (versus  ~15%  on  the  A-C  version).  This  may  have  included  a  high 
proportion of false positives, although I cannot be sure with the available data. Even 
so, on their respective culturally appropriate versions, the difference in the proportions 
screening positive between the two ethnic groups, approached statistical significance. 
When  this  association  was  controlled  for  by  potential  confounders  (age  and 
socioeconomic  class)  using  logistic  regression  modelling,  the  association  was 
strengthened  considerably  and  became  statistically  significant.  This  provides  strong 
evidence that there is  a higher prevalence of cognitive impairment in older  African-
Caribbean than white-British people.  
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For all participants combined, those that screened positive were significantly older, had 
fewer  years  of  education  and  fell  into  a  lower  NS-SEC  category  than  those  who 
screened  negative.  They  were  also  more  likely  to  report  a  history  of  hypertension. 
These  findings  are  in  keeping  with  current  knowledge,  in  that  increasing  age,  less 
education and a history of hypertension are known risk factors for cognitive impairment 
and subsequent dementia (section 1.2.2). The significance of NS-SEC is less clear as 
discussed  earlier  (section  6.1.1), a n d  I  h a v e  i n t e r p r e t e d  i t s  r o l e  a s  a  p o t e n t i a l  
confounder  with  caution.  Interestingly,  hypertension  as  measured  at  the  screening 
interview was not associated with cognitive impairment. This may be due to the fact 
that blood pressure falls with the onset of dementia (section 1.1.2.1).  
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6.1.3.  Screening for hypertension 
According to the measurements taken at the screening interview, approximately two 
thirds  of  all  participants  were  considered  to  be  hypertensive  using  the  definition 
recommended  by  the  British  Hypertension  Society  (section  4.4.10.2). N o  s i g n i f i c a n t  
difference  was  found  between  the  two  ethnic  groups  in  this  respect,  despite  the 
literature  indicating  a  higher  frequency  of  hypertension  in  African-Caribbean  people 
(section  1.4). T h i s  e x c e s s  o f  m e a s u r e d  h y p e r t e n s i o n  m a y  r e p r e s e n t  u n r e c o g n i s e d  
hypertension, inadequate treatment, poor adherence to antihypertensive medication or 
‘white coat hypertension’ as the research interview may be anxiety provoking. Another 
possible explanation for this finding is observer or measurement bias (section 6.5.7.2). 
Significantly higher proportions of African-Caribbean than white participants reported a 
known  history o f  h y p e r t e n s i o n .  T h i s  c o u l d  e x p l a i n  w h y  n o  d i f f e r e n c e  i n  t h e  r a t e  o f  
measured hypertension between ethnic groups was found, in that proportionally more 
African-Caribbean people were receiving antihypertensive treatment than in the white-
British sample. 
 
The  mismatch  between  reported a n d  measured h y p e r t e n s i o n  s h o u l d  b e  i n t e r p r e t e d  
with caution, as data on both was only available on 317 (73%) participants. However, 
in  those  for  whom  we  have  both  items o f  d a t a ,  t w o  t h i r d s  o r  m o r e  o f  p a r t i c i p a n t s  
reporting a history of hypertension were not receiving adequate treatment for this. This 
was not significantly different between ethnic groups.  There was also a further one 
third  of  participants  who  were  hypertensive  at  the  screening  interview  and  reported 
taking  no  treatment  for  this.  These  were  potentially  undiagnosed  hypertensives, 
although it is likely that a proportion were diagnosed but had denied, forgotten or never 
understood their diagnosis or treatment. Notably, significantly more African-Caribbean 
than white-British participants fell into this category. I therefore conclude that in this 
study,  it  is  probable  that  African-Caribbean  participants  had  a  higher  rate  of 
hypertension overall, both diagnosed (treated) and undiagnosed.   158 
6.1.4.  Diagnostic phase 
Of  the  51  participants  who  screened  positive,  36  were  diagnosed  with  dementia 
according to at least one set of criteria. Another five had objective evidence of cognitive 
impairment but no known functional impairment and were categorised as having MCI.  
These  were  excluded  from  the  main  analysis.    Although  the  crude  (unadjusted) 
prevalence estimates for dementia were higher in the African-Caribbean than the white 
group,  the  difference  was  not  significant.  There  was n o  s i g n i f i c a n t  c h a n g e  t o  t h e  
significance ‘p’ value if participants with MCI were included in the analysis. 
 
A dementia diagnosis was strongly associated with increasing age and less so with 
shorter duration  of education. African-Caribbean participants with dementia were on 
average  nearly  eight  years  younger  than  white-British  participants  with  dementia, 
although there was no information regarding the age of onset, or duration of illness.  
There was no sex difference in dementia diagnosis overall or between ethnic groups 
and these findings are what we would have expected according to current literature 
(section  1.1). There w as also a relatively strong relationship between dementia and 
NS-SEC distribution and as previously discussed, socioeconomic status was probably 
a proxy for other risks factors such as education and other health variables. Unlike 
cognitive impairment however, there was no significant association between dementia 
and reported (or measured) hypertension, although the trend remained. This may not 
have  reached significance  due to a lack of statistical power  at the diagnostic stage 
(section 6.5.3). 
 
As predicted, controlling for the most plausible (negative) confounder, age, significantly 
strengthened  the  association  between  African-Caribbean  ethnicity  and  dementia 
diagnosis  and  this  reached  statistical  significance.  Strikingly,  the  final  logistic 
regression model predicted a 1.2 times increase in the prevalence of dementia for each 
year  increase  in  age  above  60.  This  is  equivalent  to  approximately  double  the 
prevalence  every  five  years  and  is  in  keeping  with  the  literature  (section  1.2.3.2).   159 
Despite the unclear role as a second but weaker (positive) confounder, NS-SEC was 
included in the logistic regression analysis. Its inclusion  had little effect on the final 
model  and  the  strength  of  the  primary  association  was  strong,  with  an  odds  ratio 
approximating three (95% CI 1.3 - 7.3). I therefore concluded that there is evidence 
supporting my primary hypothesis. 
 
Proportionally more participants from both groups met the less stringent DSM-IV than 
the ICD-10 criteria for dementia. This was because unlike DSM-IV, ICD-10 requires 
both  a  minimum  period  for  symptoms  (six  months)  and  a  reliable  informant  history 
(section 1.2.1). One of the limitations of the study was that a detailed informant history 
was  not  available  for  15  (31%)  of  participants  and  it  was  not  possible  to  specify  a 
subtype in six participants, who were classified as ‘dementia unspecified’. For those 
who were given a subtype diagnosis, the numbers were small and I have interpreted 
my  analysis  with  caution.  As  expected  the  majority,  approximately  69%  of  all 
participants were diagnosed with Alzheimer’s Disease according to at least one set of 
criteria.  This  is  close  to  the  recent  ‘Dementia  UK  Report’  estimate  of  62%  (Knapp, 
2007),  although  it  did  vary  considerably  depending  on  the  criteria  used;  39%  of  all 
participants met the ICD-10 criteria, 56% DSM-IV criteria and nearly 70% the NINCDS-
ADRDA  criteria  (possible  or  probable).  Marginally  more  white-British  (73%)  than 
African-Caribbean  (67%)  participants  met  these  diagnostic  criteria.  The  overall 
prevalence of vascular (or mixed) dementia in the sample (28%) was also very close to 
the ‘Dementia UK Report’ estimate of 27%.  Remarkably, nine of the ten participants 
diagnosed with vascular dementia were African-Caribbean and seven of them had a 
history of hypertension. This may indicate that the excess of dementia in the African-
Caribbean  group  is  vascular  in  origin  and  may  be  associated  with  a  history  of 
hypertension.  However, the numbers were very small and none met the criteria for a 
Probable d i a g n o s i s  a c c o r d i n g  t o  N I N D S -AIREN  criteria.  There  was  also  a  trend  for 
proportionally more African-Caribbean than white participants to fall within the severe 
category, although this was not statistically significant.   160 
6.2. MEDICAL NOTES SURVEY 
 
The proportion of participants with dementia who had a clear diagnosis recorded in the 
electronic  primary  care  records  (42%)  was  marginally  higher  than  that  given  in  the 
National Dementia Strategy (approximately one third) (DoH, 2009). This suggests that 
the general practices sampled, were at least as likely to record a diagnosis of dementia 
as the national average. Paradoxically, when compared to the white-British group, the 
rate  of  documented  dementia  was  higher i n  A f r i c a n -Caribbean  participants  (52% 
versus 27%), whereas the rate of referral to specialist dementia services was lower 
(33% versus 40%). The difference in referral rate between groups was greater, if only 
participants with a recorded dementia or cognitive impairment were included. In this 
analysis, six of the seven (86%) white-British participants compared to only seven of 
the  thirteen  (54%)  African-Caribbean  participants  with  recognised  cognitive 
impairment/dementia had been referred for assessment. However, these findings were 
not statistically different, possibly due to the small numbers at this stage. 
 
I  therefore  conclude  from  this  study,  that  dementia  recognition  in  primary  care  is 
equitable for the African-Caribbean older population. This is an unexpected finding and 
does  not  support  my  secondary  hypothesis  that  African-Caribbean  people  are  less 
likely  than  white-British  people  to  have  their  dementia  formally  recognised  and 
documented in primary care. This could be due to changing attitudes towards dementia 
and/or  the  mental  health  of  BME  people,  as  both  have  had  a  high  media  profile 
recently. Alternatively, it could be that African-Caribbean people present to GPs at the 
more  severe  stages  of  dementia  and  that  this  is  more  easily  recognised.  Another 
possible explanation is that the sample of general practices selected was biased, in 
that they had a particular interest in this subject and therefore agreed to participate. 
These, and other possible sources of error are discussed further in section 6.5.6.2.  
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The lower rates of referral for African-Caribbean participants, although not statistically 
significant, do provide some evidence towards my secondary hypothesis, that the rate 
of referral to specialist dementia services is lower for African-Caribbean than white-
British people. The reasons for this are not clear from this study and warrant further 
investigation using qualitative methods (section 6.7). 
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6.3. COMPARISON OF FINDINGS WITH OTHER STUDIES 
 
My primary findings are in line with the existing literature. For example, my estimate for 
dementia  prevalence  in  white-British  participants  over  60  years  of  6.9%  is  only 
marginally  higher  than  the  Delphi  consensus  study  estimate  for  Western  Europe  of 
5.4% (Ferri et al., 2005). Assuming that the prevalence of dementia doubles for every 
five year increase in age, this is also similar to the Islington study estimate of 10% in 
UK-born participants over 65 years, which like my study included people in residential 
care homes (Livingston et al., 2001).  
 
With regard to African-Caribbean people, my estimate of 9.6% in participants over 60 
years, corresponded closely to the Islington study estimate of 17.3% in those over 65. 
Although their sample is not strictly comparable to mine, in that it was a mixed group of 
black African and Caribbean people, the majority (>60%) were of African-Caribbean 
origin. The findings are less similar to the other cross-sectional studies identified in my 
systematic  review  (Chapter  2) i n  t h a t  m y  e s t i m a t e  o f  d e m e n t i a  p r e v a l e n c e  w a s  
considerably higher than the Liverpool study (8%) (McCracken et al., 1997), and lower 
than the South London pilot study (34%) (Richards et al., 2000), both in participants 
over  65  years.  The  Islington  study  however,  had  the  highest  validity  score  of  the 
studies identified and theirs was the most plausible estimate. I conclude therefore, that 
the evidence for an excess of dementia in older African-Caribbean people in Britain is 
strong,  and  that  the  prevalence  is  likely  to  be  at  least  50%  higher  than  in  the 
indigenous white population. 
 
It is difficult to draw any firm conclusions or make comparisons with regard to dementia 
subtype, given the small numbers in my study. However, my findings are not dissimilar 
to Steven’s secondary analysis of the Islington study (Stevens et al., 2002), in that we 
both  found  what  appeared  to  be  a  significant  excess  of  vascular  dementia  in  the 
African-Caribbean participants and that they had very high rates of hypertension.   163 
6.4. CLINICAL IMPLICATIONS 
 
The evidence for a higher prevalence of dementia in the African-Caribbean population 
is now fairly robust and in keeping with my primary hypothesis.  Although weaker, there 
is some evidence from this study to support part of  my secondary  hypothesis.  The 
clinical implications from these findings are as follows:  
 
i)  In  general  terms,  clinicians  should  readily  consider  dementia,  but  have  a  high 
threshold  of  suspicion  when  diagnosing  it  in  older  African-Caribbean  patients  who 
present with memory problems or related symptoms.  
 
ii) Clinicians should be aware that dementia may occur at younger age groups (<65 
years) more commonly in African-Caribbean than white people. As this falls below the 
normal  cut-off  for  old  age  services,  all  mental  health  professionals  should  consider 
dementia as a differential diagnosis and when appropriate refer to a specialist team for 
further assessment. It also supports the move towards ‘needs based’ rather than age 
determined health and social services.  
 
iii) When screening for dementia or assessing cognitive performance, culturally specific 
tools should be used when available. My findings suggest using the African-Caribbean 
MMSE in this population (Rait et al., 2000). It suggests that the use or development of 
acceptable, valid and reliable tests for the screening and diagnosis of dementia in other 
BME groups would be desirable. 
 
iv)  Both  primary  and  secondary  prevention  are  especially  relevant  for  African-
Caribbean people in terms of vascular risk factors. Timely and effective treatment of 
hypertension  is  very  important  and  would  be  expected  to  bring  down  the  rates  of 
dementia. This is in keeping with current government policy, and effective management 
of hypertension is one of the Quality and Outcomes Framework (QOF) indicators for   164 
GPs. This system financially rewards GPs for good clinic care, which in this instance, 
includes keeping a register of patients with established hypertension, having a record 
of their blood pressure taken within the previous nine months and maintaining this at 
under 150/90 mmHg. 
 
v) Rates of diagnosed dementia and referral to specialist dementia services are known 
to be low in all ethnic groups. This finding was replicated in this study, although not 
significantly w o r s e  i n  A f r i c a n -Caribbean  than  white  participants.  Primary  care 
physicians  may  still  benefit  from  educational  interventions  aimed  at  improving  the 
detection  of  dementia  and  should  be  encouraged  to  refer  patients  to  specialist 
dementia services for assessment, regardless of ethnicity.    165 
6.5. METHODOLOGICAL CONSIDERATIONS & LIMITATIONS 
 
6.5.1.  Design 
Cross-sectional studies have a number of limitations, such that they are often used 
primarily  to  generate  hypotheses  for  other,  more  robust  studies  (Hennekens  and 
Buring,  1987).  They  are  however  useful  for  assessing  the  health  care  needs  of  a 
population and are convenient to perform. Since exposure (risk factor) and outcome 
(disease) are  measured at the same time, it  is  not  usually  possible to determine a 
temporal relationship between the two. However, this is not the case for risk factors 
that  are  fixed,  such  as  sex  or  ethnicity,  where  reverse  causality i s  n o t  a  p l a u s i b l e  
source of error (i.e. dementia cannot precede ethnicity). I therefore conclude that the 
cross-sectional design was appropriate for this study.  There are however limitations, 
the main one being that I had little or no information regarding the onset of dementia 
and  the  course  of  the  illness.    As  prevalence  is  a  function  of  the  incidence  of  a 
condition and its duration, I can not be absolutely sure whether the higher prevalence 
of dementia in African-Caribbean people is due to a higher incidence, or whether they 
live longer with the disorder. However, the latter explanation seems unlikely, given that 
the mean age of black people with dementia in this sample was significantly lower than 
in white participants. The cross-sectional design also limited the ability to investigate 
any  temporal  relationship  between  hypertension  and  dementia  and  it  is  possible, 
although unlikely that dementia preceded the onset of hypertension and likely that the 
picture was muddied by changes in blood pressure with the onset of dementia. 
 
The two stage (screening/diagnostic) design was efficient in that only participants who 
screened positive went on to the full diagnostic interview. It did however result in the 
loss of a small number  of participants  who failed to complete the second phase.  A 
more significant limitation was that a number of participants with early dementia may 
have been missed, falsely screening negative at the first phase (section 6.5.5.).    
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6.5.2.  Target population and study sample 
The target population was well defined and included all community dwelling residents 
of Haringey over the age of 60 years (4.4.3.1). It could be argued that people in the 
sampling frame i.e.  General  Practice lists,  were different in some  way to the target 
population. This is unlikely, given 98% of the population are registered with a general 
practice and that African-Caribbean people are equally likely to be registered as the 
general  population  (4.4.4).  I m p o r t a n t l y ,  b o t h  s t u d y  a n d  r e f e r e n c e  g r o u p s  w e r e  
sampled from the same target population, at the same time. 
 
I would expect the study sample to be representative of the target population, in that all 
African-Caribbean patients from each practice were invited to participate in the study. 
However, it is likely that a proportion will have been missed due to misclassification of 
ethnicity on electronic general practice lists and in practices where identification was 
performed  manually.  The  reference  sample  was  subject  to  the  same  problems  of 
identification  as  the  study  sample,  in  addition  to  those  of  randomisation.  However, 
although the latter was achieved by a relatively unsophisticated technique (4.4.5), it 
was unlikely to have introduced an additional source of error. Another limitation with 
regard to sampling,  was the necessity to  exclude potential participants  who  had no 
working telephone number. This may have excluded a number of people in the poorest 
socioeconomic  strata  and  possibly  those  with  poorest  health.  In  practise  these 
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6.5.3.  Sample size 
The  estimated  sample  size  was  recruited  from  the  anticipated  number  of  general 
practices  and  a  statistically  significant  outcome  detected  with  regard  to  the  primary 
hypothesis. However, it could be argued that the study was underpowered, in that the 
numbers  of  participants  reaching  the  diagnostic  stage  were  very  small,  making  it 
insufficiently powered to adequately examine the relationships between ethnic groups 
and dementia subtype or risk factors. This was not however the original intention and 
the  numbers  needed  to  investigate  dementia  subtypes  would  have  been  at  least 
double. This approach was therefore pragmatic given the time and resources and it 
would not have been possible to have screened significantly more participants. 
 
 
6.5.4.  Response/participation rate 
One  of  the  main  limitations  of  this  study  was  the  modest  participation  rate, 
approximating  64%  of  those  who  were  contacted.  If  people  with  working  phone 
numbers who were not contactable were included, the response was  lower at 57%. 
This falls short of the criterion for a minimum threshold of 70% in studies which have 
shown  responders  to  be  similar  to  non-responders  in  terms  of  socio-demographic 
characteristics  (Boyle,  1998).  When  compared  to  similar  prevalence  studies,  the 
participation rate was lower than that achieved in Islington Study (85%) (Livingston et 
al., 2001) and the Liverpool study (83%) (McCracken et al., 1997) but higher than that 
in the South London study (56%) (Richards et al., 2000). All three of these studies 
recruited participants directly from the community through door knocking and it may be 
that  it  is  generally  easier  to  recruit  people  ‘face  to  face’  than  on  the  telephone. 
Interestingly  in  their  study,  Steward  et  al.  similarly  identified  African-Caribbean 
participants from primary care lists and obtained a very similar participation rate to my 
study (62%) (Stewart et al., 2001b). Chaturvedi et al. also used a similar method and 
only achieved 58% (Chaturvedi et al., 1993). I therefore conclude that my response 
rate although low, is comparable to other similar studies.   168 
6.5.5.  Screening and diagnostic tools 
One of the main strengths of this study was that I used a culturally valid instrument for 
the screening phase. The advantages of such tools are well documented and it has 
been shown that BME people tend to be misclassified as cognitively impaired on the 
standard  MMSE  (section  4.4.10.1).  Rait  et.  al.  demonstrated  that  their  African-
Caribbean version was valid for use in this population with high sensitivity (83%) and 
specificity (78%) at a cut-off of <26 (Rait et al., 2000). We used the same cut-off for 
both versions of the MMSE, one point higher than that routinely used clinically, and 
found  that  this  maximised  sensitivity  whilst  keeping  the  false  positive  rate  to  an 
acceptable level (9.8%). Although no participants screening negative were given the 
full  diagnostic  interview  (to  assess  for  false  negatives),  the  majority  with  dementia 
scored well below the cut-off. Only three of the 36 were borderline, scoring 25/30. I 
therefore  conclude  that  very  few  people  with  dementia  will  have  be  missed  at  the 
screening stage of the study. 
 
One limitation of the study regarding the screening instrument was that I had combined 
the two versions of the MMSE into one, extended tool. This was necessary, as it was 
not feasible to administer both versions consecutively, given that many questions were 
identical. Although this was designed to maintain the time interval for delayed recall, it 
is possible that the performance of each test was altered in some way. The combined 
test  took  longer  than  the  usual  MMSE,  and  I  observed  that  participants  were  tiring 
towards the end of the test, sometimes performing less well on the final questions. Due 
to  the  order  of  the  questions,  this  may  have  biased  the  scores  towards  a  better 
performance  on  the  standard  version,  although  this  was  not  borne  out  in  the  final 
results.  Worth  noting  is  that  all  researchers  were  given  training  and  observed 
administering  the  screening  test.  Inter-rater  reliability  for  scoring  was  also  checked 
between each researcher and myself, and found to be 100%. 
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Another  commonly  cited  disadvantage  of  using  the  MMSE  is  that  it  is  particularly 
insensitive in those with very high levels of education (section 4.4.10.1),  giving rise to 
a high proportion of false screen negatives. However, our sample of participants was 
found  to  be  homogenous  in  relation  to  education,  with  relatively  low  levels  in  both 
ethnic groups as measured by duration in full-time study (median 10 years). 
 
With regard to the diagnostic interview, it could again be argued that the CAMDEX-R 
interview was modified from the original, and had not been validated, either in white-
British  or  African-Caribbean  people.  However,  as  justified  in  section  4.4.11 i t  w a s  
simply used to develop a structured proforma with the purpose of gathering information 
systematically. Similarly, the CAMCOG neuropsychological assessment has not to my 
knowledge, been validated in African-Caribbean people and is likely to be culturally or 
educationally biased (section 6.5.6.2). Therefore, rather than generating a meaningful 
score, specific subsections were used where necessary to assist with the diagnosis of 
dementia in accordance with operationalised criteria (section 1.2). Another strength of 
this study is that these diagnoses were made by independent assessors. They were 
experienced psychiatrists who did not know the ethnicity of the participants, in order to 
reduce observer bias (section 6.5.6.2). 
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6.5.6.  Epidemiological sources of error. 
 
6.5.6.1.  Chance 
Chance findings (random or type I error) are inherent to any epidemiological study and 
can be reduced but not eliminated. In keeping with convention, I set the statistical level 
of significance, alpha at 0.05 (p<0.05), indicating that the chance of falsely rejecting the 
null hypothesis is 5% (1 in 20). However, the probability of a chance finding increases 
with the number of variables being investigated. It can be argued that when multiple 
statistical tests are being performed, as in my univariate analyses, the likelihood of one 
or more chance findings are high. This is sometimes overcome by setting the level of 
significance, alpha  at 0.01 (1 in 100). I did not do this as the hypothesis being tested 
was a  pre-determined primary hypothesis. The rest of the univariate analyses were 
performed to identify which socio-demographic variables to include in the multivariate 
analysis, of which only two were performed. It is unlikely that the erroneous inclusion of 
a variable in the multivariate analysis due to a ‘chance finding’ would  have altered the 
model  significantly.  In  my  final  logistic  regression,  the  primary  association  under 
investigation (ethnicity and dementia diagnosis) was statistically significant at a level of 
p=0.012. This can be interpreted as a small likelihood of it being a chance finding at 1 
in 83. 
 
6.5.6.2.  Biases 
Bias can be defined as “any systematic error in an epidemiological study that results in 
an  incorrect  estimate  of  the  association  between  exposure  and  risk  of  disease” 
(Hennekens  and  Buring,  1987).  It  can  broadly  be  divided  into  selection  bias, 
information bias and confounding, which is discussed separately (6.5.6.3). 
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Selection  bias c a n  b e  p r o b l e m a t i c  i n  c r o s s -sectional  surveys,  especially  when  the 
response rate is low (section 6.5.4).  It occurs when those who participate, differ in 
some way from those who do not, and that this systematically alters the prevalence of 
the outcome of interest. In this study for example, it could be that people who were not 
contactable were more likely to be working, and hence less likely to be suffering with 
dementia. Alternatively they may have been less likely to answer the phone or respond 
to letters because they had dementia. Either scenario would have biased my estimate 
of dementia, the former increasing the apparent prevalence and the latter reducing it. 
Clearly this introduces an additional source of error into an analytical study, if the bias 
is stronger in one group than the other.  
 
Selection bias can be minimised by maximising response, and assessed by comparing 
basic socio-demographic variables between responders and non-responders, or failing 
that, the target population (section 6.5.4.). Non response can be viewed separately, in 
terms of people who were not contactable and in terms of those who were, but who 
declined  to  participate.  Regarding  the  former,  approximately  10%  of  potential 
participants  with  a  working telephone number  did not answer or  reply to  messages 
after several attempts. As those who were not contactable were on average younger 
and more likely to be male, it is plausible that many were still employed, especially 
those in the 60-65 year age group. On this basis, it is possible that I may have slightly 
overestimated t h e  p r e v a l e n c e  o f  dementia  in  my  target  population.  Importantly, 
although marginally less African-Caribbean than white-British people were contactable, 
the  difference  in  their  mean  age  compared  to  contactable  people  was  less  than  in 
whites and there was no significant difference in sex distribution. I therefore conclude 
that  the  likelihood  of  selection  bias  on  this  basis  was  low.  Notably,  people  who 
participated,  were  very  similar  to  those  who  declined  in  terms  of  age  and  sex  and 
ethnicity. Therefore, this was not likely to be a source of bias. 
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More problematic, was with the recruitment of General Practices to the study. Rather 
than being a random selection, they were for pragmatic reasons self selecting as very 
few  GPs  agreed  to  participate  and  none  could  be  excluded.  It  is  therefore  highly 
probable, that the sample of practices was biased, in that they were more likely to have 
had an interest in research, dementia, BME or older people. The implication, is that 
clinicians  from  the  selected  practices  may  have  been  more  likely  to  recognise  and 
diagnose dementia than from other practices in the borough. It is also plausible that 
their  patients  receive  better  or  different  treatment  than  the  average  provided  in 
Haringey e.g. better treatment for hypertension. 
 
Several types of information biases h a v e  b ee n  d e s c r ib ed ,  b u t   t h e y  c an  b e  br oa d l y 
divided  into  differential a n d  non-differential t y p e s .  I n  t h i s  s t u d y ,  n o n -differential 
information bias would simply refer to the random misclassification of participants in 
terms  of  outcome  i.e.  cognitive  impairment  or  dementia.  It  can  be  due  to  random 
measurement or recall error and by definition would be distributed equally between the 
two  study  groups,  diluting  any  observed  association.  Differential  information  bias 
results in the systematic misclassification of participants, depending on the group they 
are in (study or reference). It can either increase or reduce any observed association, 
depending on the circumstances. The most common types are recall bias, observer 
(interviewer) bias and in this case, cultural test bias.  Recall bias is unlikely to be a 
source of error in this study as exposure (ethnic group) is not subject to recall and 
outcome  (dementia)  was  measured  using  standardised  instruments.  Observer  bias 
however, was a potential limitation in that it was not possible to blind  the interviewers 
to  ethnicity.  The  result  of  this  can  be  the  systematic  misclassification  of  outcome 
between groups. In this study, it may have occurred during the screening interviews; in 
the way that the MMSE was administered, interpreted and scored. This was kept to a 
minimum, with the use of  the standardised MMSE which includes guidance on how to 
score each answer and on the training of interviewers. The diagnostic stage was less 
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criteria  and  by  two  raters,  blind  to  ethnic  group.  Cultural  test  bias,  refers  to  the 
propensity  of  a  screening  or  diagnostic  tool  to  perform  differently  in  one  cultural  or 
ethnic group from another. In this case, the standard MMSE is known to overestimate 
the  prevalence  of  cognitive  impairment  in  BME  groups,  especially  those  for  whom 
English is a second language (section 4.4.10.1). This was highlighted by the very poor 
performance of the African-Caribbean participants on the standard MMSE in this study. 
Cultural test bias was minimised by the use of the culturally specific African-Caribbean 
version. However, the two tests may still differ slightly in performance and an element 
of differential misclassification cannot be excluded. 
 
 
6.5.6.3.  Confounders 
A confounding variable (confounder) is one that is independently associated both with 
the  exposure  and  outcome  of  interest  and  can  either  lead  to  an  overestimate  or 
underestimate  of the true association. By convention, positive confounders increase 
the apparent effect whilst negative confounders reduce or reverse it. It is possible to 
take likely confounders into account when designing a study and they can be adjusted 
(controlled) for  at the  analysis stage.  This can  be  done  using classical stratification 
techniques  for  individual  confounders  or  logistic  regression  modelling  to  control  for 
several confounders simultaneously (Results - Chapter 5). T ypically, these variables 
include socio-demographic and health factors that are likely to be associated with the 
exposure and outcome of interest. In this study a  number  of plausible confounders 
were  measured  including  age,  sex,  duration  of  education  and  two  measures  of 
socioeconomic  status;  home  ownership  and  NS-SEC  (by  occupation).  Notably, 
hypertension,  either  measured  or  reported  was  not  considered  to  be  a  potential 
confounder  as  it  likely  to  be  on  the  causal  pathway a n d  s h o u l d  n o t  t h e r e f o r e  b e  
controlled for during the analysis stage. 
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Of the potential confounders  measured, age had by far the strongest  effect. It was 
closely  associated  with  both  ethnic  group  and  dementia  diagnosis,  reducing  the 
observed difference in dementia prevalence between the younger African-Caribbean 
and  white-British  samples  (results  and  section  6.1.4). S o c i o e c o n o m i c  status a s  
measured  by  NS-SEC  was  a  weaker  but  positive  confounder,  although  its  role, 
especially in the African-Caribbean sample is not clear and should be interpreted with 
caution (section 6.1.1). Interestingly, duration of education, although associated with 
dementia diagnosis as expected, was not associated with ethnicity and therefore not a 
source of confounding in this study. It is possible that there were other, unmeasured 
factors that may have confounded the primary association to some degree in either 
direction, although it is unlikely that the overall effect would have been significant.  
 
6.5.7.  Other limitations 
6.5.7.1.  Physical dementia screen 
It was  beyond the  means  of this study, to request further physical investigations to 
assist the assessors with their diagnosis. However, such investigations are routinely 
performed during normal clinical practice and would as a minimum include a ‘dementia 
blood screen’ and neuroimaging in the form of a CT (computerised tomography), MRI 
(magnetic  resonance  imaging)  or  SPECT  (Single  photon  emission  computed 
tomography)  brain  scan.  The  purpose  of  these  tests  are  to  exclude  other  general 
medical conditions or intra-cranial pathology that may account for cognitive impairment. 
Neuroimaging  is  also  helpful  to  distinguish  between  dementia  subtypes,  especially 
when a diagnosis of Vascular Dementia is suspected. Where available in the medical 
notes, such information was included for the diagnostic assessors, but in most cases 
the  relevant  investigations  were  incomplete  or  absent.  This  especially  limited  their 
ability to distinguish between Alzheimer’s Disease and Vascular Dementia, making it 
impossible  to  make  a  diagnosis  of  the  latter  with  any  certainty,  according  to 
operationalised diagnostic criteria. 
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6.5.7.2.  Measurement of hypertension 
Other than for participants who screened positive, blood pressure was only measured 
on  one  day,  although  repeated  up  to  three  times  during  the  screening  interview. 
Diagnostically  this  is  notoriously  unreliable,  and  if  hypertension  were  suspected 
clinically, measurements would be repeated several days or weeks apart. It was also 
not  always  possible  to  measure  blood  pressure  under  ideal  conditions  as 
recommended by the British Hypertension Society (http://www.bhsoc.org) or the Blood 
pressure  association  (www.bpassoc.org.uk). R e c o m m e n d a t i o n s  i n c l u d e  f o r  e x a m p l e  
waiting at least 30 minutes after drinking tea or coffee, smoking a cigarette, physical 
exertion and to take the measurement on an empty bladder. None of these conditions 
could  be  guaranteed  during  the  screening  interview  although  a  blood  pressure 
measurement  was  repeated  at  the  end,  up  to  30  minutes  after  the  initial  reading. 
Automated  blood  pressure  monitors  had  been  purchased  new  for  the  study,  and 
neither the research assistants nor I, had previous experience of using one. Although 
the manufacturer’s claimed accuracy was +/- 3mmHg, poor measurement technique 
may have been a source  of error. Also, an additional large cuff was  purchased for 
obese participants, but only some months into the study, and it was not available for all 
participants. Using the wrong cuff size is known to generate inaccurate blood pressure 
readings. These measurement errors are likely to have been the same for both study 
groups and as such, were a potential source of non-differential bias, (section 6.5.6.2) 
leading to an attenuation of any true difference in hypertension between them.  
 
For  many  participants  it  was  not  possible  to  establish  a  clear  history  regarding  the 
duration  of  their  hypertension  or  treatment.  I  was  also  unable  to  corroborate  the 
information, except in those that screened positive, whose medical records I checked. 
The frequency of reported hypertension  may therefore represent an under-estimate, 
with participants being more likely to under than over report hypertension. It was also 
not possible to draw any conclusions regarding the temporal relationship between a 
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6.5.7.3.  Residential care homes 
Another significant problem that I encountered, was in relation to participants living in 
residential  care  homes.  Although  they  were  selected  in  the  same  way  as  other 
participants,  they  were  usually  not  seen  until  after  all  the  other  people  from  each 
general practice list.  This was a pragmatic approach, as these visits were difficult to 
arrange and it was easier to see people from the same residential home together. An 
unforeseen complication was that a number had died or were in hospital by the time I 
asked to visit them. Another problem was that of obtaining informed consent and an 
informant  history  for  people  in  residential  care.  This  resulted  in  a  relatively  small 
number being interviewed (~3.5% of the total participants). 
 
As  a  significant  proportion  of  people  at  the  later  stages  of  dementia  move  into 
residential care, and the majority of people living in residential care have dementia, 
recruiting the correct number from each ethnic group was important in order to exclude 
selection bias. The possibility that people from one group may be more likely to move 
into residential care than the other, or that they may move into different homes, maybe 
out of the borough, introduced additional and unknown sources of error. However, the 
final  numbers  recruited  from  residential  care  homes  were  small  and  of  these,  the 
numbers from each group with dementia were approximately equal. Also, I found that 
although  excluding  these  participants  from  my  analysis  reduced  the  combined 
prevalence  of  dementia,  the  relative  difference  between  the  two  groups  remained 
unchanged  (section  5.1.9.1).  I  concluded  that  any  potential  selection  bias  in  this 
respect would have been minimal, although I may therefore have underestimated the 
true prevalence of dementia overall. 
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6.5.7.4.  Missing data 
Missing data was a limitation for this study both at the screening and diagnostic stages.  
 
Quantitative data:  
Completeness for demographic data varied from 100% for age, sex and ethnicity, and 
#95%  for  marital  status,  home  ownership  and  NS-SEC  to  only  85%  for  years  of 
education. Blood pressure was only measured in 83% of participants whilst only 74% 
knew their existing hypertension status. Missing data was less problematic for analysis 
at the screening stage than the diagnostic stage of the study where the numbers were 
small (only 36 in the dementia group). In addition to this, was the complication that data 
was more likely to be missing for participants with dementia than those without. In the 
final logistic regression analysis for example, NS-SEC data was missing for 19% of 
participants with dementia compared to only 4% without. This was mainly due to the 
former  being  unable  to  recall  the  information.  Data  on  age  and  ethnicity  was  not 
problematic as it was 100% complete. I therefore decided to impute data for NS-SEC 
using  SPSS  software  rather t h a n  e x c l u d e  p a r t i c i p a n t s  f r o m  t h e  a n a l y s i s .  A s  t h e  
inclusion of NS-SEC had little effect on the final model, I concluded that this did not 
adversely influence my final findings. 
 
Qualitative data:  
This  was  a  significant  limitation  at  the  diagnostic  stage  of  the  study  as  only  46% 
completed all parts of the interview. It was often difficult to obtain a clear history from 
participants  and  informants  were  not  always  available.  A  significant  proportion  of 
participants  refused  to  complete  part,  or  all  of  the  CAMCOG  based  cognitive 
assessment. Where possible, additional information was gathered from other sources, 
such  as  primary-care  records,  sheltered  housing  scheme  managers  and  residential 
home staff. In practice, it was not necessary for participants to have completed all parts 
of the diagnostic interview for the assessors to be able to make a diagnosis according 
to  operationalised  criteria.  There  were  a  number  of  participants  where  a  dementia   178 
diagnosis  was  likely  but  the  history  incomplete,  and  it  was  unclear  whether  the 
cognitive  deficit  impacted  on  their  level  of  functioning.  In  these  situations,  the 
assessors  were conservative  and categorised the participants as  having   MCI. It is 
therefore probable that I under, rather than over estimated the prevalence of dementia. 
It is unlikely that this varied between the two ethnic groups as the assessors were blind 
to ethnicity (see biases – 6.5.6.2). 
 
 
6.5.7.5.  Primary care records 
General practices have been using electronic patient records for several years and the 
majority that participated in the study had EMIS$ software installed. Although I did not 
receive any formal training, the windows based interface is fairly intuitive and I was 
easily able to access data including demographics, consultation records, diagnoses, 
medication, investigation results and referrals. This allowed me to gather data to assist 
with diagnosis and to conduct the medical records survey. The main limitation of this 
approach was that detailed electronic records were only available for a maximum of 
five  to  ten  years.  This  was  not  problematic  for  the  majority  of  participants,  as  this 
usually predated the onset of cognitive impairment or dementia. However, electronic 
data was often missing in patients who had changed general practices, and particularly 
for those who had recently moved into residential care. Their previous medical records 
were  not  readily  accessible,  and  details  pertaining  to  their  dementia  diagnosis  and 
referrals for specialist assessment were often unavailable. In some cases, a diagnosis 
of ‘senile dementia’ was recorded with no other details. It is therefore possible that I 
underestimated the rate of referral to specialist dementia services for participants in 
residential care. However, this source of error should be equal in both ethnic groups 
and even if all has been referred it would only have changed the rate to 73.0% in the 
white-British group and 52.3% in the African-Caribbean group (Chi
2=1.616; p=0.204).   179 
6.6. Alternative study designs 
 
Given limitations imposed  by time and resources, m y chosen study design was the 
most appropriate, and it answered my primary research question. It is also the largest 
study of its type with regard to the size of the  African-Caribbean  sample.  However, 
although  the  results  generated  indicative  data  towards  my  secondary  aims,  the 
evidence  here  was  weak  and  questions  remain  unanswered.  The  study  was  not 
sufficiently  powered to  adequately investigate the distribution  of dementia subtypes, 
and  the  cross-sectional  design  precluded  any  further  investigation  of  the  temporal 
relationship between putative risk factors and dementia in this sample.  
 
A larger prevalence study would address the issue of statistical power. This could be 
achieved  simply  by  recruiting  from  additional  general  practices.  However,  given  the 
relatively poor recruitment rate from primary care, alternative sampling methods could 
be used, such as door knocking or participants selected from other community lists. 
However,  in  order  to  further  investigate  risk  factors  for  dementia,  and  to  calculate 
dementia incidence, a longitudinal approach is required (section  6.5.1). Longitudinal 
(cohort) studies can be conducted prospectively or retrospectively. To be informative, 
the  former  would  require  high  rates  of  follow  up  over  a  substantial  period  of  time; 
possibly decades in the case of hypertension. Although a retrospective cohort study 
would be quicker and cheaper to conduct, it is subject to recall bias and missing data 
regarding the exposure/risk factor of interest.  
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6.7. FURTHER WORK 
As discussed (section 6.6), further high quality longitudinal studies would be desirable, 
both  to  estimate  the  incidence  of  dementia  and  to  further  investigate  putative  risk 
factors.  Such  studies  should  consider  the  subtypes  of  dementia,  as  well  as  the 
association with education levels, current hypertension or a history of hypertension and 
adequate treatment. This may provide more evidence as to the potential of controlling 
hypertension to prevent Alzheimer’s disease or Vascular Dementia.  
 
Although African-Caribbean participants were at least as likely as white participants to 
have their dementia or cognitive impairment documented in primary care notes, the 
trend w a s  f o r  a  l o w e r  r a t e  o f  r e f e r r a l  t o  s p e c i a l i s t  d e m e n t i a  s e r v i c e s  i n  t h i s  g r o u p .  
Another planned area of investigation is a qualitative analysis, investigating possible 
reasons  for  under-referral  to,  or  low  take-up  of  specialist  dementia  services  in  the 
African-Caribbean population. The plan is to recruit a purposively selected sample of 
10-15 African-Caribbean participants with dementia from both primary and secondary 
care. It is anticipated that some will have a formal diagnosis and be known to local 
dementia services and some will not. The former group will be recruited from the local 
memory  treatment  clinic  and  the  remainder  from  existing  cross-sectional  study 
participants. Participants will be interviewed with their family or carers. The extent of 
their access to services will be assessed by recording the help seeking pathways of 
each participant using in-depth, semi-structured interviews. This will include all formal 
and  informal  helping  networks  and  agencies  contacted  en  route  to  care  (primary, 
secondary, voluntary and statutory sector services). The time between first symptoms 
and first contact, type of first contact, number of contacts with each agency, perception 
of usefulness and outcome of each contact will be recorded. Data will also be collected 
on i) social networks ii) other health and social service use and iii) explanatory models 
of  dementia.  These  interviews  will  last  approximately  90  minutes,  will  be  audio-
recorded and later transcribed for analysis.   181 
7. CONCLUSIONS 
My study found the prevalence of cognitive impairment and dementia (all types) to be 
significantly  higher  in  African-Caribbean  than  white-British  older  people,  after 
controlling  for  age  and  socioeconomic  status.  This  is  in  keeping  with  my  primary 
hypothesis and provides more conclusive evidence than that available from previous 
UK  studies.  African-Caribbean  people  with  dementia  were  on  average  eight  years 
younger than white participants, indicating that they are likely to develop the condition 
earlier, and more frequently at ages below the normal cut-off for ‘old age’ psychiatric 
teams. This has implications for dementia services as they are currently structured and 
supports the move towards ‘needs based’ rather than ‘age determined’ services. There 
was also evidence that African-Caribbean people have a significantly higher proportion 
of vascular, or mixed vascular/Alzheimer’s dementia than white people. However, as 
numbers at the diagnostic stage were small and participants only met the diagnostic 
criteria for possible rather than probable vascular dementia, the data in this respect 
was less robust. 
 
I found relatively high rates of inadequately treated and untreated hypertension in the 
study  participants  overall.  Notably,  African-Caribbean  participants  had  significantly 
more hypertension than white participants (both treated and untreated) and a history of 
hypertension was found to be associated with cognitive impairment (but not dementia). 
Strikingly,  seven  of  the  nine  African-Caribbean  people  diagnosed  with  possible 
vascular dementia reported a history of hypertension. Although not conclusive, these 
findings are consistent with the published literature and I hypothesise that the high rate 
of  hypertension  may  contribute  to  an  excess  of  cognitive  impairment  and  dementia 
found  in  this  group.  This  provides  additional  evidence  supporting  the  benefits  of 
effective hypertensive treatment for reducing dementia, especially in African-Caribbean 
people.   182 
Another  important  finding  from  this  study  was  that  African-Caribbean  participants 
performed significantly better on the culturally adapted ‘African-Caribbean’ version of 
the MMSE, whilst white-British participants scored more highly on the standard version. 
As existing screening tools have a tendency to over-estimate cognitive impairment in 
BME people, it supports the use of this tool as a valid screening instrument in this 
population and its use in routine clinical practice as well as research. 
 
Findings from the medical notes survey were less conclusive and only partly supported 
my secondary hypotheses. Paradoxically, I found a marginally higher rate of diagnosed 
dementia  recorded  for  the  African-Caribbean  group b u t  a  h i g h e r  r a t e  o f  r e f e r r a l  t o  
specialist dementia services recorded for the white-British group. Neither finding was 
significantly different, although numbers were small. This unexpected finding indicates 
that African-Caribbean people are at least as likely to have their dementia recognised 
in primary care but may be less likely to be referred to secondary care. This warrants 
further  investigation,  either  through  a  larger  quantitative  survey,  or  using  qualitative 
methods.  
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